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This thesis focuses on the development of antimicrobial coatings through the use 
of aerosol assisted chemical vapour deposition (AACVD). The spread of 
nosocomial infections in healthcare settings can be attributed to contact between 
healthcare personnel and infected patients. Consequently, it can be proposed that 
the utilisation of antimicrobial surfaces may cause a decrease in hospital 
microbial contamination as well as enhancing infection-control.  
Aerosol assisted chemical vapour deposition (AACVD) is used as the main 
deposition technique. It involves the formation of an aerosol through the 
dissolution of a precursor in a solvent and depends on solubility rather than the 
volatility of the precursors. A major advantage for AACVD is the ability to be an 
industrially scalable process and to deposit on a wide range of substrates 
including the commonly used materials on touch surfaces in hospitals such as 
stainless steel. This is an approach that offers a fast and easy route to the 
deposition of nanocomposite thin films.  
Recently, much research has been invested into the preparation of these thin 
films, particularly for applications in antimicrobial coatings on surfaces. 
Moreover, it has been noted that the doping of metal oxide thin films with natural 
antimicrobial species can increase the antibacterial effectiveness. 
During the course of this research project, the development of nanocomposite 
films based on copper, copper oxide, gallium oxide and zinc oxide was explored, 
with the aim of forming robust stable films with antimicrobial efficacy.  The 
effectiveness of the antimicrobial films was investigated under lighting conditions 
found in hospital environments using serial dilution and viable colony counts. All 
experiments were carried out in duplicate and the number of survivors were 
determined by visible counting. Due to the high antimicrobial activity exhibited 
for copper, incorporating copper into metal oxides (gallium oxide and zinc oxide) 
were investigated in order to produce transparent films that will increased 
bactericidal activity.  
Abstract 
 
iv 
The investigation examined the precursor delivery, effect of substrate 
temperature, solvent and additives on the CVD reactions. All of the films that were 
prepared were characterised using a number of techniques such as SEM/EDX, 
XRD, UV/Visible spectroscopy, XPS and XAS.  
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Introduction 
 
The following is an introductory chapter to the thesis. This will provide the reader 
with background into the aim of this investigation and the contribution of touch 
surfaces to the spread of infections in a hospital environments as well as the impact 
of multi-drug resistant bacteria.     
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2 
1.1 Nosocomial Infections 
 
There is a great interest in the epidemiology of Hospital Acquired Infections (HAI), 
which has become a major problem for hospitals and healthcare institutions 
worldwide. HAI are also known as nosocomial infections that are described as 
infections acquired during hospital care, which were not present at the time of 
admission. Infections that occur 48 hours after being discharged (up to 4 weeks) 
are also included.1,2 
Nosocomial infections can also be considered endemic or epidemic, where 
endemic infections are more frequent. Epidemic infections are described as the 
unusual increase of specific infections and usually occur during an outbreak.1 
Many different variables facilitate the spread of nosocomial infections including 
patient care practise and the hospital environment. 
Statistics have shown that 1 in 10 patients who are admitted to a UK hospital 
contract a HAI, which accounts for 300, 000 cases a year and costs the NHS 
approximately £1 billion annually.3 Similar figures are also seen in the United 
States where nosocomial infections were reported as one of the top ten leading 
causes of death. An estimated that 2 million infections contributes to 100, 000 
deaths annually.4 The Centers for Disease Control and Prevention (CDC) has 
estimated that 1 in 20 hospitalised patients contract nosocomial infections costing 
US hospitals over $30 billion.5  
The rise of HAI has become a progressively more important issue globally due to 
the increase in mortality rates, medical costs and length of stay. The World Health 
Organization (WHO) carried out a survey that involved 55 countries and indicated 
that approximately 8.7% of patients contract an HAI meaning that over 1.4 million 
people in the world suffer from these infections.6,7  
HAI are on the rise and cause major complication for hospitals due to the 
infections associated with increasing invasive surgeries and medical devices. 
Nosocomial infections also present a heavy financial and resource burden for 
hospitals and healthcare institutions, resulting in prolonged hospital duration, 
patient discomfort, and in some cases death.    
 
3 
There is a large distribution of the different types of nosocomial infection sites. 
The most common nosocomial infections sites are: 
 Surgical site infections – described as any kind of discharge or abscess at the 
surgical site within a month after the operation. During the process of wound 
dressing, cross contamination can occur by either contaminated hands or 
instruments. Infection rates can range between 0.5 – 15% depending on the 
type of surgery.8 
 Urinary tract infections (UTI) – occurs due to the cross contamination of 
microbes. This is the most common type of infection accounting for 40% of 
HAIs. Approximately 80% of UTIs are associated with catheters. Infections are 
usually identified with urine culture being taken, with or without symptoms 
showing.9–11 
 Respiratory pneumonia – commonly occurs to patients in the intensive care 
unit (ICU) with a rate of 3% per day. Patients placed on ventilation are prone 
to infection due to cross contamination when handling and maintaining the 
ventilator instruments and associated devices.4,12,13  
 Bloodstream infections – the second most common type of infection causing 
the failure of the immune system. It has been reported that 35% of mortalities 
associated with nosocomial infections are attributed to bloodstream 
infections. These also increase hospital duration to 24 days that leads to an 
economic loss of approximately $40, 000 per patient.14–16 
 
There are two major causes of nosocomial infections: 
 Long term, irrational and irresponsible use of antimicrobial agents leading 
to the development of resistant bacterial strains. 
 The quality and maintenance of sterile conditions in the hospital.   
 
 
 
 
 
4 
1.1.1 Types of HAI bacteria 
 
There are many different types of nosocomial infecting bacteria that someone can 
contract at a hospital. The CDC described S. aureus and E. coli as two of the most 
common bacteria that cause HAI and these are the two types of microorganisms 
that are used in this investigation. 
 Staphylococcus aureus (S. aureus) 
S. aureus is a gram positive bacterium that appears under a microscope as 
spherical organisms grouped together and is commonly found in the anterior 
nostrils of around one-third of the population.17,18 It can also have the ability to 
spread to other areas causing infections in wounds and the bloodstream 
(septicaemia), which could cause disseminated diseases.19 
In the 1950s, antibiotic Methicillin was developed and was effective against S. 
aureus however by the 1960s, S. aureus strains were seen to be resistant to 
methicillin.20 Methicillin resistant staphylococcus aureus (MRSA) is resistant to the 
β-Lactam group found in antibiotics that greatly reduces the antibiotics available 
for treatment.21,22 MRSA is found to be commonly transmitted between patients 
and healthcare workers. This can lead to spread of infections via contaminated 
hands that can spread and colonise on the floor, bedframe, and lockers. 
 Escherichia coli (E. coli) 
E. coli is a gram negative bacterium that appears rod shaped under a microscope. 
It is one of the most commonly studied microorganisms in microbiology. E. coli is 
one of the leading causes of bloodstream infections in the USA. E. coli accounts for 
approximately 22% of mortality rate for HAIs and can frequently be found in the 
gastrointestinal tract of humans and many animals.23,24  
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1.2 Antibiotics 
 
Antibiotics are a substance that kills or inhibits the growth of microorganisms and 
have been described as a ‘miracle drug’ that revolutionised the medical field. The 
first antibiotic, Penicillin was discovered accidently in the late 1920s.25,26 As time 
went on, an increase in knowledge saw new antibiotics develop at a fast rate. The 
next big discovery was Streptomycin in 194327 and with improvement in hospital 
hygiene it was thought to be the end of infectious diseases as the mortality rates 
decreased. Alexander Fleming predicted in his Nobel lecture in 1945 that the 
misuse of antibiotics will lead to antibiotic resistance. However, at that moment, 
the rate of antibiotic development was faster than bacterial resistance.28,29 
The rate of antibiotic resistance bacteria has become untreatable and 
uncontrollable. There is also a lack of antibiotics development with the majority 
of antibiotics discovered decades ago and the last antibiotics developed were in 
1987. This is creating worrying situation which could potentially see a return to 
the pre-antibiotic era.30–32 
The rise of multi-drug resistance (MDR) bacteria strains, such as MRSA and the 
reliance on antibiotics has led to the survival and maintenance of MDR and is seen 
as an integral part of the nosocomial infection problem. 
The emergence and rise in bacterial drug-resistance and lack of development in 
novel antimicrobial agents, threatens the effectiveness of medical treatments. 
This is a global problem that requires actions to be taken across all governments 
and societies.33 
MDR strains of bacteria occur due to the natural evolutionary concepts. This 
phenomenon occurs when microorganisms duplicate erroneously or possess 
resistant genes that can be exchanged consequently, allowing these resistant 
microorganisms to grow and replicate, transferring their resistant genes to a 
larger population resulting in an increase in MDR bacteria strains.34,35  
A new report released at the end of 2014, looking at the future of antimicrobial 
resistance predicted what would happen between now and 2050 if nothing is 
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done. It predicts a bleak future resulting in over 100 million premature deaths 
globally by 2050. One of the reasons the report stated was the massive 
underinvestment into antibiotic research.36,37 
 
1.3 Spread of Infection 
 
Surfaces surrounding patients are frequently saturated with bacterial 
microorganisms. A commonly touched item can act as significant reservoirs of 
microbes. Semmelweis in 1846 described the importance of clean hands in the 
prevention of infections. He noticed a higher mortality rate of women when 
physicians delivered their children when compared to deliveries carried out by 
midwives. The difference was observed to be due to the physicians studying 
autopsies before attending to patients and not washing their hands, which 
allowed the transfer of infection to the women in labour. Semmelweis proposed 
that all examiners should clean their hands with carboxylic acid before treating 
patients. This reduced the childhood mortality rate from 11.4 to 1.8% in 2 years. 
Frequently touched surfaces in the hospital environment are referred to as ‘hand-
touch surfaces’ such as bed-frames, door handles, toilet seats, bedside tables, and 
toilet rails. 38–41 
In 2004, the NHS National Patient Safety Agency launched a nationwide the 
‘cleanyourhands’ campaign in order to improve hand hygiene to reduce the 
incidences of HAIs. The aim of the campaign was to educate, prompt, and enable 
healthcare workers to clean their hands at the right time, while treating patients 
with the use of soap and water or alcohol hand rub.42,43 It is recommended by the 
WHO that healthcare workers should decontaminate their hands before and after 
treating a patient, after any exposure to bodily fluids, and before any aseptic 
procedures (Fig. 1-1).44,45  
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The process of cleaning reduces the microbial loads and any nutrients that 
microorganisms can feed on to grow. The cleaning can assist in the breakdown of 
the cycle of infection transmission in the healthcare institution. Statistics have 
shown that regular cleaning of hospital surfaces with detergent can reduce 
transmission of nosocomial infections by 40% but out sourcing of contracts and 
budget limitations has caused some decrease in cleaning frequency.46,47 
The management of healthcare related waste is an important part of maintaining 
the hospital hygiene and controlling infections. Like surfaces, hospital waste can 
be considered a reservoir of infectious bacterial organisms. If this waste is 
inadequately disposed of, it can contribute to the spread of infections. The main 
sources of infections are healthcare workers, the patients, and the hospital 
environment.48,49   
 
Figure 1-1: Diagram illustrating the 5 moments where infections can be 
contracted. 
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The healthcare environment can be contaminated with pathogens that can cause 
an outbreak without proper cleaning procedures. Hospital workers can be 
colonised or infected and can become a symptomless carrier. This can lead to 
infecting patients and contaminating other hospital environments. The source 
that contributes most to hospital epidemics is infected patients. Colonised 
patients contaminate their surrounding environment, which can lead to 
contamination of other patients and healthcare workers.50–52 Fig. 1-2 shows the 
flow diagram of how infections can spread.    
Organised and frequent cleaning can efficiently remove bacterial contamination 
from hospital surfaces. Research has shown that hospital surfaces are not 
adequately cleaned and are re-contaminated very quickly. One of the most 
effective ways of preventing the spread of infections is the basic maintenance of 
hygiene in the hospital environment. The effect cleaning has is mechanical 
whereby the microorganisms are removed from the surface by being suspended 
in cleaning fluid. This can remove approximately 90% of microorganisms.1,53  
 
Figure 1-2: Diagram showing how infection can spread in a hospital. 
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1.3.1 Levels of Contamination 
 
It is difficult to quantify and measure the minimum level of contamination needed 
on a surface to initially colonise a patient that can lead to an infection. Nosocomial 
infecting bacteria has the ability to survive for days to months on hospital surfaces 
even with cleaning procedures in place to reduce the level of microbial burden. 
Some research has suggested that the level of contamination of surfaces should be 
below 250 cfu per 100 cm2 to minimise the transmission of infections and within 
the limits that are safe for patient care. However, the rapid re-contamination of 
pathogens on these touch-surfaces in the hospital after cleaning is of major 
concern. 
The best results observed have been a routine that involves cleaning and 
disinfecting the hospital environment at regular intervals. This will increase the 
already full work load for understaffed healthcare workers.54 
 
1.3.2 Bacterial Adhesion  
 
Bacteria can exist as planktonic where they drift in great number in a solution or 
part of biofilm community. Biofilms are a vital structure for microorganisms 
composed of various biomolecules such as proteins, lipids and water.55 The 
microorganism self-assembles the microbial structure and is capable of 
optimising the conditions. Surfaces can act as a microbial habitat due to their 
ability to adsorb nutrients and provide a surface for microbes to be attached. 
Biofilms act as functional communities where the matrix can trap nutrients for 
microbial growth and help prevent detachment of cells from the surface.56  
Biofilm development is a major problem for healthcare institutions due to the 
contamination of medical devices. Biofilms can also be a problem for water supply 
and oil extraction where the pipes can be damaged, corroded or contaminated.57–
60 
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In 1847, Antoine van Leeuwenhoek used effective but primitive microscope 
observation of aggregation of ‘animalcules’ (little animals) that were scraped from 
the surface of a human tooth.61 This would be the first documentation of biofilms. 
As technology and investigations developed, researchers have observed that 
bacteria grow differently once adhered to a surface.62 
Planktonic microbial cells are transported in solution and are attached to a 
particular surface. If the environmental factors (available energy, orientation, 
temperature, pressure) are favourable the bacteria can attach to the surface either 
by attractive and repulsive forces such as electrostatics and/or Van der Waal’s 
forces that are described in the DVLO (Derjaguin, Verwey, Landau and Overbeek) 
theory.63–65 At this stage, the attachment of the bacteria is irreversible due to the 
process of cell adhesion. Colonisation, growth and division of the bacteria occur 
and can take hours to days. The biofilm matures and grows consisting of attached 
islands of bacteria with water channels running through it, Fig. 1-3. 
 
 
 
The formation of biofilms on various industrial and biomedical surfaces is a 
problem. Mature biofilms are persistent and can develop a tolerance to cleaning 
products such as disinfectants. Controlling the bacterial adhesion and stopping 
the initial stages of biofilm formation can control the development of biofilm. 
 
Figure 1-3: Diagram depicting the stages of biofilm  growth.  
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There are many advantages for microbes to attach and form biofilms, which 
include: 
 Enhanced resistance to antibiotics and a variety of antimicrobial agents. The 
resistance can be from the polymeric matrix enclosing the community of 
microorganism which hinders the penetration of any antibacterial agents. The 
biofilm can provide a protective matrix that is mainly made up of 
polysaccharides, which allows the structure to be kept in place and not be 
swept away. The matrix can also prevent toxic molecules such as antibiotics 
and disinfectants due to its ability to an ion exchanger.66 
 Development of the matrix allows for optimised conditions for growth. The 
microorganisms have the nutrients and moisture to grow making it 
advantageous for newly attached planktonic bacteria to become a part of the 
community. The biofilm structure consists of pores, which act as water 
channels that allows for the transport of nutrients.66 
  A genetic factor can also increase the resistance due to the cell-to-cell 
signalling and communication that can lead to the production of vital genes 
that favour the maintenance of the microorganisms. Biofilms have the 
enhanced ability to adapt to hostile conditions and environments due to their 
structure. The bacterial cells are in close proximity to each other, which allows 
for opportunities to exchange genetic material. This cell-to-cell 
communication (quorum sensing) can allow for further resistance to 
antibacterial agents.66–68  
 
There are two types of strategies for combating the formation of biofilms. One 
approach is the antimicrobial surface that prevents microbes adhering to the 
surface for example superhydrophobic films69,70 or the development of other 
surfaces that kill approaching microbes.9,71 
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 1.4 Antimicrobial surfaces 
 
Hospitals are undergoing stewardship programmes to manage the over-
prescription and mishandling of antibiotics. With the rapid increase of MDR 
bacterial strains and the lack of new antibiotics, there is a need to preserve the 
availability of existing antibiotics. Different approaches are needed to tackle this 
problem.   
Cleaning procedures can help reduce the spread of infection, however there is a 
need to remove the surface, which acts as a microbial reservoir. Most strategies 
focus on the transfer of microbes, which is important, or development of 
antibiotics that can treat HAI. There is a need to remove the bacterial reservoirs. 
A preventable approach to reduce bacterial infections involves the use of self-
cleaning surfaces. Figure 1-4 shows how antimicrobial surfaces can break the 
cycle in the spread of infections.72 
 
 
 
 
 
 
 
The longer a nosocomial pathogen persists on a surface, the longer it may be a 
source for transmission to a susceptible patient or healthcare worker. Frequently 
touch surfaces such as doorknobs, push plates, bed rails and poles have been 
identified as reservoirs for the spread of pathogens microbes which can easily 
contaminate hands and equipment of healthcare workers, who, in turn can 
transmit these pathogens to patients during routine care. Coating these touch 
surfaces with antimicrobial agents can potentially reduce infection rates.    
Figure 1-4: Flow chart showing how the spread of contamination 
can be reduced using antimicrobial surfaces. 
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Due to bacterial infections on medical devices and surfaces, there are a number of 
strategies employed to reduce this problem in order to prevent the formation of 
biofilms on the surface.73 The topological and chemical characteristic of the 
surface can play a role in how well microbes can attach to the surface. There are 
different ways antimicrobial coatings can prevent the formation of biofilms. An 
antiadhesive coating that can be applied to act as a repellent to contaminations 
that are usually in the form of physiological fluids. This can prevent electrostatic 
interactions described in the DLVO theory. This can be obtained by chemically 
modifying surfaces or building nanostructure on that surface.74  
The use of bioactive compounds with natural antimicrobial properties are often 
used. These material do not need any modification to exhibit antibacterial action. 
Copper and silver are known antibacterial agents used throughout history.75 Their 
effectiveness as compounds and dissolved ions have been investigated76–78. 
Coatings or devices containing these metals/nanoparticles are prominent.79 In 
this thesis, copper is investigated and is discussed further in chapter 3. Other 
metals discussed in this thesis are gallium (chapter 4) and zinc (chapter 5).  
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1.5 Project Aims 
 
The purpose of this work is to study metal oxide antimicrobial thin films 
deposited by aerosol assisted chemical vapour deposition. The properties will be 
assessed for their potential as antimicrobial surface coatings. The ultimate goal is 
to produce materials which exhibit antimicrobial effectiveness for the use in 
reducing the spread of nosocomial infections in a hospital environment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 15 
 
 
 
 
 
 
 
 
 
 
Experimental and Characterisation 
 
The chapter describes the experimental methods used to deposit coatings by Aerosol 
Assisted Chemical Vapour Deposition and the theory behind the analytical 
techniques used to characterise the films. The main analytical techniques this 
chapter concentrates on are X-ray diffraction (XRD), scanning electron microscopy 
(SEM) and X-ray photoelectron spectroscopy (XPS). The microbiological analysis 
carried out (serial dilution and susceptibility testing) on the film is also discussed.  
2 
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2.1 Thin Film Deposition 
 
Thin films can be described as a solid layer of material deposited on a substrates 
that give an enhanced representation of the bulk material. Thin films can vary in 
thickness and can give heighten surface properties. There are a wide range of 
methods of forming thin films. Some of the most popular are Chemical Vapour 
Deposition (CVD), Physical Vapour Deposition (PVD) and Atomic Layer 
Deposition (ALD). Choosing a deposition technique depends on the properties 
that the thin film is required to possess and the availability of precursors.  
CVD is a versatile technique used for depositing gas phase reactants (precursors) 
onto a solid substrate creating thin films. CVD can be used to deposit films on to 
large areas, for example glass/steel and small scale coatings.80,81  
PVD is a technique that involves deposition via atoms/ions in a gas phase. This 
process involves sputtering and evaporation. It is known as a line of sight 
technique which causes the coating to appear only where the atomic beam can 
‘see’ it, causing minimal surface reactions. The atoms will cover the top of the 
substrate but not the side of the walls. This does not produce conformal coverage 
and can come at a high cost. The difference between CVD and PVD is how the 
precursors are delivered. In CVD thin films grow by using gas phase precursors 
that adhere to the substrate. However, PVD grows thin films by using sputtered 
or evaporated atoms usually under high vacuum conditions. CVD is the opposite 
of PVD whereby it is not a line of sight method therefore it can produce films that 
have conformal coverage. During a CVD process the atoms have the ability to 
move freely across the substrate, which results in uniform coverage that follows 
surface contours.82   
ALD is similar to CVD as it forms uniform and conformal thin films however, ALD 
is based on films being built up by layer-by-layer growth. At first the surface is 
exposed to gaseous reactants which are chemisorbed to the surface until it is 
saturated. The excess precursor vapour is purged and a second precursor is 
allowed to react with the surface, then the excess gas is pumped away. The 
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sequence can be repeated so as to increase the thickness of the film. It can have 
very slow growth rate (monolayer growth).83 
Even though ALD is a variation on CVD, there are some major differences.  The 
precursors are much more reactive in ALD when compared to CVD. Precursors in 
ALD react separately with the substrate, whereas in CVD the precursors can react 
together in the gas phase and on the surface. Precursor concentration is not 
needed in ALD as it is dependent on the surface type. 
 
2.2 Conventional CVD 
 
Chemical Vapour Deposition (CVD) involves the formation of a thin solid of 
material on a substrate created by a chemical reaction using volatile precursors 
transported in a carrier gas.  
The first type of CVD process recorded was by John Howarth who produced a 
pigment called ‘carbon black’.84 Around the 1800s industries saw CVD processes 
as being economically viable for extraction. However, in the past 40 years, there 
has been a strong interest in its fundamental understanding. There was increased 
effort into discovering the scientific and technological process behind CVD and 
incorporating that into a wide range of applications.  This was due to the change 
of focus on extraction to deposition allowing CVD to become a more important 
technique.80  
The CVD process involves a sequence of reactions that can occur in the gas phase 
or on the surface. It involves a chemical reaction of gaseous atoms with an 
activated environment that can initiate the reaction. This can be heat, light or 
plasma conditions. There is an inert carrier gas such as nitrogen that allows for 
easy transport of the precursor to the substrate. This is followed by the formation 
of a stable solid material, within the reaction chamber. 
The deposition process involves a heterogeneous reaction in the gas phase near 
the heated substrate.  The process starts by the transport of precursors into the 
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reactor, which allows for weak physisorption of precursors on to the surface (Fig. 
2-1). Decomposition occurs and it generates atoms and unwanted by-products 
onto the surface. There is a mass transport of atoms across the surface allowing 
for adsorption of atoms. The nucleation of the atoms leads to film growth. There 
is desorption and migration of the remaining fragments.  
 
 
 
 
 
 
 
 
 
 
 
The fabrication of thin films by CVD allows highly reproducible uniform films and 
composition control with excellent conformal coverage. This technique is able to 
deposit films that are highly pure and dense as well as being adherent and 
inexpensive. The CVD technique has the capability to control crystal structure, 
surface morphology and orientation by adjusting the CVD process parameters 
such as deposition rates and temperatures. Moreover, the rate of deposition can 
be tuned, allowing for a finer control over the thickness of the film produced. 
There are also a number of drawbacks that can hinder the applications of CVD. 
This includes chemical and safety hazards that can be encountered when using 
toxic, flammable or corrosive precursor gases. There can also be a challenge in 
Figure 2-1: Schematic diagram of the CVD transportation and 
growth process. 
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forming multicomponent materials when using multi-source precursors as it can 
be difficult to control the stoichiometry of the resultant thin film. Therefore there 
are concerns when utilizing the CVD technique when it comes to the selection of 
the precursors, as it can have an effect on the growth rate, electrical properties, 
and transparency of the film. 
 
2.3 Aerosol Assisted Chemical Vapour Deposition 
 
Aerosol assisted chemical vapour deposition (AACVD) is a variation on the 
conventional CVD process. This method involves the precursor being dissolved in 
a solvent in order to form an aerosol. The formation of an aerosol is generated by 
ultrasonic humidifier (nebulizer) forming aerosol droplets creating a precursor 
mist (Fig. 2-2). This mist is transported to the CVD reactor via a carrier gas. This 
mist evaporates once it enters the chamber due to the increase in temperature 
causing the precursor to be in its gaseous state, where decomposition occurs. 
There is a need for the carrier gas to have enough pressure to be able to transport 
the aerosol to the CVD reactor. As a result, the optimal flow rate for the system 
has to be established allowing a high deposition rate due to the high mass 
transport of precursor to the substrate.  There is a need for high vapour pressure 
at room temperature, which is created by the nebulizer.80,85  
There are many advantages in using AACVD over conventional CVD. AACVD uses 
a nebulizer to form the aerosol droplets of precursor so that it does not rely on 
the evaporation of precursor solution and overcomes the need for precursors to 
be volatile when a carrier gas passes over it. This simplifies the delivery and 
vaporisation of the precursors, which would reduce the cost as well as 
overcoming the restriction in the range of precursors that can be investigated. 
AACVD allows a reduction in the synthesis of multicomponent products while still 
having stoichiometric control. This creates more dynamic surroundings that can 
allow AACVD processes to be carried out at low pressure and even in open air.  
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The AACVD reactor consists of a cylindrical quartz tube that is 60 mm in diameter 
and 160 mm in length. Within the quartz tube there is a carbon block that holds a 
cartridge heater and two thermocouples. On either end of the quartz tube there 
are stainless steel end plates at both ends. Gas is allowed to enter the reactor 
through a brass baffle attached to one end of the stainless steel plates and the gas 
is allowed to exit through the exhaust on the opposite end. 
The substrate is cleaned with copious amounts of isopropanol/acetone and dried. 
Then the substrate is placed on top of the carbon block and SiO2 coated float glass 
(supplied by NSG) is placed 10 mm above acting as a top plate. The top and bottom 
plates are loaded into the reactor, and it is sealed and the substrate is directly 
heated. The experimental set-up is known as cold-walled CVD since the bottom 
plate substrate is the only part that is heated.  
 
Figure 2-2: Schematic diagram of the AACVD process. 
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The precursor solution was loaded into a glass flask with a thinned base, which 
allows for a more effective transfer of power from the piezoelectric device 
(attached to the humidifier) to allow for an easier generation of aerosol mist (Fig. 
2-3). Aerosol droplets can be generated from liquid surfaces with the application 
of high-frequency sound waves in a process known as ultrasonic generation. The 
size of the aerosol droplet is related to Lang’s equation (2.1).86,87 The equation 
states that the aerosol droplets size (d, diameter) is related to the liquid density 
(ρ) and surface tension (γ) of the solvent as well as the frequency (f) of the sound 
waves.  
𝑑 =  (
2𝜋𝛾
𝜌𝑓2
)
1
3⁄  
The size of the aerosol droplet decreases as the ultrasonic vibration frequency 
increases. Usually, the finer the droplet, a higher quality film is produced due to 
more efficient evaporation of the solvent and vaporisation of the precursor. In this 
piezoelectric humidifier used in our labs had an operational frequency of 20 kHz 
and methanol (the main solvent used throughout this project), the diameter of the 
droplets was 45 mm at 25 oC.  
Figure 2-3: Schematic diagram of the AACVD set up. 
(2.1) 
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The aerosol droplets were carried into the reactor through the brass baffle 
through a laminar flow. Once the reaction was complete, the substrate was 
allowed to cool down under the flow of nitrogen until it has reached room 
temperature. The films were handled in air and stored in plastic wallets. 
During AACVD, the morphology of the films can often change depending on a 
range of factors such as, temperature, solvent or substrate used. Scanning electron 
microscopy (SEM) was used to analyse the thin films to see if their morphology 
were different when using different temperatures, solvents or precursor 
concentration.  
a) Precursors 
With the use of different precursors AACVD has been shown to produce 
different thin film microstructure. Difference in morphology can cause an 
enhancement in the thin film properties. Concentration of the precursor can 
also affect the quality of film deposited.88  
 
b) Temperature 
Temperature is another variable that affects the microstructure of films grown 
via AACVD. Temperature can also affect the coverage of the deposited thin 
films on the substrate. For example, different microstructure has been 
exhibited when [PbS2CNRR’)2] (where R, R’ = Me, benzyl, heptyl, octadecyl, 
dioctyl, Hex, Et or nPr) was used to deposit thin films of lead sulfide. Thin film 
deposited at 350 oC formed particles on the substrate that had a dense 
granular microstructure whereas for depositions at 425 °C, the films consisted 
of non-uniform particles. Increasing the deposition temperature to 450 °C 
changed the morphology to a mixture of acicular platelets and non-uniform 
particles.89,90 
 
c) Solvent 
Solvent can cause a major difference in the morphology of the film due to the 
change in how the aerosol mist evaporates in the AACVD chamber. The effect 
of solvent on crystallographic phase has also been recently reported in the 
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deposition of TiO2 on steel substrates using titanium(IV) isopropoxide with a 
variety of solvents.91 Depositions using ethanol, hexane, dichloromethane and 
isopropanol produced exclusively anatase films, whereas employing methanol 
under identical conditions yielded exclusively rutile phase TiO2. Solvents not 
only influence the morphology but can affect the compositions of the thin film. 
Solvents such as toluene can cause carbon contamination within the thin film, 
which can affect the transparency. Decolourisation of the films can be achieved 
by annealing in air.92, 93  
 
2.4 Film Growth 
 
AACVD is a solution based technique that therefore leads to a number of different 
ways of film growth. This can be controlled which is unavailable for other 
techniques. Different factors and deposition conditions can influence the 
morphology of the thin film deposited via AACVD. These factors include 
precursors, temperature, solvent, growth period, and additives.  
When thin films are grown, they can either be amorphous or crystalline. 
Crystalline thin films can be divided into epitaxial or polycrystalline films. Films 
are epitaxial when the lattice planes in the substrate match up with the planes in 
the film. This shows that the substrate and the film have very similar crystal 
structure and unit cells. To grow films of this type, there needs to be a low growth 
rate which allows for surface deposition of the atoms to be fast when compared 
to the arrival of new atoms. This causes the precursors to be absorbed on growth 
step sites that form a layer that is a replica of the substrate. High temperatures 
(>700 oC) are required for the formation of epitaxial films because it increases the 
rate of impurities being desorbed as well as increasing the mobility of precursors 
on the surface.   
Polycrystalline is its opposite, whereby the lattice planes do not match up. This is 
caused by having an intermediate temperature and growth rate. This type of film 
occurs due to growth at different surface sites that form ‘islands’. These ‘islands’ 
combine and form a layer. 
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On the other hand, amorphous films have no crystallinity and this kind of film 
growth is encouraged by low temperatures and high growth rate. These 
conditions cause the rate at which the precursors arrive to be faster than the 
surface diffusion.  
 
2.4.1 Thin Film Growth models 
 
The Volmer Weber or island growth model occurs when the atoms/molecules 
deposited have a much stronger bond to the growing surface than to the substrate 
(Fig. 2-4). Small clusters are nucleated directly on the substrate surface and then 
grow into islands of the condensed phase. Low precursor concentration and low 
decomposition temperatures encourage an island growth formation to occur.94  
The Frank-van der Merwe or Layer growth model is the opposite of island growth 
whereby the atoms/molecules are much more strongly bound to the substrate 
(Fig. 2-4). This is caused by the initial atoms depositing to form a layer on the 
surface, which is then covered by another second layer that is not as tightly bound. 
The Stranski-Krastanov or intermediate growth model is a combination of island 
and layer growth models. In general, the first few monolayers adhere to the 
substrate, after that layer growth becomes unfavourable and island growth 
occurs.  
All three of these growth models produce films that are adhesive. However, when 
gas phase reaction predominates, it gives rise to films that have weak interparticle 
interactions and tend not to be adhesive. This is known as particulate film growth. 
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2.4.2 Variations on CVD 
 
The type of CVD technique selected is down to the type of film needed and the 
reactants available. Some variations on CVD are listed below: 
• Metal – Organic CVD (MOCVD); this is a process that uses metal organic 
precursors in the CVD process. This is usually used in the formation of films 
with semiconducting properties.95,96  
• Plasma Enhanced CVD (PECVD); this CVD process uses electrical energy 
instead of thermal energy allowing for depositions to occur at very low 
temperatures. This enable the use of temperature sensitive substrates.81.97 
• Low Pressure CVD (LPCVD); depositions take place at low pressure which will 
result in the reduction of unwanted by-products increasing the quality of the 
film. The pressures used are typically between 10-3 – 10-10 atm.98 
• Atmospheric Pressure CVD (APCVD); this process is widely used in industry 
and uses pressure between 1 – 10-3 atm, which can deposit adhesive films.99   
• Laser Assisted CVD (LACVD); a deposition technique that uses either 
atmospheric or low pressure or the use of a laser to heat the precursor or 
substrate.81 
Figure 2-4: Diagram of three film growth models that can be seen in 
thin films. 
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• Liquid Injection CVD; a CVD process involving the injection of the precursor 
within a gas system.81 
• Combinatorial CVD; this technique can be carried out in atmospheric pressure 
and low pressure. It involves the use of a number of different precursors to 
form gradient composition films. A modified reactor is used to create a 
compositional spreads that can be mapped to represent the optimised 
properties.100 
 
2.4.3 Variations on AACVD 
 
There are many variations on AACVD offering additional control over film 
microstructure and potential to overcome problems associated with precursor 
delivery. These variations on the technique can further increase its versatility 
towards materials fabrication and control of film growth and morphology.85 Some 
such variants are listed below: 
• Aerosol assisted combustion CVD (AACCVD): Like AACVD, a precursor aerosol 
is generated by nebulization of a solution of precursor. Precursor aerosol 
droplets are then transported by a carrier gas through a flame where 
combustion occurs. This can offer higher deposition rates but problems can 
arise due to difficulties in controlling the flame temperature and the 
production of poor film coverage.85,101  
• Electrostatic spray assisted vapour deposition (ESAVD): this technique involves 
the atomization of a liquid precursor followed by charging of the droplets by 
corona or induction charging. The charged droplets are then directed towards 
a heated substrate by an electric field where deposition occurs. Good quality 
thin films with high purity can be produced with this ESAVD.85  
• Electrostatic aerosol assisted jet deposition (EAAJD): there is a formation of 
charged aerosol droplets in the same way as in ESAVD, however EAAJD 
incorporates a carrier gas for transport of the droplets in an electric field 
towards the heated substrate where the film is deposited.85 
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• Electric field assisted aerosol (EFAA) CVD: involves an application of a potential 
difference between electrodes on a deposition substrate creating an electric 
field, which has been found to influence film microstructure.85 
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2. 5 Analytical Techniques 
 
2.5.1 Powder X-ray Diffraction 
Powder X-ray Diffraction (XRD) is a technique performed on polycrystalline 
material such as films and gives information on the crystallinity, phase identity 
and crystallite size. X-ray beams interact with the sample and are diffracted off a 
set of periodic planes according to the Bragg’s equation.  
nλ=2dsinθ 
Constructive interference between incident and diffracted X-rays only occur with 
a monochromatic X-ray beam of a particular wavelength. Diffraction peaks are 
only arising at diffraction angles that meet Bragg’s Law. 
Nearly all crystalline materials have distinct diffraction peaks, which are 
determined by atomic distances and different lattice spacing even though some 
materials may share the same unit cell type. Therefore materials can be 
characterised by comparing against referenced patterns of known compounds as 
well as calculating lattice parameters and unit cell.  
In this thesis, the XRD was carried out using a Bruker D8 general area diffraction 
detector system (GADDS). The samples are usually analysed at low angles of 
incidence with an incident beam angle of 5o. The diffractometer uses a 
monochromatic Cu X-ray source with a major component CuKα1 radiation of 
wavelength 0.154056 nm (CuKα2 at 0.154439 nm is also present, which is not 
filtered), a voltage of 40 kV and current of 40 mA.  
 
2.5.2 Scanning Electron Microscopy 
Scanning Electron Microscopy (SEM) is an electron imaging technique used to 
record high resolution images of samples. A focused high-energy electron beam is 
used to interact with the sample causing emission of two types of electrons; 
backscattered electrons and secondary electrons. 
(2.2) 
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Secondary electrons are ejected from the sample by high energy incident 
electrons. These electrons are usually much lower in kinetic energy than 
backscattered electrons therefore, can only escape from the sample and be 
detected if they are created near the surface of the sample. Secondary electrons 
are heavily influenced by the morphology of the sample. The electrons are more 
readily created near the peaks rather than the troughs. 
SEM images were taken on a JEOL JSM-6301F Field Emission instrument with 
acceleration voltage ranging from 3 to 10 kV. The probe current range was 6 to 8 
μm. The images were captured using SEMAfore software. Sample preparation 
involved cutting the films down to coupons 1 cm x 1 cm or less and adhered to 
stainless steel holders using conductive carbon tape. Contacts from the top of the 
film to the carbon tape were made using a solution of silver paint. Once dried the 
samples were coated with a fine layer of carbon or gold to avoid charging. 
 
2.5.3 Cross-sectional SEM 
SEM is not only used to examine the microstructure of the thin film but the film 
thickness as well. The film is rotated to be perpendicular to the electron beam. In 
order to measure the thickness from the image taken, the film and glass substrate 
need to be distinguishable.   
 
2.5.4 Energy Dispersive X-ray  
Energy Dispersive X-ray (EDX) uses high energy beam that dislodges an inner-
shell electron that leaves a vacancy. An electron in a higher shell falls to fill that 
vacancy. This fall emits radiation which is a characteristic X-rays that is specific to 
an element.  The energy at which this occurs is measured and from the energy of 
the X-ray and the intensity, it is possible estimate the amount and nature of 
elements present in the system. 
EDX in this thesis was carried out using JEOL JSM-6301F Field Emission 
instrument with acceleration voltage ranging from 20 kV. Sample preparation 
involved cutting the films down to coupons 10 mm x 10 mm or less and adhered 
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to stainless steel holders using conductive carbon tape. Contacts from the top of 
the film to the carbon tape were made using a solution of silver paint. Once dried 
the samples were coated with a fine layer of carbon to avoid charging. 
 
2.5.5 X-ray Photoelectron Spectroscopy 
X-ray photoelectron spectroscopy (XPS) is a surface sensitive technique based on 
the photoelectric effect that measures the kinetic energy of photoelectrons 
released. A sample is irradiated by a fixed wavelength (hv) to excite the 
photoelectrons. The ejected photoelectron has kinetic energy that can be related 
to: 
K.E. = hv – B.E. - ϕ 
B.E. = Electron Binding Energy, K.E. = Electron Kinetic Energy, Φ = Spectrometer 
Work Function  
XPS is a technique that can obtain the oxidation state, chemical environment, and 
concentration of an element in a sample. Each element has a characteristic binding 
energy for the electrons core atomic orbitals that influences the position of the 
photoelectron peak on the XP spectrum whereas the intensity of the peak relates 
to amount of the particular element. 
X-ray photoelectron spectroscopy (XPS) was performed using a Thermo Scientific 
K-alpha photoelectron spectrometer using monochromatic Alkα radiation. 
Samples were earthed using copper tape. Higher resolution scans were recorded 
for the principal peaks of Cu(2p), Ga(3d, 2p), Zn (2p), O(1s) and C(1s) at a pass 
energy of 50 eV. The peaks were modelled using CasaXPS software with binding 
energies adjusted to adventitious carbon (284.5 eV) for charge correction. 
 
 
(2.3) 
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2.5.6 X-ray Absorption Spectroscopy  
X-ray absorption spectroscopy (XAS) describes how X-rays are absorbed by atoms 
at energies near and above the core-level binding energies. This technique is 
sensitive to the oxidation state, coordination chemistry, and bond distances of the 
atom of interest.   This technique requires a tuneable X-ray source and therefore 
is carried out using a synchrotron radiation; XAS was carried out by Dr. Husn-
Ubayda Islam. 
X-rays are absorbed by the atom and the energy of the X-ray is transferred to the 
core electrons that is ejected to an unoccupied or partially occupied energy levels. 
As energy increases, the absorption dramatically increases that gives rise to an 
absorption edge.  This region with the dramatic raise in absorption is known as 
the XANES region.  As the photoelectron leaves the excited atom, a backscattered 
waves are caused by the interaction with neighbouring atoms. The incoming and 
outgoing wave interferes leading to a constructive and destructive interference 
which appears as maxima and minima on the spectrum. This region is called 
extended X-ray absorption fine structure (EXAFS).  Therefore, two features that 
can be identified on a XAS spectrum are X-ray Absorption Near Edge Structure 
(XANES) and Extended X-ray Absorption Fine Structure (EXAFS). The EXAFS 
region occurs at high energy caused by the scattering of neighbouring atoms 
occur.  
XAS measurements were performed on the Dutch-Belgian EXAFS beamline 
(BM26A) at the ESRF in Grenoble. Monochromatic radiation was produced by a 
double Si(111) crystal monochromator, and fluorescence was measured using a 9 
element germanium solid state detector. XAS data of the films was acquired in 
fluorescence mode. Measurements of the thin film and pelletized copper 
standards were taken on the copper K-edge (8987eV). XAS data were processed 
and XANES analysis was performed using Horae Athena software, and detailed 
EXAFS analysis was performed on Excurve version 9.273. 
 32 
2.5.7 UV/Visible Spectroscopy 
UV/Visible spectra were recorded in the range 190 – 1100 nm using a Helios 
double beam instrument. Reflectance and transmission spectra were recorded 
between 300 – 2300 nm by a Zeiss miniature spectrometer. Reflectance 
measurement were standardised relative to a rhodium mirror and transmission 
relative to air. 
 
2.5.8 Band Gap Measurements 
Band gap measurements were calculated using the UV/Vis measurements. This 
involves using Tauc plot calculations plotting (αhν)1/2 against hν (eV), where α is 
the absorbance coefficient of the thin film (α = -logT/To), where T is the sample 
optical transmission and To is the substrate optical transmission) and hν is the 
incident photon energy. The plot is linear when approaching the absorption band 
energy and an extrapolation of this region is taken where the extrapolation linear 
line crosses the y axis, this is the band gap value for the thin film (Fig. 2-5).102    
 
 
 
 
 
 
 
 
 
 
  
Figure 2-5: Example of the extrapolation of a Tauc plot to 
calculate the band gap measurements. 
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2.6 Microbiology Analysis 
 
2.6.1 Viable Colony Counting Technique 
In all microbiological experiments described analysis of microbes was performed 
using serial dilutions (Fig. 2-6) and viable colony counting technique on agar 
medium, which is a standard technique used in microbiology. Overnight inoculum 
of bacterial cell culture has a concentration of approximately 106 colony forming 
units (cfu). 
 
 
 
 
 
 
 
 
 
 
Incubation of an agar plate with this concentration will cause a confluent amount 
of growth resulting in individual colonies being indistinguishable from one 
another rendering the plates uncountable. It is important that the number of 
colonies developing on the plate is not too many or too few. A crowded plate 
causes some colonies not to form and others may fuse together. However, if the 
numbers of colonies are too small this causes the statistical significance of the 
calculated colony number to be low.  In order to avoid this, it is necessary to dilute 
the overnight inoculum to allow fewer colonies to grow. This is commonly 
achieved by carrying out 10-fold dilutions of the sample solution using a suitable 
Figure 2-6: Diagram describing the steps involved in serial dilution. 
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medium. Each successive dilution is 10 times more dilute than the previous 
solution (Fig. 2-6). These dilutions are then plated and incubated. After 24 hours 
of incubation, there should be at least one plate with a countable number of 
colonies with suitable counts (10 – 400). The colony count number is then 
multiplied by the dilution faction in order to find the colony count in the initial 
sample. Data is often expressed as the number of colony-forming units (cfu) 
obtained rather than the actual number of viable cells because cfu may contain 
one or more cells. 103 
 
2.6.2 Experimental Design 
The method of microbiology analysis involved the use of an individual moisture 
chamber that consists of a petri dish with filter paper at the base, which has been 
moistened with sterilised distilled water. Sterilised wooden sticks cut to size were 
placed on top of the filter paper and a microscope slide was placed on top of the 
sticks. The thin film samples deposited on microscope slides cut to 1x1 cm in size 
are placed on top of the microscope slide and a lid was placed to cover the testing 
samples (Fig. 2-7). 
 
 
 
 
 
 
 
 
 
 
Figure 2-7: Diagram of the experimental set up of the humidity chamber. 
 35 
2.6.3 Microorganism Selection  
The microorganism selections for this study represent both gram positive and 
gram negative type bacteria (Table 2-1). The difference between the two types 
depends on their cell wall morphology (Fig. 2-8). The cell wall of the bacteria can 
govern the organism’s behaviour. 
 
 
  
 
 
 
 
 
 
Table 2-1: List of bacterial strains used in this thesis and their cell wall type. 
Bacterial Strain Gram positive or negative 
Escherichia coli ( NCTC 25522) Gram negative 
Staphylococcus aureus (E1162) Gram positive 
Pseudomonas aeruginosa (PA01) Gram negative 
Enterococcus faecium (E1162) Gram positive 
 
Gram positive bacteria have a cell envelope consisting of an inner cytoplasmic 
membrane and an outer membrane separated by peptidoglycan containing 
periplasm. The outer layer acts as a barrier against its environment. Within the 
outer layer, there are several proteins where some act as passages and are 
composed of a thick peptidoglycan layer, which is porous, enveloping the 
cytoplasmic membrane. Gram negative bacteria have a cell envelope consisting of 
Figure 2-8: Diagram of the cell wall of gram positive and gram negative bacteria.  
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an inner cytoplasmic membrane and an outer membrane separated by 
peptidoglycan-containing periplasm. This outer layer acts as a barrier against its 
environment. Within the outer layer, there are several proteins where some act 
as passages to allow nutrients, while other proteins act as enzymes.104,66 
 
2.6.4 Light Source 
For light photocatalysis experiments, a General Electric 28W Biax 2D compact 
fluorescent lamp (GE Lighting Ltd., Enfield, UK) was used. This lamp emits light 
across the visible spectrum, as shown in Fig. 2-9 and is commonly found in UK 
hospitals. During the experiments, the lamp was affixed inside an incubator where 
the temperature is maintained at a constant of 21 ± 2 oC. The light intensity was 
measured using a lux meter (LX101 Lux meter, Lutron Electronic Enterprise Co. 
Ltd., Taiwan).   
 
  
Figure 2-9: Spectra power distribution of general electric 28W BiaxTM 2D lamp. 
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2.7 Antimicrobial Susceptibility Testing 
 
Susceptibility testing is commonly used in microbiology laboratory to test the 
performance of antibiotics. The most widely used testing methods are disk 
diffusion and broth dilution tests. In this thesis, broth dilution tests were used to 
produce quantitative results. The purpose of these tests was to measure the 
minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC). 
2.7.1 Broth Dilution Test 
One of the easiest methods for testing susceptibility is using micro broth or tube-
dilution. In this thesis, broth micro dilution was used to test the MIC and MBC as 
shown in Fig. 2-10. MIC is the measurement of the smallest amount of 
antimicrobial agent that can inhibit visible growth of the bacteria and MBC is the 
smallest amount of agent needed to kill the test bacterium. This procedure 
involved two-fold dilution of the antimicrobial agent in a liquid growth medium. 
In this case, Müller-Hinton broth was used and dispensed into the wells of the 
micro-dilution dish. The wells containing the antimicrobial agent were inoculated 
with approximately 106 cfu ml-1 and the dish was placed overnight in an incubator 
set at 37 oC. The bacterial growth was examined by observing the turbidity to 
determine MIC and MBC. The main advantage of this technique is the generation 
of quantitative results which can be easily reproduced.105,106 
 
 
 
 
  
                                                                                                        
Figure 2-10: Diagram of the broth dilution set up using a micro-dilution dish 
for MIC and MBC detection. 
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2.8 Statistical Analysis 
 
Experimental data is subjected to statistical analysis in order to determine the 
significance of the decrease in colony forming units (cfu) observed. The statistical 
analysis used is a non-parametric test known as Mann Whitney U test. This test is 
used to compare two different sets of independent data. Non-parametric test was 
chosen due to the assumption that the data is not normally distributed.  
The null hypothesis is: 
Ho; “There is no difference between the antimicrobial activity (colony counts) of the 
thin films and the control samples.” 
The alternative hypothesis: 
H1; “There is a difference between the antimicrobial activity (colony counts) of the 
thin films and the control samples.” 
Data was analysed using SPSS (version 16.0, SPSS, Inc. Chicago, Il, USA) statistical 
software package. The output from the analysis from this software includes a 
range of different data but the data point of interest to this thesis is the P value. 
The P value is needed to test the null hypothesis against the significance level. The 
statistical significance of the data will be represented by asterisks (Table 2-2).107 
 
Table 2-2: Asterisks system to define the statistical significance. 
P Value Asterisk Level of Significant 
P < 0.05 * Significant 
P < 0.01 ** Very Significant 
P < 0.001 *** Highly Significant 
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Copper and Copper(I) Oxide 
 
The following chapter presents the results obtained from an investigation into the 
use of copper and copper oxide thin films for antimicrobial applications deposited 
via aerosol assisted chemical vapour deposition. The thin films were fully 
characterised and tested for their antimicrobial properties using serial dilution and 
viable colony counts on to agar plates. A description of copper nanoparticle 
susceptibility towards a range of bacteria was investigated using Agar and Broth 
dilution methods and will also be discussed. 
 
3 
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3. Introduction 
 
Copper is a well-known antimicrobial agent that has been used throughout 
history. The oldest recorded documentation of copper’s antimicrobial ability is 
contained in an Egyptian medical text dating between 2200 and 2600 BC, 
describing the use of copper for the disinfection of water and treatment of 
wounds.108,109 In many living organisms copper is an essential trace element and 
there are many copper-containing proteins, where copper acts as an electron 
donor/acceptor due to its ability to switch between oxidation states.110 Copper is 
an essential metal needed for many functions in organisms although in large 
concentration it can be toxic.111 The development of antibiotic resistance, and the 
increase of HAI require a new approach to deal with infections (Chapter 1). An 
alternative system proposed is the use of copper surfaces for hygiene sensitive 
areas, such as hospitals.112  
 
3.1 Copper vs Stainless Steel 
In vitro experiments carried out to test the antibacterial properties of copper 
materials were first conducted over 30 years ago when it was noted that stainless 
steel doorknobs and stainless steels strips did not have antimicrobial activity 
while brass and copper strips did exhibit activity.113 More recent studies have also 
shown that copper has antimicrobial activity against a wide range of bacteria 
including Staphylococcus aureus (S. aureus)109 and Escherichia coli (E. coli).114  
Recently studies have investigated the length of time E. coli O157:H7 can survive 
on copper based touch surfaces for 2 hours and compared it to stainless steel. The 
antimicrobial copper was very effective as a touch surface material, killing greater 
than 99.9 % of the E. coli strain within 2 hours, whereas there was no significant 
reduction in the cfu counts for stainless steel. This indicates that stainless steel 
may not be the ideal choice as a touch surface in hospitals.  
In in situ investigations in a busy ward of a UK hospital, frequently touched 
fixtures and fittings were replaced with copper and copper alloys containing a 
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minimum of 60% copper. This ten week study found that all copper containing 
items on average had between 90 and 100% lower microbial contamination when 
compared to control fixtures and fittings.115,116  
Touch surfaces are described as door handles, bed railings, call buttons and toilet 
seats. Studies have shown that microbes can survive on these touch surfaces and 
hence they can be seen as a microbial reservoir. Touch surfaces are predominately 
made from stainless steel due to the clean appearance and its resistances to 
corrosion. However, stainless steel does not possess any antimicrobial 
properties.117 
The use of copper instead of stainless steel has the potential to reduce infections 
rates due to the intrinsic self-sanitising properties. There have been hospital trials 
worldwide indicating how copper can provide protection from the spread of 
infections. 
 
3.1.1 Clinical Trials 
 
 Birmingham, UK 
A clinical trial took place at Selly Oak Hospital located in Birmingham, UK in a 
general medical ward containing copper touch surfaces as well as standard 
components. This method was chosen to demonstrate the ability of copper to 
reduce the bacterial burden on the surrounding environment.  A 10 week trial 
were carried out where the copper and control surfaces were interchanged after 
5 weeks. Over the trial period, all copper fixtures had 90 – 100% less microbe 
contamination when compared to their controls made from chrome-plated brass, 
aluminium and plastic.115  
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 United States 
Three institutions, (the Medical University of South Carolina, Charleston (MUSC), 
The Ralph H Johnson Veterans Administration Medical Centre, Charleston, South 
Carolina and the Memorial Sloan Kettering Cancer Centre, New York City), 
replaced frequently touched surfaces and objects made from stainless steel, 
aluminium and plastic with copper. These studies were carried out over 43 
months and the microbial burden was analysed for six objects.  
Results showed that the introduction of copper touch surfaces significantly 
reduced the microbial burden by 83% on average and gave a reduction on a 
continuous basis. These trials also examined the recontamination of newly 
installed copper surfaces compared with control plastic surfaces.  Copper was 
found to consistently limit surface bacterial burden before and after cleaning and 
gave a continuous antimicrobial effectiveness to the copper surfaces and the 
surrounding items. The use of copper touch surfaces inside the intensive care unit 
(ICU) led to a 58% reduction in nosocomial infections.118 
 
 Hospital de Cobre, Chile 
Approximately 70, 000 people contract a nosocomial infection annually in Chile. 
A clinical trial at Hospital del Cobre, Calama, inside the ICU took place for 30 
weeks. Six types of surfaces (bed rails, bed levers, tray tables, chair arms, monitor 
pens, and IV poles) were replaced with copper resulting in over 900 surfaces 
being replaced in 90 rooms. This was compared against the equivalent number of 
rooms and surfaces to act as a control. 
The results from this study revealed that the copper surfaces produced a 90% 
reduction in microorganism contamination and the copper demonstrated 
continuous antibacterial activity throughout the trial. The bacterial burden on the 
six surfaces studied showed a significant reduction when compared to the rooms 
without the copper surfaces with bed rails having the highest reduction (91%) 
and monitor pens having the least (49%).119,120  
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 South Africa 
A controlled study was carried out in a busy walk-in healthcare clinic located in a 
rural region of the western cape of South Africa. The trial involved two similar 
consulting rooms and was carried out over 6 months. One room was fitted with 
copper surfaces on the areas that are frequently touched by staff and patients, 
whereas the second room remained the same to act as a control. To monitor the 
effectiveness of the copper, no disinfectants were used in these environments. The 
study was carried over the winter, spring and summer to examine the effect of 
climate and temperature. The study showed that it made no significant difference 
to the antimicrobial activity of the copper touch surfaces. On average the copper 
touch surface exhibited a 71% reduction when compared to the control 
surfaces.121   
 
3.1.2 Copper toxicity  
Although the exact mechanism of the antimicrobial activity of copper is not 
known, many investigations have pointed to reactive oxygen species (ROS) 
produced through Fenton-type reactions leading to DNA damage.122 The release 
of copper ions causing inactivation of enzymes has also been attributed to its 
toxicity.123 Much research has looked into the antimicrobial mechanism of copper 
and there have been suggestions that activities take place in many different ways 
both inside and out of the bacteria cell.109,124  
The redox properties of copper can be exploited in order to cause cell damage. It 
has been suggested that copper toxicity was attributed to copper ions 
participating in a Fenton-type reaction. The creation of radicals caused by UV light 
promotes the formation of hydrogen peroxide (H2O2). A Fenton-type reaction 
occurs in many biochemical reactions that can lead to the formation of H2O2 and 
superoxide radicals leading to multiple redox reactions at specific sites causing 
‘multi-hit’ damage. The simplest form of Fenton-like reaction involves ferrous 
iron behaving as a catalyst to form hydroxyl radicals from hydrogen peroxide: 
  44 
 
 
 
HOO. is the protonated form of superoxide. Other transition metals such as copper 
can also be involved in a process like this leading to a damaging effect on DNA, 
lipids and proteins that eventually lead to the bacterial cell death. In the case of 
copper, Cu(I) undergoes an oxidation reaction with H2O2 to form hydroxyl 
radicals. These hydroxyl radicals are extremely reactive and can undergo a wide 
range of reactions that can damage cell wall of bacterium by disrupting the lipid 
bilayer and denaturing proteins.111,125 
 
The concentration of H2O2 is very low inside bacteria cells suggesting that this 
Fenton type reaction may not be the main source for copper toxicity. Research has 
shown that copper has a strong affinity for bonding to sulphur, nitrogen and 
oxygen containing groups which can cause disruptions in protein structures.123,126  
Investigations have described copper toxicity occurring due to damage to DNA 
and contact killing, which damages the membrane. A mechanism of copper 
toxicity has been proposed which involves dissolved copper ions damaging the 
cell membrane and bacteria (Fig. 3-1a). This leads to cell rupture (Fig. 3-1b) 
leading to secondary reactions of the formation of ROS (Fig. 3-1c), which in turn 
causes further damage to the cells. This leads to the eventual degrading of DNA 
(Fig 3-1d).110 The mechanism suggested for contact kill are very similar to silver 
where the mechanism of action of silver is linked with its interaction with thiol 
group compounds found in the respiratory enzymes of bacterial cells.  Silver binds 
to the bacterial cell wall and cell membrane and inhibits the respiration 
process.127 
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3.1.3 Halo Effect 
Copper surfaces also experiences a ‘halo effect’ whereby, the antimicrobial 
activity of copper spreads to other non-copper materials nearby. This helps 
prevent the spread of infection and enhances the effect of the copper touch 
surfaces.118 
 
3.1.4 Copper Oxide 
It has been reported that the antimicrobial activity of silver occurs when silver is 
ionised. As a result, copper oxide will be investigated to see if there is enhanced 
efficacy. There has been some investigation in to cupric Oxide (CuO) nanoparticle 
which previously has been shown to be effective in killing bacteria involved in 
HAI. It has been suggested that the high surface area and unusual crystal 
morphology causes the antibacterial effect. A local change in pH and conductivity, 
suggests that there is a release of Cu2+ ions into the solution. The ions are small 
enough to enter the cell and disrupt enzymes, which can lead to the death of 
pathogens.128 
 
 
 
 
Figure 3-1: Diagram illustrating the proposed events that occur during 
contact killing of copper against bacteria. 
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3.1.5 Deposition of copper 
Due to the antimicrobial properties of copper, it may be appropriate to use copper 
for hospital touch surfaces instead of stainless steel to reduce microbial 
contamination. In this chapter, the antimicrobial activity of copper and copper 
oxide deposited via aerosol assisted chemical vapour deposition (AACVD) will be 
described. Copper films have been previously deposited a using different 
variation of CVD, Metal–Organic (MO) CVD, using [Cu(hfac)2] or [Cu(hfac)L] 
(where hfac = hexafluoroacetylacetonate and L = neutral soft donor).129,130 
However, these precursors have a low thermal stability which causes them to 
have a short shelf-life. Improvements on copper precursors have been 
investigated131 and copper alkoxides, such as [Cu(OCHCH3CH2NR2)2] (where R = 
Et or Me) have been used to deposit copper successfully and have the potential 
for low budget synthesis. Copper(I) amidinate [Cu{(iPrN)2CMe}]2 has also been 
used to deposit copper on to a range of substrates.131–133 A disadvantage of this is 
the relatively high temperatures needed for depositions resulting in the formation 
of copper oxide. The structure of these precursors are shown in Fig. 3-2.  
 
 
 
 
 
 
 
 
 
Figure 3-2: Structural diagram of copper precursors a) [Cu(hfac)2], 
b) [Cu(OCHCH3CH2NR2)2] and c) [Cu{(iPrN)2CMe}]2.     
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This investigation describes the deposition of copper metal and cuprous oxide via 
a single step AACVD, and assessment of the antimicrobial activity of the resulting 
films. The copper precursors (Fig. 3-3) that were investigated are copper acetate 
monohydrate (Cu(OOCCH2)2.H2O or Cu(OAc)2.H2O) and copper(II) 
acetylacetonate (Cu(O2C5H7)2 or Cu(acac)2) and copper nitrate trihydrate 
(Cu(NO3)2.3H2O). Copper oxide thin film was also investigated in order to see if 
the antimicrobial activity increases or decreases. Previous investigations have 
shown that the efficacy of copper oxide approaches that of pure copper.134 AACVD 
is a simple and industrially scalable process that has low maintenance and set up 
costs involved in scaling up the process. The AACVD process is able to deposit 
films onto a large variety of substrates for different applications including 
antimicrobial surfaces.   
Figure 3-3: Structural diagram of copper precursors investigated in this chapter 
a) Cu(OAc)2.H2O, b) Cu(acac)2 and c) Cu(NO3)2.3H2O. 
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3.1.6 Susceptibility Testing of Copper Nanoparticles 
 
As described in Chapter 1 there are many methods for preventing the spread of 
microbes in hospitals before they can cause infection to develop. Some 
approaches include using photoactive agents such as TiO2, however this chapter 
describes the antimicrobial properties of metal nanoparticles such as copper.  
Recent research in the field of nanotechnology has been of interest since 
producing nanoparticles (NPs) can offer an alternative strategy to tackle 
nosocomial infections that are resistant to multiples of antibiotics. NPs can 
generally be described as particles that have one dimensional measurement 
ranging from 1 - 100 nm. These dimensions give the NPs unique chemical, optical 
and biological properties that can be manipulated to fit your desired application. 
Whereas, bulk materials possess relatively constant physical properties 
regardless of their size. The size of the NPs allow them to have a greater surface 
area to volume ratio giving NPs chemical properties observed.135,136  
NPs maximise the interaction between the metal and bacteria due to the increase 
surface area improving ion release. For smaller size particles, there is a rise in 
surface area which increases the probability of more interactions with bacteria 
cell membranes. The large surface area of the NPs enhances the interaction with 
the microbes.137 
Metal NPs that exhibit antimicrobial activity have been embedded or coated on 
the surface of materials that can be used in applications for medical devices, food 
processing and packaging.77,138 There is a need for the development of biologically 
compatible material at a nanoscale that can be used in medicine. The 
antimicrobial properties of copper and copper(II) oxide thin films were 
previously described. In this section, the antimicrobial properties of copper and 
copper oxide NPs is discussed.  
In this work, Dr Ralph Leech synthesised water-soluble copper NPs using 
tiopronin as a capping agent and copper nitrate (Fig. 3-4). This produced bright 
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orange copper NPs that were stable in air for up to a week. However, in 
oxygenated water, the NPs would oxidise to form a green solution.  
 
 Antimicrobial Activity of Nanoparticles 
Factors that can influence the NP toxicity can be attributed to size, shape, surface 
charge, concentration, coating on NP, and stability.  It can also be attributed to 
reactive oxygen species and membrane disruption. NPs are generally smaller in 
size than bacterial pores, and they will have the unique ability of crossing the cell 
membrane. It has been reported that the smaller the particle size, the better 
antimicrobial activity. Cu ions released by the NPs may attach to the negatively 
charged bacterial cell wall and rupture it leading to denaturising of proteins and 
cell death. Crossing of NPs from the bacteria cell membrane can then damage the 
vital enzymes of bacteria.137  
The antimicrobial activity of the Cu NPs and oxidised Cu NPs was investigated. 
The Cu NPs and oxidised copper NPs were shown to have antimicrobial activity 
against Escherichia coli (E. coli), Staphylococcus aureus (S. aureus), Pseudomonas 
aeruginosa (P. aeruginosa) and Enterococcus faecium (E. faecium). 
As a way of measuring antimicrobial activity, the minimum inhibitory 
concentration (MIC) and minimum bactericidal concentration (MBC) were 
investigated. The MIC of an antimicrobial agent is the measurement of the 
smallest amount of the agent that is needed to inhibit the growth of the test 
organism, whereas the MBC is the lowest concentration of the agent required to 
kill the test organism.66 To determine the MIC and MBC, the tube dilution 
Figure 3-4: Reaction scheme to show synthesis of tiopronin stabilised Cu NPs (From 
Ralph Leech’s thesis). 
  50 
techniques were performed. This involved a series of culture tubes with differing 
concentrations of the antimicrobial agent, with the same volume of microbial 
concentration. After incubation, the tubes were checked visibly to see if there is 
any growth (turbidity).  The MIC is the lowest concentration of the agent that 
remains clear (no growth). The MBC is observed by planting the concentrations 
that inhibited the growth of the test organism onto the agar. The lowest 
concentration where no growth on the agar, is seen is the MBC. 
The microbial growth with varying concentration of the antimicrobial agent was 
also investigated to detect the number of cells observed by recording the optical 
density.  
 
Phases of Bacterial Growth 
When a culture is allowed to grow in a closed tube/flask, a batch culture is created. 
A typical growth curve for the population of the organism’s cells can be plotted, 
which can describe the entire growth cycle (Fig. 3-5). This growth cycle can be 
broken down into four distinctive phases; lag phase, log phase, stationary phase 
and death phase.66 
There are many different ways to measure bacteria growth; viable counts, dilution 
and measuring turbidity. In the investigation, the turbidity of the cell suspensions 
was recorded. A spectrophotometer is used to measure the turbidity of the cell 
suspensions due to presence of cells causing a scattering of light. The more cells 
present, the more light scatters causing the suspension to appear cloudy. Optical 
density is recorded which indicates that the scattering is proportional to the cell 
density up to high concentrated cultures. 
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1) Lag phase   
This phase describes the time where the microbial population increases in size 
and cell mass but the organisms do not replicate. Immediately after inoculation, 
the cells are adapting to fresh medium causing the bacteria population to remain 
constant. The lag phase is the most difficult in which to predict the growth. Many 
factors influence this stage due to the change in nutrition, physical environment, 
and temperature. The prediction of this phase is important for food industry in 
order to determine the shelf life of products.139,140 
 
2) Exponential or Logarithmic (log) phase 
This is the period where the growth of organism occurs due to the division of two 
or more cells, which in turn divides into two more or cells. Multiplication of cells 
occurs at a rapid rate. The length of this phase depends on the resources available. 
There is a linear relationship between time and logarithm of the number of 
Figure 3-5: Graph depicting the different stages in the growth cycle for bacteria. 
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bacteria cells. This rapid cell multiplication increases the mass exponentially. This 
growth rate is constant and can be expressed as the generation time (the time it 
takes for bacterial cell population to double).139 
 
3) Stationary phase 
The stationary phase is due to growth being carried out in a closed system (batch 
culture) leading to limiting the multiplication of bacteria population limiting due 
to decrease of available nutrients, accumulation of toxic waste material and the 
lack of space. During this stage, the number of cell division is equal to the number 
of cell deaths causing the overall population growth to remain constant. If given 
fresh medium, exponential growth would resume.66  
 
4) Decline or Death phase 
As the resources decrease and the toxic waste material increase, the microbial 
population enters the death phase of the cycle. The number of dead cell begins to 
outnumber the number of live cells reducing the population numbers.66 
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3.2 Experimental 
 
All chemicals used in this report were purchased from Sigma-Aldrich Chemical Co. 
Nitrogen (99.99%) was obtained from BOC and was used as supplied. Deposition 
was on microscope slides or 150 × 45 × 45 mm SiO2 coated float-glass (the SiO2 
acts as a barrier layer preventing diffusion of ions from within the glass into the 
deposition film) which has been supplied by Pilkington NSG. Prior to use the glass 
substrate were cleaned with acetone and isopropanol and was monitored using a 
Pt–Rh thermocouple. 
Nitrogen was passed through a two-way tap, which was used to divert the 
nitrogen carrier gas through a glass bubbler. All deposition experiments were 
conducted by heating the cold-wall horizontal-bed reactor to the required 
temperature before diverting the nitrogen line through the aerosol into the 
reactor. The aerosol was carried into the reactor in a stream of nitrogen gas 
through a brass baffle to obtain a laminar flow. The gas flow was continued until 
all of the precursor mix had passed through the reactor, typically 1 h. The glass 
substrate was allowed to cool with the graphite block under a flow of nitrogen 
until it reached room temperature before it was removed. 
3.2.1 AACVD of [Cu(OAc)2.H2O] with MeOH 
Copper acetate, [Cu(OAc)2.H2O, 2.5 mmol] was added to 40 mL of methanol. An 
aerosol was generated at room temperature using a humidifier with the graphite 
heating block under the glass substrate heating the CVD reactor to 350 - 550 oC. 
The film was allowed to cool under a flow of N2 until room temperature. 
3.2.2 AACVD of [Cu(acac)2] with MeOH 
Copper(II) acetylacetonate, [(Cu(acac)2), 1.91 mmol] was added to 40 mL of 
methanol. An aerosol was generated at room temperature using a humidifier with 
the graphite heating block under the glass substrate heating the CVD reactor to 
350 - 550 oC. Not all of the [Cu(acac)2] was able to dissolve in the methanol and 
some of the precursor was left behind the AACVD bubbler. The film was allowed 
to cool under a flow of N2 until room temperature. 
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3.2.3 AACVD of [Cu(NO3)2.3H2O] with MeOH 
Copper nitrate trihydrate ([Cu(NO3)2.3H2O], 2.07 mmol) was added to 40 mL of 
methanol solvent. After addition the solid was allowed to dissolve and used 
immediately for AACVD deposition. An aerosol was generated at room 
temperature using a PIFCO ultrasonic humidifier. A graphite heating block under 
the glass substrate heated the CVD reactor to 350 °C. Once all the aerosol had 
passed through and had finished, the films were allowed to cool under nitrogen to 
form copper films. To form copper oxide films the experimental procedure was 
the same as for the AACVD reaction to form copper but the film was allowed to 
cool in air instead of nitrogen. 
 
3.2.4 Characterisation 
The resulting copper and copper oxide films were handled and stored in air. The 
coated glass substrates were used for powder X-ray diffraction (XRD) and then 
were cut into 1 cm × 1 cm squares for subsequent analysis by Scanning Electron 
Microscopy (SEM), on a JEOL 6301 filament scanning electron microscope. A 
Perkin-Elmer Lambda 25 UV-Vis Spectrometer was used to measure the UV-Vis 
absorption spectra of copper(I) oxide samples. 
 
3.2.5 Antimicrobial activity 
E. coli strain (ATCC 25922) and S. aureus (8325-4) were maintained by weekly 
subculture on Brain Heart Infusion (BHI) agar (Oxoid, Basingstoke, UK). One 
bacterial colony of either E. coli or S. aureus was used to inoculate 10 mL of sterile 
BHI broth (Oxoid, Basingstoke, UK) and incubated aerobically at 37 °C for 24 
hours. Bacteria from the overnight culture were harvested by centrifugation at 
13000 × g for 1 minute. Bacteria were then re-suspended in phosphate-buffered 
saline (PBS) (Oxoid, Basingstoke, UK) and again centrifuged at 13,000 × g for 1 
minute. Finally the bacterial pellet was re-suspended in PBS before use. The 
turbidity of the bacterial cell suspension was measured at 600 nm using a 
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spectrophotometer and was adjusted to an optical density which corresponded to 
approximately 106 colony forming units (cfu) per 25 μL aliquot. 
Prior to use, the copper and copper(I) oxide slides were cut into 1 × 1 cm sections. 
A humidity chamber was created to ensure that the suspensions did not dry out. 
For each exposure time, triplicate samples were analysed and uncoated glass 
microscope slides were used as a control. Each exposure time was also repeated 
on three separate occasions. A 25 μL aliquot of the bacterial cell suspension was 
spread evenly on the surface of each slide and incubated at room temperature (21 
± 2 °C) for the allocated exposure time. After incubation the slides were aseptically 
transferred to 225 μL PBS and vortexed for 30 seconds to release the bacteria into 
the solution. Serial dilutions of the resulting bacterial suspensions were prepared 
in PBS and 25 μL from each dilution was spread on to MacConkey Agar (Oxoid, 
Basingstoke, UK) for E. coli and BHI agar (Oxoid, Basingstoke, UK) for S. aureus. 
Plates were incubated aerobically at 37 °C for 24 hours. After incubation, any 
bacterial colonies were counted and viable counts of bacteria were calculated. 
Mann–Whitney U test was used to determine the significance of the activity of 
copper or copper(I) oxide slides compared to the control glass slide. 
The longevity of the copper and copper(I) oxide was investigated over 7 days. The 
experiments were repeated, as described above, however the samples were kept 
and not placed into the 225 μL PBS and were not vortexed. Instead only the 
aliquots placed on the sections were vortexed. Serial dilutions of the resulting 
bacterial suspensions were prepared in PBS and 25 μL from each dilution was 
spread on to MacConkey Agar (Oxoid, Basingstoke, UK) for E. coli and BHI agar 
(Oxoid, Basingstoke, UK) for S. aureus. Plates were incubated aerobically at 37 °C 
for 24 hours. The sections of copper and copper(I) oxide were cleaned with 
alcohol (70%) and repeated on day 4 and day 7. Each test was done in triplicate, 
duplicated and compared to glass controls. 
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3.2.6 Bactericidal Assays 
The minimum inhibitory concentration (MIC) was determined using the broth 
dilution method to achieve doubling concentrations of copper nanoparticles 
dispersed in phosphate-buffered saline solution. E. coli (NCTC 25522), S. aureus 
(8325-4), P. aeruginosa (PA01) and E. faecium (E1162) were maintained by 
weekly subculture on Brain Heart Infusion (BHI) agar (Oxoid, Basingstoke, UK). 
One bacterial colony of each of the bacteria mentioned was used to inoculate 10 
mL of sterile BHI broth (Oxoid, Basingstoke, UK) and incubated aerobically at 37 
oC for 24 hours. Bacteria from the overnight culture were harvested by 
centrifugation at 13,000 xg for 1 minute. Bacteria were then re-suspended in 
phosphate-buffered saline (PBS) (Oxoid, Basingstoke, UK) and again centrifuged 
at 13, 000 xg for 1 minute. Finally the bacterial pellet was re-suspended in PBS 
before use. The turbidity of the bacterial cell suspension was measured at 600 nm 
using a spectrophotometer and was adjusted to an optical density which 
corresponded to approximately 106 colony forming units (cfu) per mL aliquot.   
Assays were performed with initial nanoparticle solutions of concentration 8 mg 
ml-1 and were performed in triplicate. 100 µl of double-strength Müller-Hinton 
(MH) broth (Oxoid, Basingstoke, UK) was pipetted into columns of a mircotitre 
plate. 200 µl of nanoparticle solution was placed in column 1 before 100 µl was 
removed and mixed with the MH broth in column 2. 100 µl was removed and 
added to column 3 and mixed. The process was repeated until column 11, at which 
point the nanoparticle-containing aliquot was discarded so to give both a positive 
and negative control. The microtitre plate was incubated for 24 hours at 37 °C 
before the turbidity of the solution was observed by eye. The lowest concentration 
that prevented bacterial growth (clear solution) was recorded as the MIC. The 
minimum bactericidal concentration (MBC) was determined by plating the broth 
solutions from the MIC test onto nutrient agar (Oxoid Ltd) and incubating at 37 °C 
in air overnight. The MBC was defined as the lowest concentration of 
nanoparticles that prevented bacterial growth on the agar surface. 
To examine the bacterial growth rate and to determine the growth curve of E. coli 
(NCTC 25522) and S. aureus (8325-4) in the presence of the copper NPs. E. coli 
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and S. aureus was given in 100 µl of BHI broth supplemented with 2, 1, 0.5, and 
0.25 mg ml-1. The growth rates were determined by measuring the optical density 
(OD) to 600 nm each 30 minutes for 10 hours. OD values were plotted against time 
to produce the growth curve.   
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3.3 Results and Discussion 
 
Initially a range of single-source copper precursors were investigated to study 
which precursors deposited copper thin films reproducibly and with good coverage. 
Copper(II) acetylacetonate, [Cu(acac)2], copper acetate, [Cu(OAc)2.H2O], and copper 
nitrate trihydrate [Cu(NO3)2.3H2O] are readily available copper precursors for a 
single-source deposition of copper thin films and hence AACVD using these 
precursors under a range of conditions was investigated (Table 3-1). 
 
Table 3-1: The results of using a variety of copper precursors, solvents, temperature and 
cooling gas. 
 
Copper 
Precursor 
Solvent 
Temp 
/ oC 
Coolin
g Gas 
Film 
Film 
Colour 
A 
Copper Acetate, 
[Cu(OAc)2.H2O] 
MeOH 350 N2 CuO/Cu2O 
Red, 
orange, 
black 
B MeOH 400 N2 CuO/Cu2O 
C MeOH 450 N2 CuO/Cu2O 
D Acetone 400 N2 Cu/Cu2O 
E 
Copper(II) 
acetylacetonate, 
[Cu(acac)2] 
MeOH 350 N2 Cu 
Metallic 
red/brown 
F MeOH 400 N2 Cu 
G MeOH 450 N2 Cu 
H MeOH 350 Air Cu/Cu2O Orange/yellow 
I 
Copper Nitrate, 
[Cu(NO3)2.3H2O] 
MeOH 350 N2 Cu Metallic red/brown 
J EtOH 350 N2 CuO/Cu2O Red/brown, 
yellow, 
black 
K MeOH 400 N2 Cu/Cu2O 
L MeoH 450 N2 Cu/Cu2O 
M MeOH 350 Air Cu2O Yellow 
 
A number of depositions were investigated (Fig. 3-6) with a change of precursor, 
solvent, temperature and cooling gas. All these factors can have an influence on the 
purity, coverage and reproducibly of the desired thin films.  
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Copper acetate, [Cu(OAc)2.H2O] was found to be soluble in both MeOH and acetone. 
AACVD of copper acetate in MeOH was carried out at over a range of temperatures 
(350 – 450 oC) and the substrate was allowed to cool to room temperature under 
nitrogen to produce a film. For all the temperatures investigated, a non-adhesive 
powdery film was produced consisting of red/brown, yellow and black areas. 
Powder x-ray diffraction (XRD) data identified that a mixture of Cu, CuO and Cu2O 
formed (Fig. 3-7). The solvent was changed to acetone and similar results were seen. 
A non-adhesive mixture of Cu/Cu2O was deposited.   
 
 
Figure 3-6: Scheme diagram of reaction conditions using different precursors. 
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In order to attempt to overcome the formation of mixtures, an alternative copper 
precursor was investigated.  Copper(II) acetylacetonate, [Cu(acac)2] was added to a 
number of different solvents including methanol, ethanol, isopropanol and acetone. 
Methanol was chosen as the solvent for the AACVD experiment due to the copper 
precursor being more soluble in methanol compared to the other solvents. However, 
even after prolonged mixing in a sonicater, all of the [Cu(acac)2] in MeOH did not 
dissolve in the solution. AACVD of [Cu(acac)2] in MeOH was carried out at 350 – 450 
oC and the substrate was allowed to cool to room temperature under nitrogen in an 
attempt to produce an adhesive copper film. Powder XRD data was used to verify 
that polycrystalline copper films were deposited at 350 and 450 oC.  However, the 
highest temperature (450 oC) identified the presence of Cu and Cu2O (Fig. 3-8). As 
the temperature increased, the film coverage decreased with the lowest 
temperature having the most coverage on the substrate. The deposition was 
repeated at 350 oC but the film was allowed to cool in air. This resulted in a film that 
was shown by powder XRD to be mixture of Cu and Cu2O.  
 
Figure 3-7: Powder XRD pattern  of thin films deposited using copper acetate over 
a range of temperatures A) 350 oC, B) 400 oC, C) 450 oC in methanol and D) 400 oC 
in acetone with the Cu, Cu2O and CuO XRD standards. 
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[Cu(acac)2] as a copper precursor was not suitable because there were solubility 
problems, undissolved precursor remained in the AACVD bubbler at the end of the 
deposition. However, copper thin films were able to be deposited. Attempts at 
depositing Cu2O films resulted in a mixture. Therefore, a further copper precursor 
was investigated in an attempt to deposit both Cu and Cu2O without precursor 
waste. AACVD of copper nitrate, [Cu(NO3)2.3H2O], dissolved in methanol was 
investigated under a range of conditions. The temperature of deposition was varied 
from 350 – 450 oC and a range of substrates were used to obtain the optimum 
parameters (Fig. 3-9).  
AACVD of [Cu(NO3)2.3H2O] in methanol resulted in the deposition of copper at 350 
oC. At the end of the deposition, the film was relatively unstable and was readily 
oxidised. Therefore, in order to deposit pure Cu thin films, it was necessary to cool 
to room temperature under nitrogen. The film formed after cooling under nitrogen 
had a uniform coverage and was free from pin-hole defects. The film appeared to 
have a red/brown metallic colour. XRD measurements were performed which 
identified the presence of polycrystalline copper (Fig. 3-9). Using the same 
Figure 3-8: Powder XRD of thin films deposited using  [Cu(acac)2] in methanol at E) 
350 oC, F) 400 oC, G) 450 oC and cooled under N2 and H) filmed cooled in air with the 
Cu, Cu2O and CuO XRD standards. 
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conditions as previously described but allowing the as-deposited films to cool in air 
led to the formation of Cu2O. The film deposited was uniform, yellow and 
transparent. The formation of cuprous oxide was confirmed by powder XRD, which 
showed the presence of polycrystalline Cu2O.  
AACVD of [Cu(NO3)2.3H2O] in methanol at 400 oC followed by cooling under 
nitrogen, resulted in a mix Cu2O/Cu film with good coverage. Powder XRD indicated 
that a mixture of copper and cuprous oxide had formed as shown in Fig. 3-9. In 
contrast, AACVD of [Cu(NO3)2.3H2O] in methanol at higher temperature of 450 oC 
resulting Cu2O/CuO film (Fig. 3-9L) and was confirmed by XRD. Elevated 
temperatures typically results in oxide formation (Cu2O/CuO) with metallic copper 
films usually forming at lower temperatures. Using a different solvent, ethanol, 
resulted in a film with poor coverage and a mixture of copper oxides (Fig 3-9J).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-9: Powder XRD patterns of thin films deposited using [Cu(NO3)2.3H2O] using 
I) methanol at 350 oC, J) ethanol at 350 oC and methanol at K) 400 oC and L) 450 oC, M) 
methanol at 350 oC and cooled in air with the Cu, Cu2O and CuO XRD standards. 
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The optimum parameters that were reproducible were reactions (I) and (M). All of 
the films were deposited onto float glass. However, for microbiology analysis copper 
needs to be deposited onto microscope slides. This brought up challenges whereby 
there were difficulties in successfully depositing copper onto slides with good 
coverage and free of pin-hole defects. Once the float glass was replaced with the 
microscope slides, the film had a tendency to oxidise. If copper did deposit onto the 
slide, it was not easily reproducible or the coverage was poor. This may be due to 
the AACVD rig not being completely air tight although, this did not affect the 
deposition when float glass was used as a substrate.  
It has been suggested that the formation of the Cu and Cu2O films in the AACVD 
reactor occurs in a reducing environment whereby the thermodynamic 
decomposition of [Cu(NO3)2.3H2O]  would produce CuxO.141 
The most reproducible pure copper films were deposited at 350 oC. This suggests 
that there is a reducing environment since it has been reported that hydrogen is 
formed due to decomposition of methanol over a copper catalyst.  The production 
of copper films using methanol was unexpected since it is used as an oxygen source 
to deposit metal oxide thin films. Copper films deposited using ethanol instead of 
methanol (reaction J) at 350 oC did not produce pure films. It has been shown that 
the formation of hydrogen from the decomposition of ethanol is less effective. 
Therefore methanol and substrate temperature of 350 oC is required for the 
deposition of pure copper films using [Cu(NO3)2.3H2O]. 
Many attempts were made to deposit Cu onto microscope slides with good coverage. 
It was found that having the slides directly on the graphite heating block resulted in 
the best depositions when compared to depositions where slides were placed on top 
of float glass. This could be due to the aerosol mist not being disrupted and having a 
streamlined flow. However, the results were not always reproducible and oxidation 
could still occur even if there was good coverage.  
The problem with the deposition can be attributed to surface reactions occurring. 
Glass is based on SiO2 but it also contains many other oxides of elements such as B, 
Ca, Mg or S. There are major differences between the bulk and surface composition 
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of the glass. There tends to be a higher concentration of cations near the surface with 
the surface itself being made up with hydroxyl terminals. During the deposition, the 
hydroxyls form Si-OH bonds through the reaction of the surface SiO2 with 
atmospheric water. The OH groups formed promote formation of hydrogen bonds 
between itself and water/organic liquid causing the surface to become wet. This 
could cause reactions between the water and the cation present near the surface 
leading to a migration of ions to the surface, which could damage the property of the 
films. To prevent diffusion of ions from the glass, float glass has a layer of SiO2 
applied to the surface, which acts as a barrier layer. The microscope slides do not 
have this barrier layer and therefore cause the problem of oxidation that has been 
seen. However, it was found that increasing the concentration of the solution 
enabled the as-deposited films to possess much better uniform coverage, and the 
deposition was reproducible.142,143 Therefore, 1g of [Cu(NO3)2.3H2O] in 40 ml MeOH 
rather than 0.5 g used in the previously described depositions was used.  
 
 
 
Figure 3-10: Thin films deposited using [Cu(NO3)2.3H2O] at 350 oC either 
cooled under N2 to form a) copper or cooled in air to form b) Cu2O. 
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XRD patterns for the Cu and Cu2O films deposited onto microscope slides from 
[Cu(NO3)2.3H2O] produced uniform coverage. Powder XRD confirmed the presence 
of polycrystalline Cu peaks (Fig. 3-10) correspond to (111) and (200) planes 
whereas polycrystalline Cu2O reflections correspond to the (111), (200) and (220) 
planes. The XRD measurements collected not only can be used for unit cell 
refinement to yield lattice parameters but a qualitative analysis of preferred 
orientation can take place. The Cu XRD (Fig. 3-10) showed an enhancement of the 
(111) plane whereas Cu2O exhibit an enhancement in the (200) plane which may be 
related to some preferred orientation. 
All films were uniformly deposited on the microscope glass substrate and all were 
well adhered to the substrate. The films remained attached after the use of Scotch™ 
tape, with damage only observed after scratching with a scalpel. The stability of the 
Cu and Cu2O thin films were tested using different solvents. Both films were left 
unchanged and adhered to the substrate when wiped using water and acetone. 
However, when wiped using nitric acid, the films visibly looked damaged and began 
to remove from the substrate. 
Powder XRD data was used to calculate the lattice parameters. The fitting process 
used the Le Bail model where refinement is limited to (HKL) lines defined by the cell 
and space group. General Structure Analysis System (GSAS) with EXPGUI, a 
graphical user interface editor was performed to control the progression of equally 
weighted fitting to obtain unit cell parameters. Lattice parameters, a, were 
calculated for Cu and Cu2O films and compared with the literature values (Table 3-
2). There is no significant difference between the refined and literature values of 
copper. However, there is a slight difference seen for the Cu2O value. This suggests 
that there is an increase in the lattice parameters, which can be due to oxygen. The 
expansion has been observed previously for metal oxide thin films deposited on 
glass and can be caused by the interaction between the amorphous substrate and 
the crystalline film or by restricted particle size.144 
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Table 3-2: Lattice parameter calculations of Cu and Cu2O. 
 
 
 
 
The morphology of the films was investigated using scanning electron microscopy 
(SEM), as shown in Fig. 3-10. There are many different ways a film can grow on the 
substrate during the AACVD process and the microstructure can have a major 
impact on the properties of the film.81 The SEM images of the copper films deposited 
onto microscope slides are shown in Fig. 3-12a and b. The microstructure consists 
of large particles ranging from 300–600 nm. This is consistent with a Volmer–Weber 
or Island Growth model (Fig. 3-11a).94 This type of growth occurs when atoms 
experience stronger bonding interaction between themselves than with the 
substrate. Copper oxide films deposited onto microscope slides appear rougher with 
different particle sizes ranging from 100–600 nm. The SEM image corresponds to 
particulate growth where the particles have a stronger interaction with the 
substrate rather than to themselves (Fig. 3-11b). 
Cross-sectional SEM was used to directly measure the film thickness of the 
deposited Cu and Cu2O on microscope slides. (Fig. 3-12c and d). The copper and 
copper oxide films produced were relatively thick. The copper films range from 
200–300 nm whereas the copper oxide film is much thicker with a larger range of 
0.4–1 μm. Both films have a structure composed of particles ranging in sizes which 
can be related to the microstructure of the films. 
 
 
 
 
Film Cu Cu2O 
Lattice Parameter, a (Å) 3.62(6) 4.29(6) 
Fitted wRp 0.067 0.0976 
Literature Value 3.61145 4.26(9)146 
(a) (b) 
Figure 3-11: Film growth model of a) Island growth and b) Particulate growth. 
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Figure 3-12: SEM micrograph of a) Cu film grown via AACVD of 
[Cu(NO3)2.3H2O] in methanol at 350 °C and cooled under N2 (Reaction I), 
b) Cu2O film deposited from [Cu(NO3)2.3H2O] in methanol at 350 °C and 
cooled in air (Reaction M). Side-on SEM of the c) Cu film and d) Cu2O film. 
  
 
68 
3.4 Antimicrobial Activity of Copper and Copper(I) Oxide 
 
The antimicrobial properties of the copper and copper oxide films, deposited from 
[Cu(NO2)3.3H2O] via AACVD, against E. coli and S. aureus were investigated. Films 
were deposited onto microscope slides and cut in 1 × 1 cm sample sections. These 
sections were covered with 25 μL of bacterial cell suspension containing 
approximately 106 cfu. Serial dilution and spreading of the bacterial cell suspensions 
on to agar plate (MacConKey agar for E. coli and BHI agar or S. aureus) and 
subsequently incubated overnight at 37 oC. This resulted in viable counts of bacteria 
for each sample that was counted and recorded over a variety of exposure times. 
Mann Whitney U test were performed on the results of the antimicrobial testing, 
which showed that all the reduction in bacteria cell viability were highly significant 
(P < 0.001) for all exposure times. 
The results for the copper films, shown in Fig. 3-13, demonstrated that the films 
have antimicrobial activity against E. coli and S. aureus. For E. coli, a 2.1-log10 
reduction in viable bacteria was observed after 15 minutes and 4-log10 reduction 
was obtained after 30 minutes, as shown in Fig. 3-13a. In the case of S. aureus, a 2.7-
log10 reduction in viable bacteria was achieved after 30 minutes and 4-log10 
reduction was observed after 1 hour (Fig. 3-13b). For both bacteria, the copper films 
produced highly significant reduction of the bacterial cells when compared to the 
glass controls. These copper thin films deposited via AACVD have shown similar 
antimicrobial activity to previous research into copper coupons.147,148 Fig. 3-13c 
shows the antimicrobial activity of copper oxide against E. coli and S. aureus. The 
copper oxide samples tested against S. aureus gave a 2.7-log10 reduction in viable 
bacteria after 45 minutes and a 4.7-log10 reduction after 1 hour. In the case of E. coli 
the copper oxide films were less active giving a 1.2-log10 reduction in viable count 
after 45 minutes and a 2.7-log10 reduction after 1 hour.  
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In the work described, the antimicrobial activity of copper was compared to 
copper(I) oxide in order to see if the oxidation would increase the antimicrobial 
effectiveness. Both samples were tested against E. coli and S. aureus. The results 
show that the two types of film have different antimicrobial efficacies against E. coli 
(gram negative) and S. aureus (gram positive). From the results presented, E. coli 
had lower bacterial cell counts when exposed to copper than to copper oxide, 
whereas with S. aureus similar levels of bacterial activity were observed with copper 
and copper(I) oxide films. The toxicity of the samples can be attributed to the release 
of copper ions under wet conditions. Studies have shown that copper ions play an 
important role in the toxicity of copper containing materials.76 Some research has 
shown that particular strains of bacteria are more vulnerable to different copper 
Figure 3-13: Viable colony counts of bacteria after incubation on Cu thin films tested against 
a) E. coli, b) S. aureus and viable counts of bateria of Cu2O against c) E. coli  and d) S. aureus.  
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ions.148 Previous reports have shown that the antimicrobial efficacy of Cu2O 
approaches that of copper which is thought to be due to the fact that localised 
corrosion could lead to the release of Cu(I) ions.127 Therefore, oxide formation on 
copper objects should not greatly impair the antimicrobial efficiency. The 
mechanism for copper materials toxicity are not fully understood currently but the 
results presented herein demonstrate the high antimicrobial activity of both copper 
and copper(I) oxide films deposited via AACVD. 
A comparison of the results obtained in this study to other antimicrobial copper and 
copper oxide investigations is given in Table 3-3. The table indicates the results from 
this investigation were comparable to previous studies with similar inoculum 
concentration used.  The antimicrobial effectiveness was either similar or better 
than previous investigations. The previous studies also show how oxidation of 
copper does not affect the antimicrobial activity. 
 
Table 3-3: Results from copper and copper oxide against a range of activty from previous 
investigations. 
Sample Species Time / min Inoculum  Reference 
Cu 
E. coli 40 – 60 
2 x 107 cfu S. W. J. Gould et al.
124  
S. aureus 60 
Cu MRSA 75 2 x 107 cfu H. T. Michels et al.
149  
Cu E. coli 65 2 x 107 cfu J. O. Noyce  et al.
117 
CuxO 
E. coli 80 
108 cfu/ml H. M. Yates et al.
150 
S. epidermidis 80 
Cu E. coli 65 107  cfu S. A. Wilks et al.
114  
Cu E. hirae 300 
108 cfu M. Hans et al.
134 
Cu2O E. hirae 300 
Cu 
E. coli 30 
106 cfu Our results 
S. aureus 60 
Cu2O 
E. coli 60 
S. aureus >60 
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In order to investigate the films potential suitability for use in a healthcare setting, 
the antimicrobial longevity after cleaning was tested. The exposure times chosen 
were the longest times recorded that exhibited the highest bacterial reduction (one 
hour or 30 minutes). On the first day after serial dilution and plating was carried 
out, the samples were cleaned with alcohol (70%) and left to dry. This was repeated 
a further two times over a week. These results showed that the reduction in viable 
bacteria counts was maintained over the seven day testing period and the 
antimicrobial activity of the films did not significantly change when they were 
repeatedly cleaned and retested used. After the initial testing on day one, the 
reduction of E. coli and S. aureus was affected and there was a reduction in the rate. 
However, the bacterial efficacy still remained highly significant, as shown in Fig. 3-
14. HAI bacteria, such as E. coli and S. aureus, can potentially survive on touch 
surfaces for days even though cleaning procedures are used by healthcare workers'. 
The Cu and Cu2O thin films, however, have demonstrated the ability to maintain the 
reduction in bacterial cell viability over a seven day period. 
 
 
 
Figure 3-14: Viable counts of bacteria after incubation on Cu and Cu2O thin films 
tested three times over 7 days. a) Cu and b) Cu2O were tested against S. aureus (1 h 
incubation). c) Cu and d) Cu2O against E. coli (30 min or 1 h incubation respectively). 
The glass control tested against e) E. coli and f) S. aureus (1 h incubation). 
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3.4.1 Results and Discussion 
 
The antimicrobial activity of the nanoparticles dispersed in cultures of E. coli (NCTC 
25522), S. aureus (8325-4), P. aeruginosa (PA01) and E. faecium (E1162) was 
investigated by determining the minimum inhibitory concentration (MIC) and 
minimum bactericidal concentration (MBC). These are defined as the minimum 
concentration of material that inhibits the growth of bacteria and the lowest 
concentration of bactericidal agent that kills 99.9% of bacteria. 
In order to determine the MIC, the NPs were dispersed into bacterium suspended in 
PBS solution to a broth concentration of 106 cfu ml-1. The concentration of the 
copper and the oxidised copper NPs range between 0.5 – 2 mg ml-1. This was 
determined by serial dilution (see chapter 2) in a microtitre plate. The NPs were 
tested against gram negative (E. coli and P. aeruginosa) and gram positive (S. aureus 
and E. faecium). Ranges of NP concentration were achieved through serial dilution 
and incubation of the microtitre plate for 24 hours at 37 oC. Inhibition of bacterial 
growth will result in clear suspension. However, bacterial growth will cause the 
solution to be cloudy. The turbidity of the solution was recorded. The lowest 
concentration of the NPs that maintain the clear suspension is the MIC.   
There are different ways the Cu NPs, the antimicrobial agents, can affect the 
bacterial growth. The NPs can be described as bacteriostatic or bactericidal. 
Antimicrobial agent can be cidal, which will kill all the microbes whereas static 
means they inhibit growth of microbes but do not kill the existing cells. Figure 3-15 
shows how viable colony counts can be affected with bacteriostatic or bactericidal 
antimicrobial agents. With the addition of bacteriostatic agent, the number of viable 
bacteria cell remains constant. However, the addition of bactericidal agent causes 
the viable bacterial cells to drop rapidly as the antimicrobial agent kills the microbial 
cells.151   
A range of concentrations of NPs was achieved through the serial dilution of an 
initial solution until there was no inhibition on bacterial growth. The MIC of the Cu 
NPs for both S. aureus and E. faecium was observed to be 0.5 mg ml-1. Whereas, the 
MIC for E. coli and P. aeruginosa was 1 mg ml-1. For all, samples the MBC was the 
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same as the MIC except for E. faecium. This suggests that the nanoparticles may act 
in a bactericidal manner where the bacteria would be killed in the presence of 
copper NPs rather than just having their growth inhibited (Table 3-4). 
 
 
 
 
 
 
 
 
 
 
 
Table 3-4: Minimum inhibitory and bactericidal concentrations for copper and copper oxide 
nanoparticles against gram positive and gram negative bacteria strains. 
 MIC (µg ml-1) MBC (µg ml-1) 
Cu NPs CuxO NPs Cu NPs CuxO NPs 
E. coli (NCTC 25522) 1000 1000 1000 1000 
P. aeruginosa (PA01) 1000 1000 1000 1000 
S. aureus (8325-4) 500 500 500 1000 
E. faecium (E1162) 500 1000 1000 1000 
 
 
 
Figure 3-15: Diagram showing the difference in growth between bacteriostatic and 
bactericidal antimicrobial agents. 
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The concentrations required to show an inhibitory and bactericidal effect on the 
bacteria found in these experiments are higher than in much of the reported work. 
Samples of copper NPs of a similar diameter to those produced in this work were 
shown to exhibit an MIC and MBC of 0.140 - 0.28 mg ml-1 and 0.16 – 0.30 mg ml-1 
respectively, depending on the strain of E. coli used. However, this work used 
particles without stabilisation and initial bacterial concentrations of 103-104 cfu      
ml-1 whereas in our experiments, initial concentrations of bacteria were higher at 
106 cfu ml-1.  
 
Table 3-5: Table of MBC values of copper and copper oxide NPs from previous 
investigations. 
Nanoparticle 
Bacterial 
Strain 
MBC 
(µg ml-1) 
Inoculum 
(cfu ml-1) 
Reference 
Cu 
E. coli 250 
5 x 107 G. Ren et al. 128 
S. aureus 1000 
P. aeruginosa 2500 
CuxO 
E. coli 250 – 500 
S. aureus 2500 
P. aeruginosa 2500 - 5000 
Cu 
E. coli 160 - 300 
103 - 104 
J. P. Ruparelia et 
al. 152 S. aureus 160 
CuO 
E. coli 103 
105 - 106 
V. V. T. Padil et 
al. 153 S. aureus 120 
Cu 
E. coli 30 - 95 
106 A. Azam et al. 154 S. aureus 32 - 100 
P. aeruginosa 35 - 85 
 
The MIC of the copper NPs may be affected by the oxidation process that occurs over 
the course of the experiment. It has been seen that copper oxide NPs need a higher 
concentration to achieve bactericidal effect when compared to copper NPs. The 
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results in this investigation have shown that the CuxO nanoparticles had similar MIC 
and MBC to the Cu NPs suggesting that the oxidation has little effect on these NPs. 
The most likely explanation for the higher concentrations of the NPs required to 
achieve a bactericidal effect in this work is the much higher concentration of 
bacteria used in our work.  
In further experiments, strains of gram negative (E. coli) and gram positive (S. 
aureus) bacteria were incubated in Müller-Hinton broth media supplemented with 
copper NPs. The growth rate of the bacteria were monitored up to 10 hours to 
investigate how the presence of NPs can affect the different stages of bacterial 
growth. There are different phases of growth of bacteria in a liquid medium; lag 
phase, log phase, stationary phase and death phase (see Fig. 3-14). 
This inhibition of the growth of the bacteria is expected for concentrations on or 
below the MIC. Concentration on or above the MBC, complete kill of bacteria cells 
was observed in the growth curves. This inhibition in growth from antimicrobial 
agents has been seen previously. The initial lag phase occurs during the first two 
hours where the E. coli bacteria are adapting to the environment. This is followed by 
the log phase, which is a period of rapid duplication of bacteria leading to 
exponential growth. The third period is the stationary phase where the graph starts 
to plateau due to the rate of multiplication being equal to the rate of death. Similar 
growth curve was also seen for S. aureus.  
The initial lag phase for the bacteria grown in the presence of NPs is seen to cause a 
delay in the initial lag phase when compared to the control. An inhibition of growth 
and reproduction of bacteria cells was observed. The NPs have caused a delay in the 
cells adapting to the new environment and allowing cells to prepare for exponential 
growth. For E. coli (Fig. 3-16), the Cu NPs have an additional 90 minutes delay 
(inhibition) to start the lag phase when compared to the control curve. Whereas, the 
growth of S. aureus in the presence of NPs (Fig. 3-17) has a delay at the start of the 
lag phase for 210 minutes when compared to the control. This inhibition in growth 
of bacteria has been seen previously.128,152  
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For E. coli, with Cu NPS concentrations above the MIC (0.5 and 0.25 mg ml-1) bacteria 
were able to grow (Fig. 3-16). The Cu NPs were able to inhibit their growth for four 
hours. However, for S. aureus only Cu NP concentration, of 0.25mg ml-1 were they 
able to grow (Fig. 3-17). The Cu NPs were able to inhibit the growth for a longer 
period of time of over 6 hours  
 
 
 
 
Table 3-6: Generation time calculated during the log phase for the E. coli growth curve 
Growth Curve 
Generation Time 
/ min 
Control 35 
0.25 mg ml-1 50 
0.5 mg ml-1 50 
 
 
Figure 3-16: Growth curve of  E. coli cells grown with differing concentrations  of  Cu NPs. 
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Usually, serial dilution and viable colony counts at 30 minute intervals are necessary 
to calculate the colony forming counts (cfu). However, the optical density (OD) can 
be used as an indication of increasing bacterial cell density which is proportional to 
the cell population. Two points (0.2 and 0.4) on the optical density scale were chosen 
to represent the doubling of cell numbers (turbidity). The generation time was only 
calculated for E. coli with the Cu NPs. This is due to the fact that the S. aureus growth 
curves had not reached the log phase after 10 hours.  
The generation time calculated for the control curve for E. coli is 35 minutes. This 
indicates that it in the control it takes 35 minutes for E. coli growth was 35 minutes 
to double in cell mass. With the inclusion of Cu NPs in the growth of E. coli at 
concentrations of 0.25 mg ml-1 and 0.5 mg ml-1, the generation time increased to 50 
minutes. This indicates that the inclusion of the Cu NPs has increased the time it 
takes the E. coli mass to double, therefore decreasing the growth rate.   
 
Figure 3-17: Growth curve of  S. aureus cells grown with differing concentrations of  Cu 
NPs. 
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3.5 Conclusion 
 
The antimicrobial efficacy and repeatability of copper and copper(I) oxide thin films 
deposited via AACVD using [Cu(NO3)2.3H2O] in methanol at 350 °C either cooled 
under nitrogen or air were investigated. This thin film technique is a simple and 
industrially scalable process. An advantage of AACVD is the ability to deposit on a 
wide range of substrates including the commonly used materials on touch surfaces 
in hospitals, such as stainless steel. We examined the antimicrobial activity of copper 
and copper(I) oxide films against E. coli and S. aureus. The antimicrobial activity of 
both copper and copper(I) oxide showed a highly significant reduction in viable 
bacterial counts. The results indicate that antimicrobial effectiveness is not reduced 
when copper is oxidised. The results have also shown that after repeated cleaning 
and testing over seven days the activity of the thin films is still highly significant. 
Further studies would involve quantifying the release of copper ions from the films, 
as well as investigating the impact of morphology on antimicrobial activity.   
The MIC and MBC of Cu NPs were tested against a range of bacteria and found to 
have a MIC and MBC of 0.5 – 1 mg ml-1. These values are higher than expected due 
to the high concentration of initial bacterial suspension. The growth curve of the Cu 
NPs was carried out over 10 hours against E. coli and S. aureus. It was seen that Cu 
NPs concentration was below the MIC concentration. However, the Cu NPs were able 
to inhibit the growth between 4 – 6 hours.  
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Indium Oxide and Gallium Oxide 
 
The following chapter presents the results obtained from the deposition of indium 
oxide and gallium oxide thin films and investigating the different properties of the 
films. The thin films materials were fully characterised and the transparent 
conducting properties of indium oxide were investigated whereas the gallium oxide 
films were tested for their antimicrobial properties using serial dilution and viable 
colony counts on to agar plates.  
4 
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4. Introduction 
There has been a lot of interest in thin films of group 13 metal oxides. In this 
chapter we will be looking at indium oxide and gallium oxide and exploring their 
different properties. Indium oxide (In2O3) and gallium oxide (Ga2O3) were 
deposited using methanol as an oxygen source as well as a solvent. In2O3 is a 
transparent conducting oxide (TCO) and these properties will be explored. The 
antimicrobial activity of Ga2O3 was also investigated.  
 
4.1 Transparent Conducting Oxides 
TCOs are found in a wide range of applications that require materials to be 
conductive and transparent in the visible region of light. Therefore, the TCO 
material must have a band gap >3.2 eV (< 380 nm). There is enormous interest in 
increasing the conductivity of existing TCOs or identifying alternatives. TCOs are 
typically composed from doped or undoped semiconductors and combine the 
ability of high electrical conductivity and high optical transparency. The standards 
of TCO are to transmit >85% of visible light and have a high electrical conductivity 
(<10-4 Ωcm).155–159 
The most widely used and developed TCO is indium-tin-oxide (ITO). It is used as a 
standard for TCOs in industry. ITO is made from the doping of tin into indium oxide. 
The Sn4+ cations replace the In3+ ions resulting in an overall positive charge 
imbalance. This results in more electrons being available in the conduction band 
(n-type doping). The conductivity of the ITO improves due to the higher 
concentration of charge carriers.160,161,157  
Conductivity is reliant on the mobility of the charge carriers and in order to 
improve the electrical conductivity, the mobility of the charge carriers must 
increase. Charge carriers are dependent on the number of defects in the film. The 
defects affect the effective mass of the charge carriers and a reduction in the 
number of defects will decrease the effective mass resulting in higher carrier 
mobility. Materials that possess high levels of doping reduce carrier mobility that 
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in turn decrease film transparency due to more charge scattering from ionised 
impurities. 
On account of these properties, TCOs can be found in optoelectronic devices such 
as flat panel displays and photovoltaic cells.162 A range of metal oxides can be used 
as TCO such as In2O3, ZnO and SnO2.163–165 To improve the properties of the TCO 
materials, doping of the metal oxide is carried out to yield highly conductive thin 
films. These are examples of n-type TCOs where the conductivity is attributed to 
shallow donor states located near the conduction band, which are far superior to 
the p-type TCOs that produce poorer materials. In order to improve the 
conductivity of TCOs, the mobility of the charge carriers must be increased.155 This 
depends on the number of defects present in the film. The selection of appropriate 
dopant is based on the knowledge of band structure for the metal oxide material.  
 
4.1.1 Band theory of solids  
Indium oxide, gallium oxide and zinc oxide (chapter 5) are examples of 
semiconductors, which falls between an insulator and a conductor. For a 
semiconductor, the electrical conductivity increases as the temperature increase. 
This is due to possessing a small enough band gap between the valence band and 
conduction band that thermal excitation can bridge the gap. The conductivity of a 
material relies on the delocalised valence electrons.  
The position of the Fermi level is important and influences the conductivity of a 
material. The Fermi level is defined as the highest occupied orbital at absolute zero 
(T=0). When the valence band is not completely full and the fermi level is close 
enough, electrons can be promoted to the empty levels. This will result in a 
movement of electrons and the material is an electrical conductor. 
There are different types of semiconductors; intrinsic, n-type and p-type. An 
intrinsic semiconductor, such as silicon, is shown Fig. 4-1b. The Fermi level lies in 
between the bands and the band gap is small enough for thermal energy to promote 
electrons to the upper band. This leaves positive holes (an absence of electrons) in 
the valence band that results in the material being conductive. 
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The Fermi level position can be altered with the addition of dopants in the form of 
electron holes or excess electrons producing p-type and n-type semiconductors. If 
a material has an addition of impurities, which contributes to the number of 
electrons (e.g. Sb and P) the Fermi level is raised towards the conduction band. This 
greatly increases conductivity due to the extra electrons being easily excited into 
the conduction band, hence these are n-type semiconductors (Fig 4-2a). If a 
material has an addition of impurities (e.g. Al and Ga) that provide ‘positive’ holes 
(electron acceptors) to the material, it is a p-type semiconductor. This lowers the 
fermi level towards the valence band allowing electrons to be mobile, which 
increases conductivity (Fig. 4-2b). 
 
 
 
 
Figure 4-1: Energy band theory for solids. 
Figure 4-2: Doping of n-type and p-type semiconductors. 
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4.1.2 Indium oxide 
Indium oxide (In2O3) is a wide band gap, n-type semiconductor, which usually have 
a cubic bixebyte structure. In2O3 can easily be doped with other metals to enhance 
the properties of the films. Unlike Ga2O3, In2O3 is an electrical conductor at room 
temperature and transparent in visible light therefore are commonly used as TCOs. 
A direct band gap of In2O3 has been widely stated to be ~3.7 eV however, a weaker 
absorption at ~2.6 eV (indirect band gap) has also been observed that is associated 
with defects.166,167  
 
4.1.3 In2O3 deposition 
There are a variety of different deposition techniques that can be used to deposit 
In2O3 ranging from sputtering, CVD and screen printing. Previous investigations 
have used InCl3 as an Indium precursor via spray pyrolysis or alternative CVD 
process such as ultrasonic spray CVD. Extensive research has been carried out in 
synthesising single-source precursor to deposit In2O3 usually using indium 
alkoxides, [R2In(OR’)]2, R = Me, Et; R’ = CH2CH2NMe2, CH2CH2OMe. However, the 
precursors can be air or moisture sensitive. In this investigation we deposit In2O3 
in a single step process via AACVD.168,169 
 
4.1.4 Gallium oxide 
Gallium oxide (Ga2O3) which crystallizes primarily in the monoclinic β crystal 
structure, has high chemical stability, and is thermally stable (melting point 
approximately 1900 °C). While being an electrical insulator at room temperature, 
Ga2O3 becomes semiconducting above 500 °C.169,170 This wide band gap 
semiconductor material, having the ability to operate at higher temperatures, 
presents a potential practical application as a gas sensor. At higher temperatures, 
(> 900 °C) its electrical conductivity is reliant on the concentration of oxygen, 
thereby it is able to measure the proportion of oxygen levels in a system.  At lower 
temperatures (> 500 °C), Ga2O3 thin films acts as a surface-control-type sensor to 
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reducing gases.  Therefore, it may be feasible to adjust the function of the gas sensor 
from reducing gases to oxidizing gases with temperature when using Ga2O3.171–173  
Gallium is a semi-metallic element that is normally inert. The main application for 
gallium (Ga3+) is as a semiconductor, such as gallium arsenide and gallium nitride. 
Gallium is not known to have any biological role due to its low bioavailability. 
However, gallium has demonstrated harmful effects on microorganisms, 
particularly in mechanisms involving the metabolism of iron.174  
Gallium has been used in biological studies despite having no known physiological 
functions in the human body. The mechanism for the antimicrobial activity of 
gallium (Ga3+) is due to its ability to mimic iron (Fe3+) but not to participate in redox 
reactions. Gallium is able to compete with iron and interferes with the absorption 
and activity of Fe3+. Iron is important for cell division and essential for the 
formation of DNA.  Therefore disruptions in the absorption of iron can cause the 
cells not to be able to produce sufficient DNA for replication, which ultimately leads 
to its death.174–176  
Iron is a vital metal used in quaternary proteins containing heme molecules such 
as haemoglobin, and myoglobin. Iron also plays an important role in forming iron-
sulphur (Fe-S) clusters inside proteins that catalyse a wide range of biochemical 
reactions and pathways. Any kind of disruption of these proteins and reactions can 
cause a shutdown in a number of cellular operations. Cytochrome is a 
metalloenzyme (protein containing a metal ion) that is important as it facilitates 
the transfer of electrons acquired from reduced molecules. Some microorganisms 
use different species as electron donors (e.g. Fe2+, H2) and electron acceptors (e.g. 
Fe3+, SO42-).176 
The poor solubility of iron materials causes a low dissolved concentration of Fe3+ 
(~10-10 mol/L).176 This leads to iron becoming a limiting factor for growth of 
microorganisms. To overcome this, bacteria and fungi excrete organic compounds 
known as siderophores. Siderophores are Fe3+ scavengers due to their solubility 
and have ligands that act as reactive sites that bind to Fe3+ cations.176–179      
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Gallium with a trivalent charge (Ga3+) has an ionic radius of ~0.55 Å that 
corresponds well with Fe3+ (~0.5 Å). This can allow Ga3+ to displace Fe3+ in 
biochemical molecules and pathways. However, iron is redox active but gallium is 
not. Therefore, the substitution of Fe3+ with Ga3+ will lead to the inactivation of Fe-
dependent biomolecules.  
Gallium is Food and Drug Administration (FDA) approved for intravenous 
administration. Studies carried out in the 1960s, demonstrated the ability of 
radioactive gallium (67Ga) at high concentration to target tumour cells. This has 
developed to a 67Ga scan that is used as imaging and detection for tumours and 
cancers. 67Ga has been seen to be most useful in the detection of viable 
lymphomatous tumours in Hodgkin’s and non-Hodgkin’s lymphoma.180–182   
The ability of 67Ga has led to an increased investigation into antitumor potential of 
gallium. Studies carried out in 1970s compared toxicity of group 13 (trivalent 
cations) including gallium, aluminium, and indium. This research showed gallium 
nitrate had the highest antineoplastic activity towards tumours and was also the 
least toxic.183,184   
The National Cancer Institute (NCI) continued research into the antitumor 
effectiveness of gallium nitrate in Phase 1 and Phase 2 clinical trials. Two different 
clinical trials used gallium nitrate administered using two arrangements; a 
constant intravenous infusion given over 24 hours for 5 – 7 days or short 
intravenous infusion over 15 – 30 minutes.180,185–187    
Antimicrobial activity of gallium has been demonstrated with in vitro investigation 
of gallium in the form of gallium maltolate188,189 and gallium nitrate.190,191 Studies 
have shown that gallium nitrate can inhibit the growth of biofilms. Biofilms were 
grown in the presence and absence of low concentration of gallium nitrate and it 
was observed that limiting the presence of Fe in the nutrients had a positive 
correlation with the concentration of Ga and microbial reduction was observed. 
However, when Fe was introduced into the medium, competition between the Ga3+ 
and Fe3+ occurred causing the antimicrobial activity of Ga to decrease.192,193 
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Gallium oxide (Ga2O3) is a potential source of Ga ions and investigations into the 
antimicrobial activity of Ga3+ were carried out using Ga2O3-doped phosphate-based 
glasses (PBGs). PBGs are durable materials used as wound dressings where 
antibacterial ions such as copper and silver are incorporated. This unique system 
would be able to deliver Ga3+ as the glass degrades. The tests demonstrated that 
the PBGs had antibacterial effects on different HAI bacterial agents. Results 
indicated that 1% mol Ga2O3-doped was sufficient to be potent against a range of 
organisms tested. Investigation on Ga2O3 nanoparticles have shown that they 
interfere with the adhesion mechanism of bacterial strains. This could reduce the 
formation of biofilms.194  
 
4.1.5 Ga2O3 deposition  
Ga2O3 can be easily deposited using aerosol assisted chemical vapour deposition 
(AACVD). In situ reaction of [Ga(NMe2)3]2 or GaR3 and ROH (R = CH2CH2NMe2, 
CH(CH2NMe2)2, CH(CH3)CH2NMe2, CH2CH2OMe and C(CH3)2CH2OMe) in toluene 
have been carried out.88 Different morphologies were observed depending on the 
donor functionalised alcohol used. This is an investigation of methanol as a 
reactant and the carrier solvent, in combination with GaMe3, to form Ga2O3 thin 
films.  We have previously shown that the in situ AACVD of GaMe3 and donor 
functionalised alcohol in toluene yielded transparent films of β-Ga2O3 at 450 oC. 
However, the use of methanol as the solvent has been shown to lead to different 
microstructures for rutile or anatase titanium dioxide films deposited via AACVD.91 
A change in microstructure or phase could in turn affect the functional properties 
of the films.  Therefore, we were interested in investigating the effect of using 
methanol in place of a donor functionalised alcohol as the oxygen source. Methanol 
was used to investigate whether it was possible to deposit Ga2O3 using a mono-
functionalised alcohol which has not been previously reported in the literature.   
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This chapter describes the deposition of indium oxide and gallium oxide, and then 
an assessment on their properties. The gallium precursors investigated are gallium 
nitrate [Ga(NO3)3] and trimethylgallium [Ga(CH3)3], whereas the indium oxide 
precursor investigated was trimethylindium [In(CH3)3]. In order to analyse the 
effect of solvent on the characteristics of the film, different additives were 
investigated. Two types of diols, ethylene glycol HOCH2CH2OH and diethylene 
glycol, ((HOCH2CH2)2O, digol), and donor functionalised alcohol HOCH2CH2NMe2 
were studied as oxygen source additives (Fig. 4-3).  
 
 
 
 
 
 
 
 
 
 
Due to gallium having natural antimicrobial activity, the effectiveness of the 
gallium oxide films will be explored. Indium is not an antibacterial agent, therefore 
the TCO properties will be analysed. The appearances, morphology and 
reproducibility of the films will be examined in order to choose conditions that 
produce films that are best for its applications.  
 
  
Figure 4-3: Structural diagram of a) M(CH3)3, b) ethulene glycol and c) 
diethylene glycol.  
  88 
4.2 Experimental 
 
4.2.1 Materials and General Methods  
The precursor solution for all AACVD depositions was placed in a glass bubbler and 
vaporised by use of a Vicks ultrasonic humidifier. This produced an aerosol of the 
precursor in the solvent used. Nitrogen (99.9%) carrier gas was used as supplied 
from BOC. Depositions were carried out on SiO2 coated float-glass that was cleaned 
using propan-2-ol, acetone and dried in air prior to use. The glass substrates were 
of ca. 90 mm x 45 mm x 4 mm in size. The heating of the glass substrate to the 
desired temperature was carried out under nitrogen gas and two-way taps were 
used to divert the nitrogen carrier gas through the bubbler. The aerosol was carried 
into the reactor in a stream of nitrogen gas through a brass baffle and a top plate 
was suspended 0.5 cm above the glass substrate to ensure a laminar flow. After all 
the precursor solution had passed through the chamber the taps were turned to 
allow only N2 gas flow through the bypass tap. This was maintained until the 
reaction chamber temperature fell below 100 °C. The N2 gas was stopped and the 
glass substrates were removed. The N2 gas flow rate was controlled by a calibrated 
flow meter positioned before the gas enters the bypass bubbler. The total 
deposition time was in the region of 50 – 80 min.  
A graphite block containing a Whatman cartridge heater was used to heat the glass 
substrate. The temperature of the substrate was monitored by a Pt–Rh 
thermocouple. Coated substrates were handled and stored in air. Large pieces of 
glass (ca. 4 cm x 2 cm) were used for X-ray powder diffraction but the coated 
substrate was cut into ca. 1 cm x 1 cm squares for subsequent analysis by SEM, 
WDX, transmission/reflectance and UV absorption studies. 
InMe3 and GaMe3 were used as supplied from SAFC HiTech. InMe3 and GaMe3 are 
pyrophoric and hence manipulations involving these chemicals were performed 
under a dry, oxygen-free dinitrogen atmosphere using standard Schlenk 
techniques or in an Mbraun Unilab glovebox. All solvents and alcohols 
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commercially procured from Aldrich were dried with anhydrous engineering 
equipment and stored in Young’s tap flasks.   
4.2.2 AACVD reaction of Ga(NO3)3 and HOCH2CH2OH  
Dried methanol or toluene (30 ml) was added to gallium nitrate [Ga(NO3)3, 1.56 
mmol] and ethylene glycol [HOCH2CH2OH, 4.69 mmol]. The resulting solution was 
mixed under N2 for 30 minutes in the AACVD bubbler. The resulting solution was 
mixed for 30 minutes using a sonicater in the AACVD bubbler. The substrate was 
heated to 450 oC and 550 oC in separate experiments under a flow of N2 at 1 L/min. 
After the N2 was diverted through the bubbler, the aerosol was transported into 
the reaction chamber. Once deposition was complete the substrate was cooled to 
below 100 oC under N2, before being removed and stored in air. The film deposition 
time was 1 hour and transparent films covering the entire glass substrate were 
produced. At each temperature a transparent film with a white powdery 
appearance was deposited.   
4.2.3 AACVD reaction of Ga(NO3)3 and (HOCH2CH2)2O 
Dried methanol or toluene (30 ml) was added to gallium nitrate [Ga(NO3)3, 1.74 
mmol] and digol [(HOCH2CH2)2O, 10.45 mmol]. The resulting solution was mixed 
under N2 for 30 minutes in the AACVD bubbler. The substrate was heated to 400 oC 
and 450 oC in separate experiments under a flow of N2 at 1 L/min. At each 
temperature a transparent film with a white powdery appearance was deposited.   
4.2.4 AACVD reaction of GaMe3 with diols 
Dried methanol (30 ml) was added to trimethylgallium [GaMe3, 1.74 mmol] and 
either ethylene glycol [HOCH2CH2OH, 10.45 mmol] or digol [(HOCH2CH2)2O, 10.45 
mmol] at -78 oC. The resulting solution was mixed under N2 for 30 minutes in the 
AACVD bubbler. The substrate was heated to 450 oC under N2 at 1 L/min. A 
transparent film was deposited with uniform coverage and a slight brown tinge.  
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4.2.5 AACVD reaction of GaMe3 and methanol  
Dried methanol (30 ml) was added to trimethylgallium [GaMe3, 4.35 mmol] at -78 
oC. The resulting solution was mixed under N2 for 30 minutes in the AACVD 
bubbler. The Ga2O3 films deposited at 450 oC were amorphous. In order for the 
crystalline phase to be observed, the films were annealed at a high temperature. 
The same procedure was carried out but a quartz piece placed on top of the glass 
substrate. The quartz piece was placed in a furnace set at 1000 oC overnight. This 
produced the crystalline β-Ga2O3 on quartz glass. 
 
4.2.6 Preparation of copper gallium oxide thin film 
Copper nitrate trihydrate ([Cu(NO3)2.3H2O], 2.06 mmol) was added to dried 
methanol (30 ml) at room temperature and allowed to dissolve. The copper nitrate 
solution was then slowly added to GaMe3 (4.35 mmol) at -78 oC. After 30 minutes 
of mixing the solution was used for an AACVD experiment. An aerosol was 
generated at room temperature. A graphite heating block under the glass substrate 
heated the CVD reactor to 450 oC. Once deposition was complete, the substrate was 
cooled to room temperature under N2. The film deposition time was 1 hour and 
transparent films covering the glass substrate were produced. Crystalline copper 
gallium oxide films were obtained by depositing onto quartz glass and annealing at 
1000 oC overnight in a furnace. 
 
4.2.7 Characterisation of thin films 
The resulting thin films were handled and stored in air. The coated glass substrates 
were used for powder X-ray diffraction (XRD) measured on a Bruker D8 X-ray 
diffractometer with CuKα1 and CuKα1 radiation of wavelength 0.154056 and 
0.154439 nm respectively emitted with an intensity ratio of 2:1, a voltage of 40 kV 
and current of 40 mA. The samples were indexed using the GSAS programme, 
refined via the Rietveld method (LeBail model), and compared to database 
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standards. Energy dispersive X-ray analysis (EDX) was obtained on Philips 
XL30ESEM instrument and Scanning electron microscopy (SEM) on a JEOL 6301 
instrument. UV-Vis-NIR spectra were recorded in the range 190 – 1100 nm using a 
Helios double beam instrument. Reflectance and transmission spectra were 
recorded between 300 – 2300 nm by a Zeiss miniature spectrometer. Reflectance 
measurements were standardised relative to a rhodium mirror and transmission 
relative to air.   
X-ray photoelectron spectroscopy (XPS) was performed using a Thermo Scientific 
K-alpha photoelectron spectrometer using monochromatic Alkα radiation. Samples 
were earthed using copper tape. Higher resolution scans were recorded for the 
principal peaks of Cu(2p), Ga(3d, 2p), O(1s) and C(1s) at a pass energy of 50 eV. 
The peaks were modelled using CasaXPS software with binding energies adjusted 
to adventitious carbon (284.5 eV) for charge correction. 
Dr Husn-Ubayda Islam performed X-ray absorption spectroscopy (XAS) 
measurements on the Dutch-Belgian Extended X-ray absorption fine structure 
(EXAFS) beamline (BM26A) at the ESRF in Grenoble. Monochromatic radiation was 
supplied by a double Si(111) crystal, and fluorescence was measured using a 9 
element germanium solid state detector. XAS of the film was acquired in 
fluorescence. Measurements of the thin film and pelletized copper standards were 
taken on the copper K-edge (8987eV). XAS data were processed and X-ray 
absorption near edge structure (XANES) analysis was performed using Horae 
Athena software, and detailed EXAFS analysis was performed on Excurve version 
9.273. 
 
4.2.8 Microbiology Assay  
E. coli strain (ATCC 25922) and S. aureus (8325-4) was maintained by weekly 
subculture on Brain Heart Infusion (BHI) agar (Oxoid, Basingstoke, UK). One 
bacterial colony of either E. coli or S. aureus was used to inoculate 10 mL of sterile 
BHI broth (Oxoid, Basingstoke, UK) and incubated aerobically at 37 oC for 24 hours. 
  92 
Bacteria from the overnight culture were harvested by centrifugation at 13, 000 xg 
for 1 minute. Bacteria were then re-suspended in phosphate-buffered saline (PBS) 
(Oxoid, Basingstoke, UK) and again centrifuged for 13, 000 xg for 1 minute. Finally 
the bacterial pellet was re-suspended in PBS before use. The turbidity of the 
bacterial cell suspension was measured at 600 nm using a spectrophotometer and 
was adjusted to an optical density which corresponded to approximately 105 
colony forming units (cfu) per 25 µL aliquot.   
Prior to use, the gallium oxide and copper gallium oxide samples were cut into 1x1 
cm sections. A humidity chamber was created to ensure that the suspensions did 
not dry out. For each exposure time, triplicate samples were analysed and uncoated 
glass microscope slides were used as a control. Each exposure time was also 
repeated twice. A 25 µl aliquot of the bacterial cell suspension was spread evenly 
on the surface of each slide and incubated at room temperature (21 ± 2 oC) for the 
allocated exposure time. After incubation the slides were aseptically transferred to 
225 µL PBS and vortexed for 30 seconds to release the bacteria into the solution. 
Serial dilutions of the resulting bacterial suspensions were prepared in PBS and 25 
µL from each dilution was spread on to MacConkey Agar (Oxoid, Basingstoke, UK) 
for E. coli and BHI agar (Oxoid, Basingstoke, UK) for S. aureus. Plates were allowed 
to dry before inverting and incubating aerobically at 37 oC for 24 hours.  After 
incubation, any bacterial colonies were counted and viable counts of bacteria were 
calculated.  Mann-Whitney U test was used to determine the significance of the 
activity of gallium oxide and copper gallium oxide compared to the control glass 
slide. As well as, determining the significance of the activity of gallium oxide 
compared to the copper gallium oxide. 
 
4.2.9 AACVD of InMe3 and MeOH in toluene 
The substrate was heated to 450 °C under a flow of N2 at 1 L/min. Toluene (20 mL) 
and MeOH (0.46 mL, 11.2 mmol) was added to InMe3 (0.3 g, 1.88 mmol) at -78 °C. 
The resulting solution was mixed under N2 for 30 mins in the AACVD bubbler. After 
this time the N2 was diverted through the bubbler transporting the aerosol into the 
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reaction chamber. Once deposition was complete the substrate was cooled to 
below 100 °C under N2, before being removed and stored in air. No film deposition 
was observed. 
4.2.10 AACVD of InMe3 and MeOH 
Dry MeOH (20 mL) was added to InMe3 (0.20 g, 1 mmol) at -78 °C. The resulting 
solution was mixed under N2 for 30 mins in the AACVD bubbler. The substrate was 
heated to 4 different temperatures; 350, 400, 450 and 500 oC in separate 
experiments under a flow of N2 at 1 L/min. At each temperature a uniform 
transparent film was deposited with the greatest substrate coverage observed at 
450 ˚C. 
4.2.11 AACVD of InMe3 with HOCH2CH2NMe2 in toluene 
The substrate was heated to 450 °C under a flow of N2 at 1 L/min. Toluene (30 mL) 
and the donor-functional alcohol HOCH2CH2NMe2 (1.12 mL) was added to InMe3 
(0.3 g, 1.88 mmol) at -78 °C. The resulting solution was mixed under N2 for 30 mins 
in the AACVD bubbler. After this time the N2 was diverted through the bubbler 
transporting the aerosol into the reaction chamber. Once deposition was complete 
the substrate was cooled to below 100 °C under N2, before being removed and 
stored in air. A transparent film with a brown tinge with 35% coverage of the 
substrate was deposited.  
4.2.12 AACVD of InMe3 with HOCH2CH2NMe2 in MeOH 
Dry MeOH (20 mL) and 6 mol equivalents of HOCH2CH2NMe2 (0.78 mL) were added 
to InMe3 (0.20 g, 1 mmol) at -78 °C. The resulting solution was mixed under N2 for 
30 mins in the AACVD bubbler. The substrate was heated to 4 different 
temperatures; 350, 400, 450 and 500 ˚C in separate experiments under a flow of N2 
at 1 L/min. At each temperature a uniform transparent film was deposited with the 
greatest substrate coverage (60%) observed at 350 oC. 
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4.2.13 Characterisation of In2O3 films 
X-ray diffraction patterns were measured on a Bruker-Axs D8 (GADDS) 
diffractometer using CuKα1 radiation in glancing angle mode. Scanning electron 
microscopy (SEM) was carried out on a JEOL JSM-6301F field emission SEM at an 
accelerating voltage of 5 keV. Wavelength dispersive X-ray (WDX) analysis was 
obtained on a Philips XL30SEM instrument. UV/VIS/Near IR transmittance and 
reflectance spectra were obtained on a Perkin Elmer Fourier transfer Lambda 950 
spectrometer using an air background and recorded between 190 and 1100 nm.   
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4.3 Results and Discussion 
4.3.1 Gallium Oxide 
Initially two different gallium precursors with different oxygen sources (diols and 
alcohols) were investigated to study which conditions deposited adherent gallium 
oxide thin films reproducibly and with good coverage (Table 4-1, Fig 4-4). Gallium 
nitrate (Ga(NO3)3) depositions were investigated with a masters student Rushita 
Mehta. AACVD with the use of gallium nitrate were carried out initially with 
Rushita, however they were repeated and full characterisation was carried out.    
 
Table 4-1: Experimental conditions and resultant films deposited. 
 Gallium Precursor Diol Solvent 
Temp.  
/ oC 
Film 
appearance 
A 
Gallium Nitrate, 
[Ga(NO3)3] 
Ethylene 
glycol 
Toluene 450 
No film 
deposition 
B 
Ethylene 
glycol 
MeOH 450 Non-adherent, 
white 
powdery film C 
Ethylene 
glycol 
MeOH 550 
D Digol Toluene 450 
No film 
deposition 
E Digol MeOH 450 
White 
powdery film 
F 
Trimethylgallium, 
[GaMe3] 
Ethylene 
glycol 
MeOH 450 
Transparent 
film with a 
slight brown 
colour 
G Digol MeOH 450 
H None MeOH 450 
Transparent 
film 
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Gallium oxide thin films were generated in situ from the AACVD between gallium 
nitrate precursor and excess diol. An excess of diol was used to ensure the gallium 
oxide thin film was not oxygen deficient. The gallium precursor that was initially 
investigated was gallium nitrate (Ga(NO3)3), which was mixed with two different 
diols; ethylene glycol (HOCH2CH2OH) and digol ((HOCH2CH2)2O). 
Initially toluene was chosen as the solvent (Reaction A), however there was some 
difficulties with the solubility of ethylene glycol and Ga(NO3)3 in toluene. Not 
enough of the precursor and diol was able to dissolve in the solvent for a film to 
deposit. Most of the reactants were left at the bottom of the AACVD bubbler after 
the experiment had completed.  
Methanol was then investigated as the solvent and the gallium precursor and diols 
easily dissolved in this solvent. The substrate was heated to 450 oC and 550 oC with 
ethylene glycol (Reaction B and C). Both conditions produced non-adherent 
Figure 4-4: Aerosol-assisted CVD reactions to deposit gallium oxide films. 
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transparent thin films with a white powdery appearance. A different diol was then 
investigated, digol ((HOCH2CH2)2O), in an attempt to improve the solubility and 
hence quality of film produced. Gallium nitrate was mixed with digol in toluene 
(Reaction D) however, there were solubility issues whereby no film was deposited 
and the reactants remained in the AACVD bubbler. MeOH was also investigated 
(Reaction E) in combination with Ga(NO3)2 and digol which produced a non-
adherent powdery film. 
XRD measurements were performed on the thin films but no XRD pattern were 
seen. This suggests that the films are non-crystalline, which is expected since Ga2O3 
films deposited at temperatures below 700 oC are amorphous. To produce 
crystalline Ga2O3, the films need to be deposited on quartz and annealed in a 
furnace at 1000 oC overnight. This was attempted for the films deposited using both 
diols, however no film was present on the quartz substrate after annealing. This 
could be due to the film deposited being too thin to be identified or the annealing 
process destroyed the film. 
With the investigation  of the use of the precursor, Ga(NO3)3, it was established that 
deposition of 450 °C resulted in complete coverage of the substrate and therefore 
AACVD runs were chosen at this particular temperature for further study and 
analysis. As mentioned earlier, the films formed using Ga(NO3)3 as a precursor 
were not adherent to the glass substrate, and so, a more reactive gallium source 
precursor was required in order for this to occur. It has been previously reported 
that the chemical reaction between GaMe3 and donor-functionalized alcohols 
produced films that were adherent to the substrate. Thereby the use of GaMe3 with 
the diols was expected to produce similar results (Reactions F and G).  
Transparent films with a slight brown colour were deposited on glass from the 
AACVD reaction of GaMe3 and diol, either ethylene glycol (HOCH2CH2OH) or digol 
[(CH2CH2OH)2O] in dry MeOH at 450 °C.  The films deposited were uniform and 
covered the substrate completely. The films were adherent to the substrate.  
EDX measurements were taken to determine the composition of the films. EDX 
confirmed the presence of gallium and oxygen. However, due to the films being 
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thin, there was breakthrough to the underlying glass substrate. This leads to an 
increase of oxygen present in the data obtained since the oxygen detected is from 
the film itself and from the glass substrate. This was taken into account when 
calculating the Ga:O ratio. Reaction F produced Ga2O3 film with a Ga:O ratio of 1:1.4 
whereas, Reaction G was 1:1.8. EDX also indicated 5% carbon contamination which 
can explain the brown tinge in the appearance of the film. However, there are 
errors associated with this method of calculation due to not all of the oxygen 
present in the glass being detected. 
It has been shown that methanol as solvent can lead to the formation of films with 
unusual microstructure such as TiO2.91 The formation of Ga2O3 films using 
methanol as the alcohol and/or solvent were investigated. AACVD of GaMe3 and six 
equivalents of methanol and toluene as a solvent with a deposition temperature of 
450 oC resulted in no film growth. Therefore the use of methanol as both the oxygen 
source and solvent was investigated.  
The AACVD reaction of GaMe3 and excess methanol was carried out at 450 oC 
(Reaction H). A transparent film was deposited that covered the entire substrate. 
The successful formation of Ga2O3 thin film via the in situ AACVD reaction of GaMe3 
and methanol indicates that there is no need to prepare, isolate and purify a single-
source precursor. 
The temperature of deposition was too low for crystalline Ga2O3 to form since 
temperatures above 700 oC are necessary. For crystalline Ga2O3 to form, the film 
was deposited onto quartz substrate instead of glass and annealed overnight in a 
furnace set at 1000 oC. The film changed from being transparent to a white, less 
adhesive film. The crystallinity of the annealed Ga2O3 films was investigated using 
powder XRD data on the annealed Ga2O3. Peaks seen in Figure 4-5 match to the 
positions expected for β-Ga2O3.  
  99 
 
 
 
 
 
 
 
 
 
 
 
The films deposited using Ga(NO3)3 produced non-adherent films that could be 
easily removed with touch and suspending in organic solvents (methanol, acetone). 
However, the films deposited using GaMe3 were adherent to the substrate and were 
not changed after suspending in organic solvents (methanol, acetone) although 
they were damaged and completely removed under acidic conditions (conc. HNO3).  
 
4.3.2 Optical Properties  
The transmission and reflectance measurements were taken for the Ga2O3 thin 
films. All the as-deposited films displayed minimal reflectivity (5 – 15%). However 
depending on the gallium precursor, the transmission varied. Ga2O3 deposited from 
Ga(NO3)3 with ethylene glycol, or digol in MeOH  had transmission between 65 – 
77% whereas the films deposited using GaMe3 were more transparent with 
transmissions between 77 – 89%.  
Figure 4-5: XRD pattern of crystalline Ga2O3 film (black) deposited using 
GaMe3 and MeOH at 450 oC and annealed with standard reference Ga2O3 
XRD pattern (red). 
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The UV/Visible measurements were taken between 300 – 1100 nm. All films 
displayed a slight shift in the absorption edge towards the visible relative to plain 
glass substrate. A Tauc plot was constructed to calculate the band gap of the Ga2O3 
films. This is constructed by plotting photon energy (hv) against the square of the 
materials absorption coefficient multiplied by the photon energy, ({αhv}2).102 Films 
deposited using Ga(NO3)3 had a band gap between 4 – 4.2 eV, which is lower than 
the literature value of 4.5 – 4.9 eV. This could be due to impurities present in the 
film that skew the band gap calculated. The band gap calculated for the Ga2O3 
deposited using GaMe3 was between 4 – 4.8 eV, which is comparable to the 
literature value.88  
 
4.3.3 Morphology of Ga2O3 films 
SEM of the Ga2O3 thin films deposited using Ga(NO3)3 and GaMe3 are shown in Fig. 
4-6. It can be seen that the gallium precursor, diol and annealing films have an 
effect on the morphology of the film.   
Ga2O3 films deposited using Ga(NO3)3 and diols produced films with uniform 
spherical particles with sizes ranging from 0.4 – 1.2 µm, which can be related to the 
formation of powdery-like depositions seen. Whereas, the films deposited using 
GaMe3 and diols produced different microstructure corresponding to the more 
adherent transparent deposition. For these films, larger agglomerated particles 
ranging between 0.5 – 1.8 µm have formed.   
The morphology of Ga2O3 deposited using GaMe3 and MeOH produced a 
morphology consisting of smaller particles (~100 nm) agglomerated together. 
When the film was annealed producing crystalline Ga2O3, the microstructure 
changed and consisted of larger particles (~0.8 µm) conforming to island growth 
model.  
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Figure 4-6: SEM images of Ga2O3 deposited using reactions: 
a) Reaction B [Ga(NO3)3/MeOH/HOCH2CH2OH], b) Reaction E 
[Ga(NO3)3/MeOH)/(CH2CH2OH)2O], c) Reaction F [GaMe3/MeOH/HOCH2CH2OH,], 
d) Reaction G [GaMe3/MeOH/(CH2CH2OH)2O], e) Reaction H [GaMe3/MeOH] and  
f) Annealed film of Reaction H at 450 oC.  
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4.3.4 Gallium Oxide film 
The gallium precursor that produced the most reproducible and adherent films 
was GaMe3. In comparison to the use of diol, when methanol was used as the 
oxygen source, the films produced were more transparent and adhesive. This is an 
advantage for antimicrobial coatings because there will be a wide variety of 
surfaces that these coating can be potentially deposited on. Therefore, AACVD 
depositions using GaMe3 and methanol were repeated and deposited on to 
microscope slides instead of float glass and further analysis was carried out. The 
film thickness of the amorphous Ga2O3 thin films deposited on microscope slides 
were taken using side-on SEM. Fig. 4-7 shows that the thickness of the film is 
uneven, therefore an average of the film thickness was calculated, which was 
approximately 250 nm. 
 
 
 
 
 
 
 
 
 
4.3.5 XPS analysis of Ga2O3 films 
XPS was performed on these amorphous thin films (Fig. 4-8) to confirm the 
presence of Ga2O3 without annealing the film. The binding energies of Ga 3d5/2 and 
3d3/2 were seen at 20.5 eV and 20.1 eV respectively, which corresponds to Ga3+ 
found in Ga2O3.88 The binding energies of Ga 2p3/2 and 2p1/2 were seen at 1117.9 
and 1144.9 eV respectively. This region was observed due to the low doublet 
Figure 4-7: Side-on SEM of amophous Ga2O3 thin films. 
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splitting in the Ga 3d. These binding energy values also correspond to Ga3+ in Ga2O3 
confirming the presence of Ga2O3 on the surface of the amorphous thin films 
deposited on a microscope slide.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-8: XPS spectra of a) Ga 3d and b) Ga 2p peaks from 
the surface of the amorphous Ga2O3 films. 
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4.4 Copper Gallium Oxide Thin Films 
 
The high antimicrobial activity of copper has been previously discussed in chapter 
3. Therefore, in order to enhance the efficacy of the Ga2O3 films, an investigation 
into incorporating copper into the films were carried out. The antibacterial 
mechanism of copper is different to gallium, which could allow for more effective 
films.  
AACVD of GaMe3 and copper nitrate [Cu(NO3)2.3H2O], in a ratio of 2:1 respectively 
in dried methanol at -78 oC was carried out. The suspension was allowed to mix for 
30 minutes forming a dark yellow solution. AACVD of the solution was carried out 
at 450 oC and once the deposition was complete, the film was allowed to cool to 
room temperature under nitrogen. A colourless transparent film was produced.  
 The films deposited were adherent to the glass substrate and were not changed 
after suspension in organic solvents (methanol, acetone) although they were 
damaged and completely removed under acidic conditions (conc. HNO3).  
XRD measurements were performed on these films but no XRD pattern was 
observed. This would indicate that the films were deposited at a temperature too 
low to form crystalline thin films. However, it also confirms that no crystalline 
copper or copper oxide was formed. 
The films deposited on quartz was clear and transparent but once annealed at 1000 
oC, the films appeared white. The film become less adherent to the quartz surface 
and were easily removed using organic solvent.  XRD measurements were taken 
from these crystalline film, which produced an XRD pattern, as shown in Fig. 4-9. 
The XRD pattern does not fit with β-Ga2O3 previously seen, however some peaks 
observed correspond to Ga2O3 as well as copper(II) oxide (CuO). Since the films 
transparency decreased and the films were less adhesive to the surface, the 
amorphous material appears more appropriate for microbiological analysis and 
will be further analysed.   
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4.4.1 EDX Measurements  
EDX analysis was utilised to obtain the composition of the film and carried out to 
determine the stoichiometry of the amorphous material. The EDX measurements 
(Table 4-2) have shown there is on average 4.4 at% Cu incorporated into the film. 
The gallium to copper ratio was 4.7:1 indicating that not all the copper in the 
precursor starting solution was transferred to the deposited film.  
 
Table 4-2: EDX measurements taken from the amorphous copper gallium oxide film. 
 Atomic % Average 
Gallium 23.4 23.6 12.5 14.1 24.4 26.5 20.7 
Copper 3.0 3.2 5.2 5.3 5.1 4.6 4.4 
 
Figure 4-9: XRD pattern of crystalline copper gallium oxide film 
with standard patterns of Ga2O3 and CuO. 
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4.4.2 XPS analysis of copper gallium oxide films 
XPS was performed on the amorphous material in order to identify what was 
present and gallium and copper were identified on the surface. The binding 
energies of Ga 3d5/2 and 3d3/2 were seen at 20.5 and 20.1 eV respectively that 
corresponds to Ga3+ found in Ga2O3 (Fig 4-10).88 The oxidation state of copper was 
investigated for the amorphous material and the binding energies observed for Cu 
2p3/2 was 932.6 eV corresponds to Cu2+ and Cu1+. Satellite peaks usually found 
between 940 – 946 eV for Cu2+ were not observed suggesting that Cu2+ is not 
present at the surface and the peaks correlate to Cu1+.195,196 The binding energy of 
Cu 2p1/2 is 952.37 eV also corresponds to Cu1+. XPS has identified both Ga2O3 and 
Cu2O present on the surface of this amorphous material suggesting that a 
composite may have been deposited.  Quantification using peak areas determined 
by the Shirley method and empirical sensitivity factors gave a gallium to copper 
ratio of 6.6:1. This differs from the ratio obtained from the EDX measurements 
which was 4.7:1. This suggests that there may be more copper in the bulk than on 
the surface. 
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Figure 4-10: XPS spectra of a) Ga 3d, b) Ga 2p and c) Cu 2p peaks from the 
surface of the amorphous copper gallium oxide films. 
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4.4.3 Optical Properties  
The optical properties of the amorphous copper gallium oxide films were studied 
by transmission and reflectance measurement between 300 and 2300 nm and by 
UV-Vis spectroscopy between 90 – 1100 nm. The amorphous films showed a slight 
shift in the adsorption edge towards the visible relative to a glass substrate. The 
films displayed minimal reflectivity (5 – 10%) and high transmission (74 – 84%). 
This is very similar to the results seen for the Ga2O3 film deposited but the pure 
Ga2O3 films had higher transmission.   
The optical properties were investigated using UV/Visible spectra measurement 
between 300 – 1100 nm. This data can be used to find the band gap of a material 
by converting the data in to a Tauc plot.102  This is constructed by plotting photon 
energy (hv) against the square of the materials absorption coefficient multiplied by 
the photon energy ({αhv}2). The amorphous material had a band gap calculated at 
2.05 eV, which corresponds to Cu2O (2.1 eV).197 This correlates with the results 
obtained from XPS indicating the presence of Cu2O in the film suggesting that the 
amorphous material is a composite of Ga2O3-Cu2O.  
 
4.4.4 X-ray absorption spectroscopy 
XAS was used to elucidate the local structure of the copper species within the 
amorphous thin film. XAS is a powerful atom specific, average technique which can 
be used to determine oxidation state, geometry, bond distances and coordination 
numbers.   
Linear combination analysis (LCA) and X-ray absorption near edge structure 
(XANES) were performed on the Ga2O3-Cu2O thin films. Cu k-edge XANES data for 
the sample is shown in Fig. 4-11 along with the corresponding data for metal 
powders: Cu, Cu2O and CuO. The energy scales of all the spectra have been 
consistently normalised. Fig. 4-11 shows the local environment of the Cu can have 
an effect on the shape of the XANES spectra making it easier to identify the local 
environment of the Cu present in the Ga2O3-Cu2O films. In this case, the XANES 
  109 
spectra for the amorphous Ga2O3-Cu2O films match that of Cu, Cu2O and CuO 
standards indicating that copper is present in the film in all three oxidation states.  
LCA for the Ga2O3-Cu2O (Table 4-3) calculated the Cu/Cu2O/CuO ratio present in 
the film is 0.37/0.60/0.03. The XPS data and band gap calculations previously 
discussed the presence of Cu2O however, the XANES data indicates that Cu, Cu2O 
and a very small amount CuO were identified. XPS only identified the presence of 
Cu2O on the surface of the material. This could be due to Cu and CuO not being 
present at the surface but can be detected in the bulk of the film. The LCA also 
shows that Cu2O has the largest amount in the ratio, which corresponds to the 
identification that the composite is Ga2O3-Cu2O material.  
EXAFS were analysed and revealed the presence of two distances (Table 4-3). The 
local structure of Cu2O with 2 Cu-O distances that were found to be 1.87 Å, which 
corresponds to bond distances found in Cu2O (1.85 Å). The Cu-Cu distances were 
identified as 2.55 Å, which is comparable to Cu-Cu bond distance found in pure 
copper films (2.54 Å). 
 
Table 4-3: Linear combination analysis (LCA) of XANES fit for amorphous Ga2O3-Cu2O film 
LCA of XANES of Ga2O3-Cu2O 
Standard Ratio R-factor 
Cu2O 0.60 (0.03) 
2.51 x 10-4 CuO 0.03 (0.02) 
Cu 0.37 (0.02) 
EXAFS fit of Ga2O3-Cu2O 
Scatter N RXRD (Å) REXAFS (Å) σ2 (Å2) F 
O 2.0 
1.85 (Cu2O) 
1.87 (0.03) 0.010 
12 1.95 (CuO) 
Cu 4.6 2.54 (Cu) 2.55 (0.02) 0.010 
 
  110 
 
 
 
 
 
 
 
 
Figure 4-11: Normalised copper K-edge XANES spectra for Cu metal foil, Cu, 
Cu2O and Ga2O3-Cu2O thin film sample. b) K3-weighted χ(k) spectra Ga2O3-Cu2O 
and theoretical fit. c) Fourier transform of EXAFS of the χ(k). 
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4.4.5 Morphology of Ga2O3-Cu2O films 
SEM was used to examine the surface morphology of the deposited films.  The 
microstructure of the amorphous Ga2O3-Cu2O films was shown to have particles 
approximately 100 – 200 nm (Figure 4-12). The particles appear to cluster 
together. This microstructure observed is different from the Ga2O3 films previously 
discussed (Fig. 4-12). The morphology of pure Ga2O3 films appear to consist of 
larger particles that were uniform and similar in shape.  
 
 
 
 
 
 
 
 
  
Figure 4-12: SEM and side-on SEM images of  amorphous Ga2O3-Cu2O thin film. 
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4.5 Antimicrobial activity of Ga2O3 and Ga2O3-Cu2O 
 
Copper gallium oxide thin film would be advantageous due to the films possessing 
the ability to have multi-route antimicrobial activities while maintaining 
transparency. This will enable the thin films to have a wide variety of applications 
since AACVD has the ability to deposit on a diverse range of substrates including 
stainless steel that is primarily used for touch surfaces in hospitals.  
The antimicrobial properties of amorphous Ga2O3 and Ga2O3-Cu2O films deposited 
from GaMe3 in methanol or a mixture of GaMe3 and [Cu(NO3)2.3H2O] via AACVD at 
450 oC were tested against E. coli and S. aureus. Samples were cut in 1x1 cm sample 
sections and were covered with 25 µL of bacterial cell suspension containing 
approximately 105 cfu. Through enumeration and plating of the bacterial 
suspensions and subsequent overnight incubation (37 oC), the resultant viable 
counts of bacteria for each sample section was determined. The results for the 
gallium oxide and copper doped gallium oxide films, shown in Figure 4-13, 
demonstrate that the films have antimicrobial activity against E. coli and S. aureus. 
Glass microscope slides cut into 1x1 cm2 were used as controls. Each point 
represents the log10 of the mean number of viable bacteria from three samples and 
error bars represent the standard error. The results for the films demonstrate that 
doping the Ga2O3 has an effect on the antimicrobial activity. For E. coli, a 0.9-log10 
reduction (P < 0.01) in viable bacteria was observed after 24 hours as shown in 
Figure 4-13a. In the case of Ga2O3-Cu2O, the same reduction in viable colony counts 
was achieved after 9 hours (P < 0.001) and 4-log10 reduction was observed after 24 
hours. This was similar for S. aureus, 1.2-log10 reduction (P < 0.001) for Ga2O3 was 
observed after 24 hours however, for the Ga2O3-Cu2O samples a 0.8-log10 reduction 
was observed after 9 hours (P < 0.001) and 4-log10 reduction after 24 hours (P 
<0.001). When the Ga2O3 thin films are compared to Ga2O3-doped phosphate-based 
glasses similar reduction are seen against Pseudomonas aeruginosa (0.86-log10 
reduction).193,194   
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(a) 
Figure 4-13: Viable counts of bacteria after incubation on Ga2O3 
and Ga2O3-Cu2O thin films tested against a) E. coli and b) S. aureus. 
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Overall Ga2O3 has been demonstrated to have some antimicrobial activity. With the 
copper gallium oxide, a much greater bacterial reduction was observed. When 
comparing the difference between the cfu count between Ga2O3 and Ga2O3-Cu2O, it 
was seen to be highly statistically significant (P < 0.001) demonstrating the impact 
of copper on the sample. The Ga2O3-Cu2O has a much improved antimicrobial 
efficacy over Ga2O3 due to the addition of an antimicrobial metal, copper in a 
mixture of Cu2O.  Copper has been shown to produce highly significant reduction 
to HAI bacteria. However, the results shows that bacterial reductions from Ga2O3-
Cu2O are significantly lower when compared to pure Cu and Cu2O (chapter 3). It has 
been shown that copper can get the observed microbial reduction in 30 minutes 
instead of 24 hours. However, the Ga2O3-Cu2O films were transparent and have the 
potential to be deposited on a wide variety of surfaces.    
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4.6 Indium Oxide Thin Films 
In section 4.3 the deposition of gallium oxide thin films using diols as the oxygen 
source and MeOH as a solvent was described. It was seen that the use of different 
alcohols can have an effect on the morphology of the films. A similar effect has been 
seen previously for the deposition of indium oxide thin films. For example, the 
AACVD of InMe3 and HOCH2CH2NMe2 deposited films with a microstructure 
consisting of spherical particles. However, films deposited using InMe3 and 
HOCH2CH2OMe2 produced films with a needle-like morphology. It was also shown 
in the Ga2O3 thin films deposited (Fig. 4-6), that different conditions (solvent, 
precursor) lead to different microstructures.  The effect of solvent on AACVD 
depositions has also been reported for TiO2 investigations using methanol which 
showed that it can lead to the formation of rutile TiO2 instead of anatase that was 
formed with all other solvents.  
A different morphology of a thin film can have an effect on the functional properties 
of the film. For example, the microstructure of films is important to TCO 
applications. In photovoltaic technologies such as silicon thin films,162 TCO layers 
with a rough microstructure are commonly used to gain energy such that it is not 
absorbed in visible light and lost. Therefore, the effect of different alcohols as the 
oxygen source and/or solvent for the deposition of indium oxide has been 
investigated. The In2O3 depositions were investigated alongside master student 
Arnold Ratnasothy.  
The formation of Ga2O3 films from diols was described in section 4.3. In order to 
study the effect of changing the solvent to methanol in this section (Fig. 4-14), the 
AACVD of In2O3 using a donor-functionalised alcohol (HOCH2CH2NMe2) or a diol 
(HOCH2CH2OH) with MeOH as the solvent is described (Reaction A and B). Initially 
the AACVD of InMe3 and six equivalents of MeOH in toluene (Reaction D) was 
studied. Similarly to Ga2O3, no film growth was observed and therefore AACVD of 
InMe3 and excess (Reaction C) MeOH was attempted with MeOH acting as the 
oxygen source and solvent. Transparent thin films of In2O3 were deposited and 
MeOH was used as a solvent in all subsequential depositions.     
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Figure 4-14: AACVD reaction to deposited indium oxide films. 
Figure 4-15: XRD patterns obtained for In2O3 films deposited by AACVD from the in 
situ reaction of InMe3/HOCH2CH2OH in MeOH at temperatures between 400 – 500 oC. 
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In order to investigate the dependence of the physical and chemical attributes of 
the film on temperature, depositions were also carried out at reduced and higher 
substrate temperatures between 350 °C and 500 °C. 
Following from the Ga2O3 films (section 4.3), trimethylindium (InMe3) was chosen 
as the indium precursor and methanol as the solvent. Ethylene glycol 
(HOCH2CH2OH) produced the better Ga2O3 films with better coverage. Therefore, 
this diol was used in this investigation. Transparent films were deposited 
uniformly onto glass substrate from the deposition of AACVD of InMe3 in methanol 
(Fig. 4-15). The depositions were carried out between 400 – 500 oC. The best 
coverage of the glass substrate was achieved at 450 oC in agreement with the Ga2O3 
films discussed previously. The films were adherent to the substrate and were not 
changed after suspending in organic solvents (methanol, acetone) although they 
were damaged and completely removed under acidic conditions (conc. HNO3).  
The In2O3 were analysed using a wide range of techniques. EDX analysis detected 
the presence of both indium and oxygen for all the films. However, once again there 
is a breakthrough to the underlying glass substrate. Therefore, it was not possible 
to produce accurate composition of the thin films using this technique.  
 
4.6.1 Powder X-ray Diffraction 
All the In2O3 films deposited were cubic crystalline In2O3 therefore powder X-ray 
diffraction (XRD) patterns (Fig. 4-15 – 4-17) can be taken, unlike the Ga2O3 films. 
All the films showed a strong reflection in the (222) plane, which has been seen 
previously for thin films of In2O3. XRD patterns exhibit three broad Bragg peaks at 
31.2o, 36.5o, and 52.4o 2θ, as well as features at 21.9o 2θ that are broad due to 
scattering from the amorphous glass substrate.  
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4.6.2 Lattice Parameters 
The powder XRD data was used to calculate the lattice parameters. The fitting 
process used the Le Bail model where refinement is limited to (HKL) lines defined 
by the cell and space group. GSAS with EXPGUI, a graphical user interface editor 
was performed to control the progression of the equally weighted fitting to obtain 
unit cell parameters. The model was based on an indium oxide framework, with a 
starting indium oxide lattice parameter of 10.117 Å.  
The lattice parameter calculated for the as-deposited In2O3 films are displayed in 
Table 4-4. Most of the films match with the literature value of 10.117 Å for In2O3. 
However, films deposited at lower temperatures (350 – 400 oC) have smaller lattice 
parameter values calculated than expected. This decrease could be attributed to an 
increase in oxygen deficiencies in the lattice resulting in an increase in repulsion.144 
 
Figure 4-16: XRD patterns obtained for In2O3 films deposited by AACVD from the in 
situ reaction of InMe3/HOCH2CH2NMe2  in MeOH at temperatures between 350 – 500 oC. 
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Table 4-4: Experimental conditions and resultant characterisation for In2O3 films 
deposited. 
 Reactions 
Temp/ 
oC 
a/Å 
Fitted 
wRp 
% Trans 
A 
InMe3 / HOCH2CH2OH/ MeOH 400 9.982 (5) 0.0807 74 – 92 
InMe3 / HOCH2CH2OH/ MeOH 450 10.093 (7) 0.1074 42 – 51 
InMe3 / HOCH2CH2OH/ MeOH 500 10.143 (3) 0.0599 72 – 93 
B 
InMe3 / HOCH2CH2NMe2/ MeOH 350 10.163(1) 0.0645 77 – 83 
InMe3 / HOCH2CH2NMe2/ MeOH 400 10.176(1) 0.0673 55 – 66 
InMe3 / HOCH2CH2NMe2/ MeOH 450 10.233(1) 0.0921 80 – 87 
InMe3 / HOCH2CH2NMe2/ MeOH 500 10.144(3) 0.0894 80 – 89 
C 
InMe3 / MeOH 350 10.128(1) 0.0766 91 – 95 
InMe3 / MeOH 400 10.094(1) 0.0998 71 – 88 
InMe3 / MeOH 450 10.184(1) 0.0917 80 – 88 
InMe3 / MeOH 500 10.145(3) 0.0835 81 - 89 
Figure 4-17: XRD patterns obtained for In2O3 films deposited by AACVD from 
the in situ reaction of InMe3/MeOH at temperatures between 350 – 500 oC. 
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4.6.3 Optical properties 
The optical properties were investigated using transmission and reflectance 
measurements between 300 – 2300 nm and UV/Visible measurements between 
wavelengths of 300 – 1000 nm. All the In2O3 films displayed minimal reflectivity (5 
– 10 %) and high transmissions (71 – 95%) for most of the films. Generally, the 
films using MeOH as the oxygen source as well as the solvent had higher 
transmissions on average than the others. This could be due to less carbon 
contamination due to less organic compounds used at the start of the deposition. 
In the visible region, the reflectance was high (80 – 90%) for all the In2O3 films. For 
TCOs, the transmission needs to be >85%.  
Using the UV/visible data, a Tauc plot was constructed to calculate the band gap of 
the In2O3 films. All the films had band gaps varying between 3.5 – 3.7 eV which is 
comparable with literature values of In2O3 (~3.7 eV).166 
 
4.6.4 Morphology of In2O3 Films 
The morphology of the In2O3 films was investigated using SEM. It was previously 
described how precursor and solvent can have an effect on the microstructure of 
the films. For these films, different morphologies were observed with a change of 
temperature (all other conditions the same). Fig. 4-18 show how the increase in 
temperature change the morphology from small particles (~100 nm) to larger 
particles (~400 nm) and then into needle-like clusters. This is in contrast with 
morphology observed from InMe3/HOCH2CH2OH and InMe3/HOCH2CH2NMe2 in 
MeOH. 
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Figure 4-18: SEM images of films grown from InMe3/MeOH at a) 400 oC, b) 450 oC, and c) 
500 oC, d) Film grown from InMe3/HOCH2CH2OH in MeOH at 450 oC and e) film grown from 
InMe3/HOCH2CH2NMe2 in MeOH at 450 oC. 
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Films deposited using the diol (HOCH2CH2OH) had a microstructure consisting of 
much larger particles ranging from 0.5 – 1 µm, whereas the films using the donor-
functionalised alcohol had spherical agglomeration and an even coverage. These 
results indicate that not only the alcohol and solvent used have an effect on the 
morphology but also on the temperature of deposition does as well. 
Further analysis of the films was carried out on the best films (in terms of surface 
coverage and transmission) which were InMe3/HOCH2CH2NMe2 in MeOH and 
InMe3/MeOH deposited at 450 oC, to investigate the functional properties.   
Film thickness measurements were obtained on the chosen films using side-on 
SEM. The film thickness for the films deposited at 450 oC from 
InMe3/HOCH2CH2NMe2 in MeOH and InMe3/MeOH were 750 and 250 nm 
respectively (Fig. 4-19). This indicates that the films deposited using the donor-
functionalised alcohol produced thicker films. This could be due to the increase 
solubility of the in situ precursor formed. 
  
    
 
  
 
 
 
 
 
 
 
Figure 4-19: Side-on SEM images of films grown at 450 oC from a) 
InMe3/HOCH2CH2NMe2 in MeOH and b) InMe3/MeOH. 
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4.6.5 Preferred Orientation 
The degree of preferred orientation using Bragg’s crystal plane was determined 
using the calculation of the texture coefficient. The reflections analysed for the 
In2O3 films were 211, 222, 400, 332, 431 and 440. The texture coefficient was 
calculated using the following equation:  
𝑇𝐶(ℎ𝑘𝑙) =  
𝐼(ℎ𝑘𝑙)
𝐼𝑜(ℎ𝑘𝑙)
⁄
1
𝑁
∑ 𝐼(ℎ𝑘𝑙)𝑁
𝐼𝑜(ℎ𝑘𝑙)
⁄
 
The texture coefficient (TC) of a given (hkl) plane, I is the experimental relative 
intensity, Io is the reference intensity and N is the number of reflections. Table 4-5 
show the extent of preferred orientation for each particular peak seen on the XRD. 
It is seen that In2O3 film deposited from InMe3/MeOH at 400 oC are orientated in 
the [400] direction but the increase in temperature to 450 oC changes the 
orientation to [440] direction. As the temperature increases to 500 oC, the 
orientation changes again to the [222] direction. This change from (440) to (400) 
to (222) as the temperature increases has been since for the deposition of In2O3. 
This change in preferred orientation can be related to the morphology observed in 
Fig. 4-18 from In2O3 films with small particles to needle-like clusters.   
Table 4-5: Texture coefficient intensity ratio for XRD peaks obtained from films deposited 
from InMe3/MeOH. 
 211 222 400 332 431 440 
400 oC 0.33 0.12 1.22 0.18 1.31 4.04 
450 oC 0.47 0.32 4.17 0.39 0.65 0.88 
500 oC 0.35 1.91 0.48 0.47 0.99 1.81 
 
The preferred orientation (Table 4-6) were calculated for these XRD patterns and 
the film deposited with InMe3/MeOH with either HOCH2CH2OH or HOCH2CH2NMe2 
at 450 oC. The preferred orientation is similar to the In2O3 grown at 450 oC without 
(4.1) 
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additional oxygen source in the [400] directions. Even though all the films grown 
at 450 oC have grown in the same direction, the morphology is very different.  
Table 4-6: Texture coefficient intensity ratio for XRD peaks obtained from In2O3 films 
deposited using a diol or donor functionalised alcohol at 450 oC. 
 211 222 400 332 431 440 
InMe3/ HOCH2CH2OH/ MeOH 1.00 1.41 2.09 0.60 0.89 1.47 
InMe3/ HOCH2CH2NMe2/ MeOH 0.35 0.48 1.91 0.47 0.99 1.81 
 
4.6.6 Raman Analysis 
Raman patterns were taken of these two best In2O3 films in terms of surface 
coverage and transmission (films deposited at 450 oC from InMe3/HOCH2CH2NMe2 
in MeOH and InMe3/MeOH). Characteristic In2O3 peaks were observed with the 
strongest band appearing at ~360 cm-1 with a weaker band at 307 cm-1. These 
matched well with Raman bands previously reported. The Raman pattern also 
identified the presence of graphitic carbon in the films.198  
 
4.6.7 Electric Properties 
Initially the films were tested using a two point probe which indicated a decrease 
in resistivity as temperature increased. Once again the two best films were tested 
further; films deposited at 450 oC from InMe3/HOCH2CH2NMe2 in MeOH and 
InMe3/MeOH. Linear van der Pauw four point probe technique was used to 
measure the electrical resistance.199  A current (l) was applied across two outer 
probes and a potential difference (v) measured across two inner probes. The 
negligible contact and spreading resistance associated with the voltage probes 
allows sheet resistance, Rs to be calculated using the following equation:  
 
𝑅𝑠 = 4.53
𝑣
𝑙
 (4.2) 
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The sheet resistance is defined as the resistance of one square of film and is 
independent of the square size. The resistance was measured at up to 9 points 
across the surface of each film. The measurements were taken at the centre of the 
film to ensure that enough film was present to provide a good flow of current and 
potential difference.200 The as-deposited In2O3 films show a low sheet resistance 
(Table 4-7) indicating a high electrical conductivity. Sheet resistivity was also 
calculated using the following equation (4.3) where Rs is the sheet resistance and 
d is the film thickness.  
𝜌 =  𝑅𝑠𝑑 
Sheet resistivity of Rs = 3.44 and 4.88 Ω⧠-1 for the InMe3/MeOH and 
InMe3/HOCH2CH2NMe2 in MeOH films respectively were observed. Higher value of 
sheet resistance were obtained from films deposited with HOCH2CH2NMe2. The 
presence of the donor-functionalised alcohol has therefore had an effect on the 
electrical properties of this In2O3 films.  
In order to understand more about the electrical properties of the films, detailed 
measurements of the Hall mobility and carrier concentrations were carried out. 
Hall effect measurements showed that the films exhibited n-type conductivity 
indicating that electrons were the dominant charge carrier species.  
For films deposited using InMe3/MeOH a specific resistivity (ρ) of 8.60 x 10-5 Ωcm 
and a charge carrier concentration (n) of 9.3 x 1020 cm-3 was obtained. The mobility 
of the charge carrier (µ) were 77 cm2 V-1 s-1. The results for the films deposited 
from InMe3/HOCH2CH2NMe2 in MeOH were similar with specific resistivity of 3.66 
x 10-5 Ωcm and a charge carrier concentration of 2.12 x 1020 cm-3 and charge carrier 
mobility was 79.9 cm2 V-1 s-1. Low electrical resistivity is often described as that in 
the order of 10-4 Ωcm. These undoped In2O3 films have an electrical resistivity 
which is comparable to that of doped In2O3 films.  
 
 
(4.3) 
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Table 4-7: Electrical properties of films grown from InMe3/HOCH2CH2NMe2 in MeOH and 
InMe3/MeOH at 450 oC. 
 
The electrical conductivity of a material relies on the number of charge carriers and 
the mobility of the charge. TCOs currently used have systems with n ranging 
between 1020 – 1021 cm-3 and µ for an n-type material of 10 – 40 cm2 V-1 s-1.201 It 
can be seen that the inclusion of the donor functionalised alcohol improves 
conductivity and results obtained from these In2O3 films are comparable to In2O3 
films deposited using similar procedure with n = 1 x 1020 cm-3 and µ = 71 cm2 V-1 
s-1. When compared to other doped TCOs such as Mo:In2O3, n = 4 x 1020 cm-3 and µ 
= 119 cm2 V-1 s-1 these undoped In2O3 had better conductivity.201–203 Some of the 
parameters calculated are ideal for TCO materials however the carrier mobility for 
both films need to improve when compared to current commercial material.  
These results indicate that these high conductivity undoped In2O3 are suitable 
candidates for TCO materials. The origin of the high conductivity is unknown but 
has been seen previously. It was shown that surface donors dominate the 
conductivity rather than the bulk defects.204 
 
 
 
 
 
 
Film 
Rs  
/ Ω⧠-1 
d /nm 
ρ 
/ Ωcm 
µ   
/ cm2 V-1 s-1 
n  
/ cm-3 
InMe3/HOCH2CH2NMe2 4.88 750 3.66 x 10-5 77 9.3 x 1020 
InMe3/MeOH 3.44 250 8.60 x 10-5 79.9 2.12 x1020 
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4.7 Conclusion  
 
This investigation used different types of oxygen sources; diols, donor 
functionalised alcohol and alcohol. Using this range of oxygen sources produce 
different quality of films and morphology. The most transparent, adherent films 
were the amorphous Ga2O3 deposited from GaMe3/MeOH via AACVD. Copper 
gallium oxide thin films were deposited using GaMe3/Cu(NO3)2.3H2O/MeOH. An 
amorphous material was deposited that was identified as Ga2O3-Cu2O. The 
antimicrobial efficacy of transparent Ga2O3 and Ga2O3-Cu2O films tested against E. 
coli and S. aureus. It was seen that the Ga2O3 films possessed antibacterial activity 
but Ga2O3-Cu2O were significantly more potent.  
Further investigation were undertaken using different oxygen sources and 
solvents with InMe3 to deposit In2O3. Similar results were seen with different 
microstructure observed that affected the TCO properties. The Hall effect 
measurements were carried out and saw that these In2O3 films deposited from 
InMe3/MeOH and InMe3/HOCH2CH2NMe2/MeOH had conductivity similar to 
doped In2O3. These undoped In2O3 have the potential to be TCO materials.   
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Zinc Oxide 
 
The following chapter presents the results obtained from the deposition of zinc oxide 
and copper doped zinc oxide thin films and the investigation of the different 
properties of the films. The films were deposited using AACVD and Dual Source 
AACVD. The thin films materials were fully characterised and tested for their 
antimicrobial properties using serial dilution and viable colony counts on to agar 
plates. 
5 
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5. Introduction 
Chapter 4 discussed the theory and properties of transparent conductive oxides 
(TCOs) of indium oxide. Zinc oxide (ZnO) is also a very common TCO that is used 
widely in industry. Alternatives TCOs to indium-tin-oxide (ITO) are being 
investigated due to the worldwide depletion of indium.205 ZnO is becoming more 
widely used for many different applications. ZnO thin films are of high interest 
due to it is TCO properties, the ability to have high transparency as well as high 
electrical conductivity. ZnO is a n-type semiconductor with a wide band gap of 3.3 
eV and has high optical transmittance over a wide spectrum and low resistivity. 
Research suggests that the high conductivity of ZnO is due to oxygen vacancies or 
interstitial Zn atoms present. Aluminium, one of the most commonly used dopants 
for ZnO (AZO), yields typical resistivities between 1 – 3 x10-4 Ωcm.206,207  
ZnO has a wurtzite structure with lattice parameters, a =  3.28 Å and c = 5.206 Å. 
The structure comprises of alternative planes of fourfold coordinated O2- and Zn2+ 
ions that are stacked along the c-axis alternately. The electrical properties of ZnO 
are influenced by the oxygen vacancies and additional zinc atoms that are located 
in the interstitial sites. Doping of ZnO is common in order to improve the electrical 
properties.  
 
5.1 Antimicrobial Activity of Zinc Oxide 
Zinc is an essential metal in many microorganisms due to its involvement in many 
cellular reactions.208  Zn2+ ions are non-toxic towards many microorganisms at 
low concentrations. However, above 10-7 mol L-1, homeostasis allows for Zn2+ to 
penetrate into cells and become cytotoxic.209 It has been proposed that direct 
contact of ZnO particles can destabilise bacterial membranes upon direct 
contact.210,211 The intrinsic antimicrobial properties of Zn2+ have been 
investigated. There have been studies describing the antimicrobial activity of ZnO 
however, the exact mechanism is not known. Many mechanisms for antimicrobial 
activity have been suggested. One possible mechanism is the generation of 
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hydrogen peroxide and reactive oxygen species (ROS). The generation of hydroxyl 
radicals by the reactions between oxygen and water can lead to damage to cell 
membranes, proteins, and DNA, which can ultimately lead to the death of the 
cell.212–217  
Hydrogen peroxide can be toxic due to Fenton-type reactions (discussed in 
chapter 3). Studies have also shown that the production of ROS can be different in 
the dark and when exposed to visible light. Results exhibited that the antibacterial 
activity of ZnO was reduced when not exposed to light. Further investigation 
indicated that the level of ROS increased by 400% when illuminated.216,218 
 
5.1.1 Zinc Oxide Deposition 
In this chapter, the antimicrobial activity of zinc oxide and copper doped zinc 
oxide deposited via AACVD will be discussed. Zinc oxide films have deposited 
using different variation of CVD,219,220 sol-gel221 and magnetron sputtering.222 The 
doping of zinc oxide with copper is of increasing interest in research due to the 
different properties that are exhibited. Most research on the antimicrobial activity 
of ZnO is a nanomaterials. It is of interest to see how ZnO thin films compare.   
This investigation describes the deposition of copper doped zinc oxide thin film 
via AACVD, and the assessment of the antimicrobial activity of the resulting films. 
The zinc precursors that are being investigated are Zinc nitrate hexahydrate 
[Zn(NO3)2.6H2O], and Zinc acetate dihydrate, [Zn(OAc)2.2H2O]. To dope copper 
into the ZnO films, the copper precursors investigated in chapter 3, which are 
copper nitrate [Cu(NO3)2.3H2O], copper acetylacetonate [Cu(acac)2], and copper 
acetate [Cu(OAc)2.H2O] were used. The concentration of copper incorporated into 
ZnO will be increased to see if there is an increase or decrease in antimicrobial 
effectiveness. The colour, transparency and reproducibility will be analysed in 
order to investigate the most appropriate thin films for antibacterial coatings.   
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Figure 5-1: Structural diagram of zinc precursors used in this 
investigation. 
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5.2 Experimental 
All chemicals used in this report were purchased from Sigma-Aldrich Chemical Co. 
Nitrogen (99.99%) was obtained from BOC and was used as supplied. Deposition 
was on microscope slides or 150 × 45 × 45 mm SiO2 coated float-glass (the SiO2 
acts as a barrier layer preventing diffusion of ions from within the glass into the 
deposition film) which has been supplied by Pilkington NSG. Prior to use the glass 
substrate were cleaned with acetone and isopropanol and temperature was 
monitored during the deposition using a Pt–Rh thermocouple. 
Nitrogen was passed through a two-way tap, which was used to divert the 
nitrogen carrier gas through a glass bubbler. All deposition experiments were 
conducted by heating the cold-wall horizontal-bed reactor to the required 
temperature before diverting the nitrogen line through the aerosol into the 
reactor. The aerosol was carried into the reactor in a stream of nitrogen gas 
through a brass baffle to obtain a laminar flow. The gas flow was continued until 
all of the precursor mix had passed through the reactor, typically 1 h. The glass 
substrate was allowed to cool with the graphite block under a flow of nitrogen 
until it reached room temperature before it was removed. 
5.2.1 AACVD of [Zn(NO3)2.6H2O] and [Cu(NO3)2.3H2O]  
Zinc nitrate hexahydrate [Zn(NO3)2.6H2O, 1.68 mmol] and copper nitrate 
trihydrate [Cu(NO3)2.3H2O, 0.9 mmol] were added to methanol (30 mL). An 
aerosol was generated at room temperature using a humidifier with the graphite 
heating block under the glass substrate heating the CVD reactor to 450 oC. The 
film was allowed to cool under a flow of N2 until room temperature. A yellow film 
with very poor coverage was deposited.  
5.2.2 AACVD of [Zn(NO3)2.6H2O] and [Cu(acac)2]  
Zinc nitrate hexahydrate [Zn(NO3)2.6H2O, 1.68 mmol] and copper nitrate 
[Cu(acac)2,  1.91 mmol] were added to acetone (30 mL). Solution was allowed to 
mix for 30 minutes using a sonicator. The graphite heating block under the glass 
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substrate was heated to 450 oC. An aerosol was generated at room temperature 
using a humidifier. Once the entire aerosol had passed through and had finished, 
the films were allowed to cool under N2. A yellow film was produced with very 
poor coverage.  
5.2.3 AACVD of [Zn(OAc)2.2H2O] and [Cu(NO3)2.3H2O] 
Zinc acetate dihydrate, [Zn(OAc)2.2H2O, 2.28 mmol] and copper nitrate trihydrate 
[Cu(NO3)2.3H2O, 0.9 mmol] were added to MeOH (30 mL). The resulting solution 
was allowed to mix in the AACVD bubbler. An aerosol was generated at room 
temperature using a humidifier with the graphite block under the glass substrate 
heating the CVD reactor to 450 oC. The film was allowed to cool under a flow of N2 
until room temperature. A yellow transparent thin film with 25% coverage of the 
substrate was produced.  
5.2.4 AACVD of [Zn(OAc)2.2H2O] and [Cu(acac)2] 
Zinc acetate dihydrate, [Zn(OAc)2.2H2O, 2.28 mmol] and copper(II) 
acetylacetonate, [Cu(acac)2, 1.91 mmol] were added to acetone or MeOH in 
separate experiments. After addition the solid was allowed to mix for 15 minutes 
and used immediately for AACVD deposition. An aerosol was generated using a 
humidifier. The graphite heating block under the glass substrate was heated to 
450 oC. Once deposition was completed the substrate was cooled to room 
temperature. Not all the Cu(acac)2 were able to dissolve in the methanol and some 
of the precursor was left behind in the AACVD bubbler once the deposition was 
complete. Deposition using acetone produced a blue film with 25% coverage of 
the substrate was produced. For deposition using methanol, a green film with 
good coverage was produced. 
5.2.4.1 AACVD of [Zn(OAc)2.2H2O] and [Cu(acac)2] (high concentration) 
Zinc acetate dihydrate, [Zn(OAc)2.2H2O, 4.56 mmol] and Copper(II) 
acetylacetonate, [Cu(acac)2, 3.44 mmol] were added to MeOH. The same condition 
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as reaction 5.2.4 was carried out. A dark green film was deposited with a metallic 
copper tinge that covered the entire substrate.  
5.2.4.2 AACVD of [Zn(OAc)2.2H2O] and [Cu(acac)2] (low concentration) 
Zinc acetate dihydrate, [Zn(OAc)2.2H2O, 1.14 mmol] and copper(II) 
acetylacetonate, [Cu(acac)2, 0.96 mmol] were added to MeOH. The same condition 
as reaction 5.2.4 was carried out. A dark green film was deposited with a metallic 
copper tinge that covered the entire substrate. A green film was deposited with 
good coverage. 
5.2.4.3 AACVD of [Zn(OAc)2.2H2O] with [Cu(acac)2] with CTAB (high concentration) 
The conditions of reaction 5.2.4 were repeated only using methanol with the 
addition cetyl trimethylammonium bromide, CTAB [(C16H33)N(CH3)3Br, 0.55 
mmol] producing dark green film with poor coverage.  
5.2.4.4 AACVD of [Zn(OAc)2.2H2O] with [Cu(acac)2] with CTAB (low concentration) 
The conditions of reaction 5.2.4.3 was repeated with the change of CTAB, 
[(C16H33)N(CH3)3Br, 0.055 mmol] concentration. A green thin film was produced 
with metallic copper colour at the bottom of the substrate.  
5.2.4.5 AACVD of [Zn(OAc)2.2H2O] with [Cu(acac)2] and HOCH2CH2OMe 
The conditions of reaction 5.2.4 was repeated only using methanol with the 
addition of HOCH2CH2OMe (0.1 mL) to the solution. A very dark green film was 
deposited that covered the majority of the substrate. 
5.2.5 AACVD of [Zn(OAc)2.2H2O] with methanol 
Zinc acetate dihydrate, [Zn(OAc)2.2H2O, 2.28 mmol] was mixed with 30 mL of 
MeOH. An aerosol was generated at room temperature using a humidifier with the 
graphite heating block under the glass substrate heating the CVD reaction to 350 
– 450 oC in separate experiments. The film was allowed to cool under a flow of N2 
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until it reached room temperature. At each temperature, a transparent film was 
deposited.  
5.2.6 AACVD of [Zn(OAc)2.2H2O] and [Cu(OAc)2.H2O] 
Zinc acetate dihydrate, [Zn(OAc)2.2H2O, 2.28 mmol] and copper acetate 
[Cu(OAc)2.H2O, 0.043 mmol] were added to MeOH (30 mL). The resulting blue 
solution was mixed until all precursor had dissolved. An aerosol was generated at 
room temperature using a humidifier with graphite heating block under the glass 
substrate heating the CVD reactor to 350 and 450 oC in separate experiments 
under a flow of N2. Once the deposition was complete the film was allowed to cool 
to room temperature. At each temperature, a transparent green film was 
deposited.  
5.2.7 Dual source AACVD of [Zn(OAc)2.2H2O] and [C2(OAc)2.H2O]  
Dual source AACVD was set up with two separate bubblers. In one bubbler, zinc 
acetate dihydrate, [Zn(OAc)2.2H2O, 2.28 mmol] was mixed with MeOH (30 mL) 
and the second bubbler had [Cu2(OAc)2.H2O, 0.043 mmol] and MeOH (30 ml) 
mixture. Both AACVD bubblers were attached to the reactor separately via a Y-
junction. Aerosols were formed for each AACVD bubbler using two humidifiers 
with the graphite heating block under the glass substrate heating the CVD reactor 
to 350 – 450 oC in separate experiments. Once deposition was complete, the films 
were allowed to cool to room temperature under a flow of N2. At each 
temperature, a transparent green film was deposited.   
5.2.7.1 Dual source AACVD of [Zn(OAc)2.2H2O] and [Cu(acac)2]  
Dual source AACVD was set up described in reaction 5.2.7. In one bubbler, 
Zn(OAc)2.2H2O, (2.28 mmol) was mixed with MeOH (30 mL) and the other 
bubbler had a mix of Cu(acac)2, (1.91 mmol) in MeOH (30 mL). The graphite 
heating block under the glass substrate was heated to 400 oC. Once the deposition 
was complete, a green uniform film was produced.  
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5.2.7.2 Dual source AACVD of [Zn(OAc)2.2H2O] and [Cu(OAc)2.H2O] – differing Cu 
concentration 
Dual source AACVD was set up as described in reaction 5.2.7. The concentration 
of zinc acetate remained constant in one AACVD bubbler. In the other, the 
concentration of copper acetate (0.022 – 0.41 mmol) mixed with MeOH (30 mL) 
was varied. This resulted in 1 – 18% copper solutions for a separate 9 
experiments.  The graphite heating block under the glass substrate was heated to 
350 - 450 oC. Once deposition was completed the substrate was cooled to room 
temperature. As the concentration of copper increased, the colour of the films 
become more pronounced, the films became a darker green.  
 
5.2.8 Characterisation 
The resulting zinc oxide and copper-doped zinc oxide films were handled and 
stored in air. The coated glass substrates were used for powder X-ray diffraction 
(XRD) and then were cut into 1 cm × 1 cm squares for subsequent analysis by 
Scanning Electron Microscopy (SEM), on a JEOL 6301 filament scanning electron 
microscope. A Perkin-Elmer Lambda 25 UV-Vis Spectrometer was used to 
measure the UV-Vis absorption spectra of the samples. Reflectance and 
transmission spectra were recorded between 300 – 2300 nm by a Zeiss miniature 
spectrometer. Reflectance measurement were standardised relative to a rhodium 
mirror and transmission relative to air.  Raman spectroscopy was performed 
using a Renishaw 1000 spectrometer equipped with a 514.5 nm laser. 
X-ray photoelectron spectroscopy (XPS) was performed using a Thermo Scientific 
K-alpha photoelectron spectrometer using monochromatic Alkα radiation. 
Samples were earthed using copper tape. Higher resolution scans were recorded 
for the principal peaks of Cu(2p), Zn(2p), O(1s) and C(1s) at a pass energy of 50 
eV. The peaks were modelled using CasaXPS software with binding energies 
adjusted to adventitious carbon (284.5 eV) for charge correction.  
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Dr Husn-Ubayda Islam performed X-ray absorption spectroscopy (XAS) 
measurements on the Dutch-Belgian Extended X-ray absorption fine structure 
(EXAFS) beamline (BM26A) at the ESRF in Grenoble. Monochromatic radiation 
was supplied by a double Si(111) crystal, and fluorescence was measured using a 
9 element germanium solid state detector. XAS of the film was acquired in 
fluorescence. Measurements of the thin film and pelletized copper standards were 
taken on the copper K-edge (8987eV). XAS data were processed and X-ray 
absorption near edge structure (XANES) analysis was performed using Horae 
Athena software, and detailed EXAFS analysis was performed on Excurve version 
9.273. 
 
5.2.9 Antimicrobial activity 
E. coli strain (ATCC 25922) was maintained by weekly subculture on Brain Heart 
Infusion (BHI) agar (Oxoid, Basingstoke, UK). E. coli was used to inoculate 10 mL 
of sterile BHI broth (Oxoid, Basingstoke, UK) and incubated aerobically at 37 °C 
for 24 hours. Bacteria from the overnight culture were harvested by 
centrifugation at 13000 × g for 1 minute. E. coli was then re-suspended in 
phosphate-buffered saline (PBS) (Oxoid, Basingstoke, UK) and again centrifuged 
at 13,000 × g for 1 minute. Finally the bacterial pellet was re-suspended in PBS 
before use. The turbidity of the bacterial cell suspension was measured at 600 nm 
using a spectrophotometer and was adjusted to an optical density which 
corresponded to approximately 105 colony forming units (cfu) per 25 μL aliquot. 
Prior to use, the zinc oxide and copper zinc oxide slides were cut into 1 × 1 cm 
sections. A humidity chamber was created to ensure that the suspensions did not 
dry out. A 25 μL aliquot of the bacterial cell suspension was spread evenly on the 
surface of each slide and incubated at room temperature (21 ± 2 °C) for the 
allocated exposure time. For each exposure time (3, 6 and 18 hours), triplicate 
samples were analysed and uncoated glass microscope slides were used as a 
control. The samples were then irradiated for up to 18 hours using a white light 
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source (General Electric 28 W Watt MiserTM T5 2D compact fluorescent lamp) 
emitting an average light intensity of 3,750  250 lux at a distance of 30 cm from 
the samples. A further set of samples (in triplicate) was maintained in the dark for 
the duration of the irradiation time. Each exposure time was also repeated on two 
separate occasions 
 After incubation the slides were aseptically transferred to 225 μL PBS and 
vortexed for 30 seconds to release the bacteria into the solution. Serial dilutions 
of the resulting bacterial suspensions were prepared in PBS and 25 μL from each 
dilution was spread on to MacConkey Agar (Oxoid, Basingstoke, UK). Plates were 
incubating aerobically at 37 °C for 24 hours. After incubation, any bacterial 
colonies were counted and viable counts of bacteria were calculated. Mann–
Whitney U test was used to determine the significance of the activity of zinc oxide 
or copper zinc oxide slides compared to the glass control.  
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5.3 Results and Discussion  
Initially a range of copper and zinc precursors were investigated to study which 
precursors deposited copper doped zinc oxide thin films and with good coverage. 
Zinc nitrate and zinc acetate are readily available zinc precursors for single-
source deposition of zinc oxide thin films while maintaining transparency in order 
to test their antimicrobial effectiveness. Copper nitrate, copper(II) 
acetylacetonate, and copper acetate are also readily available to deposit copper 
thin films (see chapter 3). These copper precursors were used to dope copper into 
zinc oxide. Along with the change of precursors, temperature, and solvent were 
also investigated. 
Table 5-1: The results of using a variety of zinc and copper precursors and 
solvents. 
 Zinc Precursor 
Copper 
Precursor 
Solvent Film 
Film 
Appearance 
A 
Zinc Nitrate, 
[Zn(NO3)2.6H2O] 
Copper nitrate, 
[Cu(NO3)2.3H2O] 
MeOH ZnO/CuO 
Small 
brown/yellow 
patches  
B 
Copper(II) 
acetylacetonate, 
[Cu(acac)2] 
Acetone 
Non-
crystalline 
Small yellow 
patches 
C 
Zinc Acetate, 
[Zn(OAc)2.2H2O] 
Copper nitrate, 
[Cu(NO3)2.3H2O] 
MeOH ZnO Yellow film 
D Copper(II) 
acetylacetonate, 
[Cu(acac)2] 
Acetone ZnO 
Transparent 
green film 
E MeOH ZnO 
Transparent 
green film 
A number of depositions were investigated (Table 5-1) with a change of solvent, 
zinc and copper precursors. All these factors can influence the composition, 
coverage and appearance of the desired thin films. 
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Zinc nitrate, [Zn(NO3)2.6H2O] is soluble in methanol and the first zinc precursor 
to be investigated. Either copper nitrate, [Cu(NO3)2.3H2O] or copper(II) 
acetylacetonate, [Cu(acac)2] was used to dope copper into zinc oxide using a zinc 
to copper precursor ratio of 2:1.   
Zinc nitrate [Zn(NO3)2.6H2O] and copper nitrate, [Cu(NO3)2.3H2O] were mixed 
and used at a deposition temperature of 450 oC. The substrate was allowed to cool 
to room temperature under nitrogen to produce a film. A small film made from 
patches of brown and yellow was deposited. Powder X-ray diffraction (XRD) data 
were used to identify a mixture of ZnO and CuO (Fig 5-2a).   
In an attempt to produce a film with better coverage, an alternative copper 
precursor was investigated. Copper(II) acetylacetonate, [Cu(acac)2], was added to 
a solution of [Zn(NO3)2.6H2O] in methanol. The resulting solution was allowed to 
mix in a sonicator for 15 minutes however, all the [Cu(acac)2] did not dissolve in 
the solution. The same solubility problems with [Cu(acac)2] that were 
encountered in chapter 3 were observed here. A deposition was carried out at 450 
oC and the film was allowed to cool to room temperature under nitrogen. 
Undissolved [Cu(acac)2] was left in the AACVD bubbler when deposition was 
complete. Small patches of yellow films were deposited on the substrate. The films 
were not crystalline enough to produce a XRD pattern (Fig. 5-2b).  
In order to overcome the formation of mixtures and poor film coverage, an 
alternative zinc precursor was investigated. Zinc acetate dihydrate, 
[Zn(OAc)2.2H2O], was added to a solution of copper nitrate, [Cu(NO3)2.3H2O] in 
methanol. Methanol was chosen since it is a solvent that both zinc acetate and 
copper nitrate are soluble in and the temperature of deposition was chosen to be 
450 oC since previous deposition of metal oxides (chapter 4) have been shown to 
have the best coverage and reproducible films at that temperature. AACVD of zinc 
acetate with copper nitrate in methanol was carried out at 450 oC and the 
substrate was allowed to cool to room temperature under nitrogen. This 
produced a yellow film with poor coverage. Powder XRD data were used to 
identify that ZnO was deposited (Fig. 5-3a).  
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Due to the poor films and mixtures deposited using 
[Zn(OAc)2.2H2O]/[Cu(NO3)2.3H2O], copper(II) acetylacetonate [Cu(acac)2] was 
used again as a copper precursor even with the solubility issue associated with it. 
[Zn(OAc)2.2H2O] was added to a solution of [Cu(acac)2] in acetone or methanol in 
separate experiments. The resulting solution was allowed to mix in a sonicator for 
15 minutes once again, but the copper precursor do not fully dissolve. The 
deposition was carried out at 450 oC and was allowed to cool to room temperature 
under nitrogen. At the end of the depositions, some undissolved copper precursor 
remained. For the deposition using acetone, a transparent film with a blue tinge 
was deposited with good coverage. Powder XRD data identified the presence of 
ZnO (Fig. 5-3b). The deposition using methanol produced a green film with good 
coverage, which was identified as ZnO using XRD data (Fig. 5-3c). However, the 
colours of the films suggest that Cu may have been incorporated. 
 
Figure 5-2: XRD patterns of thin films deposited from Zn(NO3)2.6H2O at 450 oC 
with a) [Cu(NO3)2.3H2O] and b) Cu(acac)2. 
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Research has shown how surfactants can be used as templates for the synthesis 
of nanomaterials. Surfactants interact with precursors in the gas phase during 
AACVD deposition which can control the structure and orientation of ZnO. By 
varying the concentration of surfactants such as cetyl trimethylammonium 
bromide, [(C16H33)N(CH3)3Br] known as CTAB, the morphology of the deposited 
ZnO thin films can be altered.223–226  
The AACVD deposition of [Zn(OAc)2.2H2O]/[Cu(acac)2] in methanol was repeated 
with the addition of CTAB. The concentration of CTAB was varied between high 
(0.55 mmol) and low concentrations (0.055 mmol). The resulting solution was 
allowed to mix in a sonicator for 15 minutes. The deposition was carried out at 
500 oC and was allowed to cool to room temperature under nitrogen. At the end 
of the depositions, some undissolved copper precursor remained in the AACVD 
bubbler. The high concentration of CTAB produced dark green film with poor 
coverage whereas, low concentration of CTAB produced green films with better 
coverage. Powder XRD identified the presence of ZnO for both films (Fig. 5-4). 
Figure 5-3: XRD patterns of thin films deposited using [Zn(OAc)2.2H2O] with either a)  
[Cu(NO3)2.3H2O/MeOH], b) [Cu(acac)2/acetone] and c) [Cu(acac)2/MeOH]. 
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It was previously discussed in chapter 4 that the addition of excess oxygen sources 
such as donor functionalised alcohols can improve the properties of the as-
deposited metal oxide thin films. Donor functionalised alcohols such as 
HOCH2CH2OMe can increase the thickness of the film, producing more adhesive 
films with better coverage as well as improve TCO properties. 
The AACVD deposition of [Zn(OAc)2.2H2O]/[Cu(acac)2] in methanol was repeated 
with the addition of HOCH2CH2OMe. The resulting solution was allowed to mix in 
a sonicator for 15 minutes. The deposition was carried out at 450 oC and was 
allowed to cool to room temperature under nitrogen once again. At the end of the 
depositions, some undissolved copper precursor remained in the AACVD bubbler. 
A very dark green/blue film was deposition that covered the entire glass 
substrate. Powder XRD identified that ZnO was present (Fig. 5-4c). 
Figure 5-4: XRD patterns of thin films deposited from Zn(OAc)2/Cu(acac)2 with the 
addition of a) CTAB (low concentration), b) CTAB (high concentration) and c) 
HOCH2CH2OMe. 
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The addition of surfactants and a donor functionalised alcohol produced films 
with better coverage but influenced the appearance of the film. With these 
additions, the films deposited were darker and less transparent. This will be a 
hindrance for their potential application. A different copper precursor was 
investigated. Even though [Cu(acac)2] produced adherent films with good 
coverage, the solubility issues associated with this precursor cause a lot of waste. 
The addition of CTAB and a donor functionalised alcohol also has an effect on the 
preferred orientation exhibited. The degree of preferred orientation using Bragg’s 
crystal plane was determined using the calculation of the texture coefficient. The 
reflections analysed for the In2O3 films were 100, 002, 101, 102, 110 and 103. The 
texture coefficient was calculated using equation 4.1, explained in chapter 4. Table 
5-2 shows the extent of preferred orientation for each peak seen on the XRD (Fig. 
5-4). It is seen that the addition of CTAB with a high or low concentration grow in 
the [101] direction however the addition of the donor functionalised alcohol grow 
in the [002] direction. The (002) and (101) plane are commonly seen in ZnO thin 
films.  
Table 5-2: Texture coefficient intensity ratio for XRD peaks obtained from films deposited 
from Zn(OAc)2/Cu(acac)2 with a) CTAB (low conc), b) CTAB (high conc) and c) 
HOCH2CH2OMe. 
 100 002 101 102 110 103 
a) 1.09 0.82 1.55 0.76 1.01 0.78 
b) 1.26 0.60 1.28 0.87 1.05 0.94 
c) 0.17 2.69 0.45 1.09 0.29 1.30 
 
Copper acetate [Cu(OAc)2.H2O] was chosen since it is very soluble in methanol. 
AACVD of copper acetate mixed with zinc acetate in methanol was investigated at 
temperatures between 350 – 450 oC in separate experiments. The films formed 
had uniform coverage and were transparent with a mainly green colour. XRD was 
performed on each film that identified the presence of ZnO (Fig. 5-7). 
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5.3.1 Dual Source AACVD 
In order to deposit thin films with better coverage and produce films that are 
more reproducible, dual source AACVD can be utilized.202 This involves having the 
precursors separated in two AACVD bubblers. Each AACVD bubbler has its own 
humidifier and the aerosol droplets are carried to the AACVD reactor via nitrogen 
gas through a Y-junction to the CVD reactor. There is a potential to obtain films 
that have unique microstructure, better coverage, are free from pin-holes and are 
more reproducible due to more efficient mixing. The precursors are not in contact 
until they are in gaseous form at the Y-junction. At this point gas particles have 
the chance to interact and mix more effectively than when mixed as solids (Fig 5-
5).  
 
 
 
 
 
The zinc acetate and copper acetate reaction was repeated but used with a dual 
source AACVD set up. In one bubbler there was a mixture of Zn(OAc)2/MeOH and 
in the other, a mixture of Cu(OAc)2/MeOH (Fig. 5-6). The temperatures of the 
depositions were carried out at 350 and 450 oC. At the end of the deposition, the 
films were allowed to cool to room temperature. Both temperature conditions 
produced transparent films with mainly green colour. XRD measurements were 
performed on the thin films, which identified the presence of ZnO (Fig. 5-7).  
Figure 5-5: Diagram of dual source AACVD. 
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Using both AACVD and dual source AACVD of Zn(OAc)2 and Cu(OAc)2 in MeOH, 
green thin films were produced which were identified as ZnO. It can be seen that 
temperature has an effect on the crystallinity of the resulting film. Each AACVD 
method had crystalline XRD patterns for thin films deposited at 450 oC. However, 
the dual source AACVD set up produced films that had a ‘cleaner’ coverage. The 
films produced were free from pin-holes and had a uniform colour. Increased 
uniformity of the films coverage, colour and reproducibility is an advantage for 
the potential use of these films. The dual source AACVD procedure was chosen to 
deposit these ZnO:Cu for further investigation.   
To investigate how the copper concentration in the starting solution affects the 
deposited film, the copper concentration was varied from 1 to 8 mol%. Dual 
source AACVD was carried out using the same conditions previously described 
but the starting Cu(OAc)2/MeOH solution was varied 1, 2, 4 and 8 mol% 
concentration when compared to the Zn(OAc)2/MeOH solution. Temperature also 
has an impact on the properties of the films investigated. Therefore the 
depositions were studied between 350 – 450 oC. These ZnO:Cu films were also 
compared to pure ZnO thin films deposited from  Zn(OAc)2/MeOH mixture at 350, 
400 and 450 oC.  
Figure 5-6: Schematic diagram of Dual Source AACVD used in this investigation. 
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The ZnO:Cu thin films deposited at 350 oC were all transparent and clear. The only 
film that had a green colour was when 8 mol% copper solution was used in the 
dual AACVD system.  XRD patterns of these films were carried out, which 
identified the presence of ZnO for all the films. At this temperature, the 
crystallinity of the films were poor however, the highest concentration (Fig 5-8) 
appeared slightly more crystalline. 
The degree of preferred orientation using Bragg’s crystal plane was determined 
using the calculation of the texture coefficient. The reflections analysed for the 
ZnO films were 100, 002, 101, 102, 110 and 103. The texture coefficient was 
calculated using equation 4.1, explained in chapter 4. Table 5-3 show the extent 
of preferred orientation for each particular peak seen on the XRD. It is seen that 
ZnO film deposited at 350 oC are orientated in the [002] direction but the 
incorporation of copper changes the orientation to [101] direction which is seen 
in all the doped films.  
Figure 5-7: XRD patterns obtained from AACVD at a) 350 oC, b) 450 oC and Dual 
source AACVD at c) 350 oC and d) 450 oC.  
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Table 5-3: Texture coefficient intensity ratio for XRD peaks obtained from films deposited 
using dual source AACVD at 350 oC. 
 100 002 101 102 110 103 
ZnO 1.09 2.34 1.74 0.34 0.37 0.12 
1 mol% 1.28 1.89 2.07 0.50 0.26 0.17 
2 mol% 1.97 0.28 2.13 0.97 0.41 0.23 
4 mol% 1.25 1.31 2.56 0.59 0.28 0.16 
8 mol% 1.13 1.59 2.31 0.56 0.28 0.14 
 
 
Figure 5-8: XRD patterns obtained from dual source AACVD depositions carried out 
at 350 oC for ZnO and 1 – 8 mol% ZnO:Cu. 
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The dual source AACVD was repeated using the same conditions previously 
described using the Cu(OAc)2/MeOH solution with  1 and 4 mol% concentration 
when compared to the Zn(OAc)2/MeOH solution but were deposited at 400 oC. 
The lower copper concentration produced a clear transparent film whereas, 4 
mol% produced an uneven green transparent film (Fig. 5-9b). XRD patterns of 
these films (Fig. 5-10) indicated the presence of ZnO only. The crystallinity of the 
pure ZnO increased when deposited at this higher temperature, however the 
copper doped ZnO were not as crystalline.  The preferred orientation (Table 5-4) 
were calculated for these XRD patterns and the film deposited with 1 mol% Cu 
grow in the [002] direction and 4 mol% Cu films grow in the (101) plane. 
 
Figure 5-9: Photos of  ZnO:Cu thin films deposited using dual source AACVD at a) 
350 oC, b) 400 oC and c) 450 oC. 
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Table 5-4: Texture coefficient intensity ratio for XRD peaks obtained from films deposited 
using dual source AACVD at 400 oC. 
 100 002 101 102 110 103 
ZnO 2.01 0.69 2.61 0.28 0.36 0.06 
1 mol% 0.77 2.94 1.26 0.60 0.20 0.22 
4 mol% 1.18 1.45 2.60 0.33 0.32 0.13 
 
Once again the dual source AACVD was repeated using the same conditions 
previously described with Cu(OAc)2/MeOH solution with  1, 2, 4 and 8 mol% 
concentration when compared to the Zn(OAc)2/MeOH solution but were 
deposited at 450 oC. The films produced at this temperature are not as uniform in 
colour and not as transparent (Fig. 5-9c). At the lowest copper concentration, the 
films were brown and became a darker green as the copper concentration 
Figure 5-10: XRD patterns obtained from dual source AACVD depositions carried out 
at 400 oC for ZnO and 1 – 4 mol% ZnO:Cu. 
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increased.  XRD patterns of these films were taken, which also only identified the 
presence of ZnO (Fig 5-11). The crystallinity of the films was greater when 
compared to the films deposited at a lower temperature. Preferred orientation 
were calculated for these XRD patterns (Table 5-5) and indicated that the pure 
ZnO and Cu doped films deposited at 450 oC have preferred orientation in the 
[101] directions. It has been reported that the preferred orientation of ZnO is 
commonly in the (002) or (101) plane. The difference has been attributed to the 
temperature, zinc precursors and depositions rates.219,227–230 In this investigation, 
it has been seen that doping zinc oxide with copper and temperature causes the 
(101) plane to be dominant for most of the films deposited, whereas ZnO 
deposited at the lower temperatures of 350 oC and 400 oC have preferred 
orientation in the (002) plane.   
 
Table 5-5: Texture coefficient intensity ratio for XRD peaks obtained from films deposited 
using dual source AACVD at 450 oC. 
 100 002 101 102 110 103 
ZnO 1.75 0.78 2.82 0.23 0.35 0.06 
1 mol% 0.63 1.79 2.57 0.58 0.20 0.21 
2 mol% 0.88 1.80 2.45 0.49 0.21 0.17 
4 mol% 0.85 1.88 2.27 0.62 0.19 0.19 
8 mol% 1.36 1.29 2.54 0.39 0.27 0.15 
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It has been seen that the temperature has a big effect on the appearance of the 
films and the crystallinity of the XRD patterns obtained. All the films showed that 
the higher the copper concentration, the higher the potential for the films to have 
a green colour. The films with the most uniform appearance and transparency 
were films produced at 350 oC. Even though the crystallinity of the films were not 
as good as the films deposited at higher temperatures, it was still sufficient to 
identify the presence of ZnO. Therefore, the deposition temperature chosen for 
the rest of the depositions was 350 oC.  
 
Figure 5-11: XRD patterns obtained from dual source AACVD depositions 
carried out at 450 oC for ZnO and 1 – 8 mol% ZnO:Cu. 
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The dual source AACVD was repeated using the same conditions previously 
described however the Cu(OAc)2/MeOH solution was varied between 10 - 18 
mol% concentration when compared to the zinc starting solution and the 
deposition temperature was 350 oC. The increase in doping concentration was 
carried out to see how an increase in copper will affect the films. 
 
 
 
All the films produced at these higher doping concentrations were all green and 
got darker from 10 – 18%. XRD pattern of these films were taken and identified 
the presence of ZnO (Fig. 5-12). However, the higher doping concentrations of 16 
and 18% had a very weak peak at ~ 44o which corresponds to a copper (111) 
plane. This could indicate that at higher % mol concentrations, a composite of ZnO 
and Cu may start to deposit. These XRD patterns were more crystalline than the 
pattern taken for the lower doping concentrations showing that the increase in 
copper concentration increases the thin film crystallinity. 
Figure 5-12: XRD patterns obtained from dual source AACVD depositions 
carried out at 350 oC for 10 – 18 mol% Cu films. 
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5.3.2 Optical Properties 
Transmission and reflectance measurements were taken for the ZnO and ZnO:Cu 
(1 – 18 mol%) thin films deposited with the dual source AACVD system at 350 oC. 
All the as-deposited films displayed minimal reflectivity (5 – 15%). However 
depending on the concentration of copper, the transmission varied. As the dopant 
concentration increased, there was a decrease in transmittance observed (Fig. 5-
13a) which could be due to scattering of photons with crystals created by 
doping227 and the colour of the films changed from clear to green. Lower 
concentration of copper doped ZnO thin films have higher transmittance with 
sharp absorption edges.  
The UV/Visible absorption spectrum of pure ZnO and Cu doped ZnO thin films 
were investigated at room temperature. As shown in Fig. 5-13b, the optical 
absorption spectra change after Cu doping increase above 8 mol%. The optical 
absorption observed from these materials can be a result of an exciton peak at 
energy corresponding to their band gap.231,232 
 
5.3.3 Band Gap 
The optical band gap values were calculated from Tauc plots and found to 
decrease from 3.2 to 2.9 eV (Table 5-2) with increased Cu concentration. This 
could be due to the higher electronegativity of the Cu-dopant to Zn host, 1.9 and 
1.65 respectively.  
It has been reported that the incorporation of copper (x – 10%) can lower the 
band gap of ZnO by ~ 0.21 eV. Studies have shown that O 2p and Cu 3d bands are 
closely matched in energy. The band gap reduction with increase in Cu doping 
concentration is consistent with results coming from the first-principles 
calculation based on density functional theory.233,234 
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Table 5-6: Band gap measurements calculated using a Tauc plot. 
Cu 
mol% 
Band Gap 
/ eV 
1 3.32 
2 3.31 
4 3.34 
8 3.09 
10 3.10 
12 3.06 
14 3.02 
16 2.86 
18 2.87 
 
Figure 5-13: a) Optical transmission spectrum taken against an air background showing 
ZnO and 1 – 18 mol% ZnO:Cu thin films, b) UV/Visible absorbance spectrum for ZnO and 1 - 
18 mol% ZnO:Cu films.  
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Overall the techniques have indicated that the films produced have adopted a 
wurtzite ZnO structure with varying amounts of Cu incorporated into the films. As 
the copper percentage increases, the appearance of the films became darker, 
intense green colour and less transparent. XRD patterns have shown that at the 
highest % mol Cu concentration, a Cu peak was starting to develop suggesting that 
a composite may have been produced. The aim of depositing ZnO:Cu films is to 
test their antimicrobial effectiveness. Therefore the ZnO:Cu films most 
appropriate for testing are between 1 – 10 mol% ZnO:Cu. As a result, these films 
will be further analysed.  
 
5.3.4 Scanning Electron Microscopy (SEM) 
SEM images were taken in secondary electron mode at 5kV and the samples were 
coated with gold before images were taken to avoid charging, as these samples 
are non-conducting. The microstructure of the films with pure ZnO, and films with 
starting copper concentrations of 1 - 10 mol% (Fig. 5-14) was found to vary.   
The pure ZnO films deposited using Zn(OAc)2/MeOH produced a microstructure 
composed for particles of different sizes. This size ranged from 100 – 600 nm. This 
morphology changed when copper was incorporated into the film. For the films 
using 1% copper concentration of Cu(OAc)2/MeOH produced films made of 
uniform smaller particles at a range between 50 – 100 nm. As the copper 
concentration increases, the size of the particles increase and the size of the 
particles become more uniform.  
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Figure 5-14: SEM images of a) ZnO and ZnO:Cu films b) 1 mol% Cu, c) 2 mol% Cu, d) 4 
mol% Cu, e) 8 mol% Cu and f) 10 mol% Cu. 
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5.3.5 EDX Measurements 
EDX analysis was utilised to obtain composition of the films and carried out to 
determine the stoichiometry of the ZnO:Cu thin films grown with the various 
copper concentrations. The measurements of the films with starting copper 
concentrations of 2, 4 and 8 mol% were studied since these were the best films 
deposited.  
Table 5-7: EDX measurements taken from the ZnO:Cu thin films. 
ZnO:Cu Zn/Atomic % Average Cu/Atomic % Average 
2 mol% 30.9 25.3 26.1 27.5 0.2 0.2 0.5 0.3 
4 mol% 32.8 30.3 26.5 29.9 0.8 1.1 1.1 1.0 
8 mol% 28.8 32.1 25.9 28.9 1.0 1.3 1.4 1.2 
 
The EDX measurements have shown that the ratio of Zn to Cu at the start of the 
AACVD deposition was different to the amount of copper detected in the films. The 
films with 2 mol% copper concentration from the starting material produced 
films with an average of 0.3 at% Cu in the film whereas, 4 mol% copper 
concentration deposited films with 1.0 at% Cu. For the thin films deposited with 
8 mol% Cu for the starting solution produced films with 1.2 at% Cu. As the copper 
precursor concentration increases, more copper is incorporated into the film.  
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5.3.6 X-ray photoelectron spectroscopy 
XPS was carried out on the three ZnO:Cu films to determine the oxide species on 
the surface of the film. Only the 2, 4 and 8 mol% films were analysed since they 
were the best films and the most transparent. The peaks observed after analysis 
of the surface of the film were modelled and the binding energy values compared 
to literature values to identify the compounds of the film. 
The presence and oxidation state of copper were investigated for the ZnO:Cu (2, 4 
and 8 mol%). The binding energy of Cu 2p3/2 were 932.5, 932.2 and 933.0 eV for 
2, 4 and 8 mol% ZnO:Cu respectively. The binding energies correspond to Cu2+ 
and Cu1+ but there were no satellite peaks observed, which are characteristic of 
Cu2+. The binding energies of Cu 2p1/2 were at 952.2, 952.1 and 952.8 eV for 2, 4 
and 8 mol% ZnO:Cu respectively. This suggests that the copper species present at 
the surface of the films are Cu1+.196  
The characteristic peaks for the Zn 2p3/2 and 2p1/2 states appeared at 1021.3 and 
1044.4 eV for 2 mol% ZnO:Cu respectively. This was similar to the values for 4 
mol% ZnO:Cu that were are 1021.5 and 1044.6 eV. The 8 mol% ZnO:Cu also had 
value for Zn 2p3/2 and 2p1/2 states were 1021.3 and 1044.3 eV respectively. These 
values correspond to Zn2+ found in ZnO. This confirms the presence of ZnO on the 
surface of all the films.202,227  
Zn and Cu have been identified on the surface of all the ZnO:Cu analysed. It has 
been identified as ZnO and Cu2O. Quantification using peak areas determined by 
the Shirley method and empirical sensitivity factors gave a copper to zinc ratio of 
1:111 for the 2 mol% Cu, 1:114 for the 4 mol% Cu and 1:129 for the 8 mol% Cu at 
the surface. This differs from the ratio obtained from EDX measurements that 
were 1:53, 1:24 and 1:23 for 2, 4 and 8 mol% Cu respectively. This difference can 
be related to XPS being a surface sensitive technique whereas, EDX can penetrate 
into the bulk of the material. This indicates that there may be more copper present 
in the bulk of the films rather than the surface and it is also seen that the % mol 
Cu increases, there is less Cu on the surface and more in the bulk. 
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Figure 5-15: XPS for ZnO:Cu thin films of Zn 2p and Cu 2p for a) 2 mol%, 
b) 4 mol% and c) 8 mol%. 
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5.3.8 Raman Analysis 
Raman spectroscopy was used to further characterise the resulting films and 
characteristic Raman peaks were observed for all films with the strongest band 
appearing ~ 440 cm-1 with a weaker band at ~ 570 cm-1. These two weak peaks 
correspond to characteristic wurtzite E2 (high) mode and A1 longitudinal optical 
(LO) mode for ZnO.235  
 
5.3.7 X-ray absorption spectroscopy 
X-ray absorption near edge structure (XANES) were performed on the ZnO thin 
films. Cu k-edge XANES data for the samples are shown in Fig. 5-16 along with the 
corresponding data for metal powders: Cu, Cu2O and CuO. The energy scales of all 
the spectra have been consistently normalised. The local environment of the Cu 
can have an effect on the shape of the XANES spectra making it easier to identify 
the local environment of the Cu present in the ZnO:Cu films. In this case, the 
XANES spectra for the 8 mol% ZnO:Cu films match that of Cu and Cu2O standards 
indicating that both are present in the film. This is comparable to the XPS data 
indicating the presence of Cu1+ on the surface of 8 mol% Cu film.  
The XANES spectra for 2 and 4 mol% ZnO:Cu films data is noisy and roughly match 
that of CuO standard indicating that copper is present in the film in the form of 
Cu2+. This does not match with the XPS data analysed indicating that there is a 
need to redo these XANES experiments to be able to fully characterise the local 
environment of the copper incorporated into the ZnO. 
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Figure 5-16: Normalised copper K-edge XANES spectra for Cu, Cu2O, CuO and 
the ZnO:Cu thin film sample. 
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5.4 Antimicrobial Activity of ZnO and ZnO:Cu 
The antimicrobial activity of a series of copper doped zinc oxide thin films 
deposited onto microscope slides were determined using a gram-negative 
organisms that is commonly found in hospital environments, E. coli. Samples were 
cut into 1 x 1 cm sections and were covered with 25 µL of bacterial suspension 
containing approximately 105 cfu.  For each experiment, a set of samples were 
illuminated with a white light source (28 W), emitting an average light intensity 
of 3750 lux at a distance of 30 cm from the sample. In all experiments, a control 
sample set was maintained in parallel and were stored under dark conditions for 
the same exposure times. This fluorescent lamp emits light across the visible 
region of the spectrum similar to those commonly found in UK hospitals. The 
white light intensity used in this is more intense (3x times larger) than what is 
found in A&E wards. However, the microbial loads used in these experiments are 
greater than those found on touch surfaces in healthcare institutions. Serial 
dilution and viable colony counts on agar with subsequent overnight incubation 
at 37 oC was performed. The resultant viable counts of bacteria for each sample 
section was determined. The results for ZnO and ZnO:Cu films are shown in Fig. 
5-17, demonstrate that the films have antimicrobial activity against E. coli with 
glass controls. Each point represents the log10 of the mean number of viable 
bacteria from three samples and error bars represent the calculated standard 
error.   
The light-activated and bactericidal activities of pure ZnO and doping ratio (to 
copper) of ZnO:Cu were tested. A range of samples were tested to deduce whether 
ZnO had antimicrobial activity and how the incorporation of copper affected the 
efficacy. At 3 hour exposure time (Fig 5-17a), all the films had an increase in 
activity in the light (L+) rather than the dark (L-) except for the 8% ZnO:Cu which 
had the same bacterial reduction rate for both conditions (1.3 log10, P <0.01). After 
6 hours, the 2 and 4% ZnO:Cu had a bacterial reduction of 4 log10 only when 
illuminated with white light. This is the same reduction observed for 8 mol% ZnO 
in light and dark (Fig. 5-17b). The exposure time was extended to 18 hours, all the 
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ZnO:Cu had a 4-log10 (P < 0.001) reduction as well as the pure ZnO but only when 
illuminated.  
The antimicrobial activity of the copper doped ZnO thin films were significantly 
better than the pure ZnO. Pure ZnO did possess a reduction rate that was 
significant but only when illuminated with white light. The most effective 
antimicrobial surface was the green 8 mol% ZnO:Cu thin film that showed high 
effectiveness in the light as well as in the dark. This can be due to the increase in 
copper doped into the thin films. The increase in activity of the ZnO films in the 
light corresponds with the studies showing the increase in the production of ROS 
when illuminated. The increase in ROS can cause the increase in microbial death. 
With the incorporation of copper, the ZnO:Cu have a number of mechanisms that 
can cause the death of the bacteria cells.209,218  
 
  165 
 
Figure 5-17: Viable counts of bacteria after incubation on ZnO, ZnO:Cu thin films 
and glass control  tested against E. coli for a) 3 hours, b) 6 hours and c) 18 hours. 
(L+ = illuminated and L- = not illuminated (in the dark). 
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5.5 Conclusion  
This investigation showed [Zn(OAc)2.2H2O] and [Cu(NO3)2.3H2O] as the 
precursors that produced adhesive, reproducible thin films with complete 
coverage. Dual source AACVD uses two separate AACVD bubblers with their own 
humidifier. The aerosol droplets join at the Y-junction for more effective mixing. 
The molar concentration, deposition temperature were varied and saw that the 
appearance, crystallinity and preferred orientation changed.  
The antimicrobial effectiveness of ZnO and ZnO:Cu (2, 4 and  8 mol%) thin films 
deposited via AACVD was investigated. Microbiological analysis saw that ZnO 
possess antibacterial properties and are increased in the presence of white light. 
The bactericidal activity of the films significantly increased with the incorporation 
of copper. As the copper atomic percentage increased (0.31, 0.99 and 1.23 at% 
Cu), the microbial reduction increased. It was also seen that illumination of the 
films increased the antimicrobial effectiveness of the ZnO:Cu apart from the 8 
mol% films, which had the same microbial reduction in the light and dark.     
 
 
 
 
 
 
 
 
 
  
167 
 
 
 
 
 
 
 
 
 
 
 
Conclusion and Future Work  
 
The abundance and prevalence of nosocomial infections caused by MDR bacteria has 
emphasized the need for new strategies to combat the spread of infections. One 
approach is the utilisation of antibacterial surfaces. This thesis describes the 
development of potential antimicrobial coatings deposited via AACVD.   
6 
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6. Conclusion 
 
Hospital acquired infections (HAI) remain a significant problem in healthcare 
institutions where touch surfaces are known to harbour bacteria. These microbes 
can be transmitted from the hospital environments to patients and healthcare 
workers via the most common vehicle of transmission, unwashed hands. If the 
bacterial load on these touch surfaces can be reduced, the acquisition and 
onwards transmission of nosocomial infections can also be decreased. The use of 
self-cleaning coatings applied to touch surfaces, along with strict hospital hygiene 
measures can potentially reduce infection rates.  
The coatings investigated in this thesis are 1) copper, 2) copper(I) oxide, 3) 
gallium oxide, 4) copper gallium oxide, 5) zinc oxide and 6) copper doped zinc 
oxide. To produce these films, a technique known as aerosol assisted chemical 
vapour deposition (AACVD) was used. This technique involves the formation of 
an aerosol through the dissolution of a precursor in a solvent. AACVD depends on 
solubility rather than the volatility of the precursors. AACVD is a useful method 
for depositing antimicrobial coatings because it is an industrially scalable process. 
A major advantage for AACVD is the ability to deposit on a wide range of 
substrates including the commonly used materials on touch surfaces in hospitals 
such as stainless steel. A wide range of analytical techniques were performed on 
the thin films that included powder XRD, SEM, XPS, and XAS.  
In order to test the bactericidal properties of these coatings, they were tested 
against E. coli and S. aureus that are bacteria which commonly cause HAIs. A 
standard technique in microbiology was preformed known as serial dilution and 
viable colony counting on to agar medium. All testing was duplicated and Mann 
Whitney analysis was performed to determine the statistical significance of the 
data. The results obtained from the different antimicrobial thin films tested are 
summarised in Table 6-1.  
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Table 6-1: Antimicrobial activity results of thin films deposited discussed in this thesis.   
Thin Film 
AACVD deposition 
conditions 
Species 
Bacterial 
reduction 
(log10) 
Time 
Cu 
Cu(NO3)2.3H2O/MeOH 
cool in N2 
E. coli 4 30 min 
S. aureus 4 60 min 
Cu2O 
Cu(NO3)2.3H2O/MeOH 
cool in air 
E. coli 2.7 60 min 
S. aureus 4.7 60 min 
Ga2O3 GaMe3/MeOH 
E. coli 0.9 24 h 
S. aureus 1.2 24 h 
Ga2O3-
Cu2O 
GaMe3/ 
Cu(NO3)2.3H2O/MeOH 
E. coli 4 24 h 
S. aureus 4 24 h 
ZnO Zn(OAc)2.2H2O/MeOH E. coli 
L+ 4 18 h 
L- 1.4 18 h 
2 mol% 
ZnO:Cu 
Dual AACVD 
1. Zn(OAc)2.2H2O/MeOH 
2. Cu(OAc)2.H2O/MeOH 
E. coli 
L+ 4 6 h 
L- 4 18 h 
4 mol% 
ZnO:Cu 
E. coli 
L+ 4 6 h 
L- 4 18 h 
8 mol% 
ZnO:Cu 
E. coli 
L+ 4 6 h 
L- 4 6 h 
 
The copper and copper(I) oxide thin films exhibited highly significant microbial 
reduction in a short time period. When compared to other thin films discussed in 
this thesis, these Cu and Cu2O films were the most effective, the closest coatings 
to these are ZnO:Cu film illuminated in white light at 6 hours.  The inclusion of the 
copper increased the antibacterial efficacy by 12 hours. This increase was also 
observed with the Ga2O3-Cu2O films. Pure ZnO (not illuminated, L-) was a more 
effective antimicrobial material when compared to Ga2O3. There is more potential 
in the ZnO thin films due to the transparency and the observed increase in activity 
in the light. Whereas, Ga2O3 gain significant microbial reduction with the 
incorporation of copper.    
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From this thesis investigation, it is obvious that copper is a candidate that should 
be further explored for antimicrobial materials. The incorporation of this natural 
antibacterial agent into metal oxide thin films can potentially produce highly 
effective coating as well as maintaining transparency. Films can be used for a wide 
range of applications and be coated on different types of substrates using AACVD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
171 
6.1 Future Work 
 
In the future to further this work quantification and an analysis of ions produced 
in solution and possible formation of radicals via techniques such as ICP-ES and 
EPR would be helpful. Other studies have carried out similar testing on films but 
were not attempted for this thesis. It would be of interest to analyse the 
mechanism of kill on microbes from these thin films.  
Some differences in bacterial reduction rate were observed between gram 
positive and gram negative strains. Increasing the number of bacteria types could 
help identify a pattern due to the difference in microbial cell walls.   
Silver is another natural antimicrobial metal and could be deposited along with 
silver oxide to see how the antimicrobial activity compares to the copper films 
investigated in this thesis. Doping silver into metal oxide such as ZnO could be 
used to further investigate the potential of ZnO.  
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Vahlas, Electrochem. Solid-State Lett., 2011, 14, 26-29. 
134 M. Hans, A. Erbe, S. Mathews, Y. Chen, M. Solioz and F. Mücklich, Langmuir, 
2013, 29, 16160–16166. 
135 G. A Ozin, C. Arsenault and L. Cademartiri, Mater. Today, 2009, 12, 46. 
136 K. Kelly and E. Coronado, J. Phys. Chem. B, 2003, 107, 668–677. 
137 W. J. Stark, Angew. Chemie - Int. Ed., 2011, 50, 1242–1258. 
138 S. Prabhu and E. K. Poulose, Int. Nano Lett., 2012, 2, 32. 
139 M. D. Rolfe, C. J. Rice, S. Lucchini, C. Pin, A. Thompson, A. D. S. Cameron, M. 
Alston, M. F. Stringer, R. P. Betts, J. Baranyi, M. W. Peck and J. C. D. Hinton, J. 
Bacteriol., 2012, 194, 686–701. 
140 I. A. M. Swinnen, K. Bernaerts, E. J. J. Dens, A. H. Geeraerd and J. F. Van 
Impe, Int. J. Food Microbiol., 2004, 94, 137–159. 
141 C. R. Crick and I. P. Parkin, J. Mater. Chem., 2011, 21, 14712. 
142 L. L. Hench and D. E. Clark, J. Non-Cryst. Solids, 1978, 28, 83–105. 
143 D. J. Semin and K. L. Rowlen, Anal. Chem., 1994, 66, 4324–4331. 
144 R. Ghosh, D. Basak and S. Fujihara, J. Appl. Phys., 2004, 96, 2689–2692. 
  
178 
145 M. E. Straumanis and L. S. Yu, Acta Crystallogr. Sect. A, 1969, 25, 676–682. 
146 S. Poulston, P. M. Parlett, P. Stone and M. Bowker, Surf. Interface Anal., 
1996, 24, 811–820. 
147 S. L. Warnes, V. Caves and C. W. Keevil, Environ. Microbiol., 2012, 14, 
1730–1743. 
148 S. L. Warnes and C. W. Keevil, Appl. Environ. Microbiol., 2011, 77, 6049–59. 
149 H. T. Michels, J. O. Noyce and C. W. Keevil, Lett. Appl. Microbiol., 2009, 49, 
191–195. 
150 H. M. Yates, L. A. Brook, D. W. Sheel, I. B. Ditta, A. Steele and H. A. Foster, 
Thin Solid Films, 2008, 517, 517–521. 
151 G. A. Pankey and L. D. Sabath, Clin. Infect. Dis., 2004, 38, 864–870. 
152 J. P. Ruparelia, A. K. Chatterjee, S. P. Duttagupta and S. Mukherji, Acta 
Biomater., 2008, 4, 707–716. 
153 V. V. T. Padil and M. Černík, Int. J. Nanomedicine, 2013, 8, 889–898. 
154 A. Azam, A. S. Ahmed, M. Oves, M. S. Khan and A. Memic, Int. J. 
Nanomedicine, 2012, 7, 3527–3535. 
155 T. Minami, MRS Bull., 2000, 25, 38–44. 
156 G. Kiriakidis and N. Katsarakis, J. Phys. Condens. Matter, 2004, 16, 3757–
3768. 
157 C. G. Granqvist and A. Hultåker, Thin Solid Films, 2002, 411, 1–5. 
158 E. L. Ratcliff, J. L. Jenkins, K. Nebesny and N. R. Armstrong, Society, 2008, 
11, 414–420. 
159 S. Lany and A. Zunger, Phys. Rev. Lett., 2007, 98, 045501. 
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